<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://biotechlicense.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.9.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.2" -->
<!-- generated-on="January 8, 2010 2:32 pm" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://biotechlicense.com/</loc>
		<lastmod>2010-01-08T14:30:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology.html</loc>
		<lastmod>2010-01-08T14:30:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.4</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vira-biotech-stock-how-to-you-find-it-to-purchase-online.html</loc>
		<lastmod>2010-01-08T14:29:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.4</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech.html</loc>
		<lastmod>2010-01-08T14:29:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/law-offices-of-howard-g-smith-announces-investigation-on-behalf-of-shareholders-of-hemispherx-biopharma-inc.html</loc>
		<lastmod>2010-01-07T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology-program-health-sciences-bcit.html</loc>
		<lastmod>2010-01-06T19:46:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech-image-gallery.html</loc>
		<lastmod>2010-01-05T20:28:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech-news-and-videos.html</loc>
		<lastmod>2010-01-05T19:42:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/zinc-finger-techniques-could-be-gene-therapy-breakthrough.html</loc>
		<lastmod>2010-01-05T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/advaxis-awarded-european-patent-for-new-listeria-vector.html</loc>
		<lastmod>2010-01-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neopharm-announces-ind-filing-for-il13-pe38qqr-for-the-treatment-of-idiopathic-pulmonary-fibrosis.html</loc>
		<lastmod>2010-01-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/snpedias-top-ten-snps-of-the-year.html</loc>
		<lastmod>2010-01-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/checking-in-on-the-century-of-biology.html</loc>
		<lastmod>2009-12-31T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/astrazeneca-saves-150m-with-better-data-management.html</loc>
		<lastmod>2009-12-29T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/23andme-gains-27-8-million-in-funding.html</loc>
		<lastmod>2009-12-28T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cosmeceutical-factors-for-anti-aging-applications.html</loc>
		<lastmod>2009-12-22T09:18:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/e-us-01-clinically-proven-formula-to-support-kidney-health-2.html</loc>
		<lastmod>2009-12-22T09:18:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/finkelstein-thompson-llp-announces-investigation-of-javelin-pharmaceuticals-inc.html</loc>
		<lastmod>2009-12-22T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/santarus-receives-previously-announced-20-million-milestone-for-fda-approval-of-zegerid-otc.html</loc>
		<lastmod>2009-12-22T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/arena-pharmaceuticals-submits-new-drug-application-to-fda-for-lorcaserin-for-weight-management.html</loc>
		<lastmod>2009-12-22T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/shire-submits-biologics-license-application-bla-for-replagalr-with-the-u-s-food-and-drug-administration-fda.html</loc>
		<lastmod>2009-12-22T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/goldshield-is-looking-for-ready-pharma-registrations.html</loc>
		<lastmod>2009-12-21T09:17:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fibrocell-science-inc-receives-fda-complete-response-letter-regarding-azficel-t-for-wrinkles.html</loc>
		<lastmod>2009-12-21T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nstar-to-sell-district-energy-operations-in-boston%e2%80%99s-longwood-medical-area.html</loc>
		<lastmod>2009-12-21T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/european-medicines-agency-grants-cell-therapeutics-orphan-drug-designation-for-pixantrone-in-diffuse-large-b-cell-lymphoma-dlbcl.html</loc>
		<lastmod>2009-12-20T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-peptide-coated-stent-device-recruiting-endothelial-progenitor-cells-for-prevention-of-in-stent-thrombosis.html</loc>
		<lastmod>2009-12-18T08:09:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-behavioral-bioassay-for-preclinical-testing-and-characterization-of-cns-agents.html</loc>
		<lastmod>2009-12-18T08:09:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/silencing-of-mortalin-with-sirna-as-adjuvant-for-cancer-immunotherapy.html</loc>
		<lastmod>2009-12-18T08:09:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-phenanthridin-pj-34-as-a-potential-treatment-for-human-non-hereditary-cancers.html</loc>
		<lastmod>2009-12-18T08:09:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/system-to-map-neuropathy-in-extremities-of-diabetic-patients.html</loc>
		<lastmod>2009-12-18T08:09:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/targeting-cancer-and-bone-metastases-with-novel-anti-angiogenic-polymer-therapeutics.html</loc>
		<lastmod>2009-12-18T08:09:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gene-tests-for-diagnostics-of-psychiatric-disorders.html</loc>
		<lastmod>2009-12-18T08:09:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/an-inhibitor-to-the-beta-secretase-pathway-of-a-beta-generation-in-alzheimers-disease.html</loc>
		<lastmod>2009-12-18T08:09:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cell-permeable-peptides-for-the-treatment-of-allergy-asthma-and-inflammatory-related-diseases.html</loc>
		<lastmod>2009-12-18T08:09:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-bioactive-marine-sponge-derived-natural-compounds.html</loc>
		<lastmod>2009-12-18T08:09:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisition-of-uk-primary-care-ethical-brands.html</loc>
		<lastmod>2009-12-17T07:52:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lung-cancer-and-melanoma-mapped.html</loc>
		<lastmod>2009-12-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/somaxon-scheduled-to-meet-with-fda-to-discuss-complete-response-letter-for-silenor%c2%ae-nda.html</loc>
		<lastmod>2009-12-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-advisory-committee-voted-favourably-to-photocures-new-drug-application-in-usa-for-hexvix.html</loc>
		<lastmod>2009-12-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/george-churchs-challenge-to-the-genomics-generation.html</loc>
		<lastmod>2009-12-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/chemgenex-pharmaceuticals-announces-omapro%e2%84%a2-to-be-reviewed-by-the-fda%e2%80%99s-oncologic-drugs-advisory-committee-for-the-treatment-of-adults-with-chronic-myeloid-leukemia-who-have-failed-pri.html</loc>
		<lastmod>2009-12-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/adriana-announces-c4-million-flow-through-financing-and-new-chairman.html</loc>
		<lastmod>2009-12-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vengrowth-i-and-vengrowth-ii-funds-announce-shareholder-approval-of-b-c-continuance-and-distribution-amounts.html</loc>
		<lastmod>2009-12-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lytix-biopharma-as-announces-regulatory-approval-by-norwegian-and-swedish-authorities-to-commence-phase-i-clinical-trial-of-oncoporetm-ltx-315-in-cancer.html</loc>
		<lastmod>2009-12-15T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-genome-sciences-announces-submission-of-marketing-authorization-application-to-emea-for-joulferon%c2%ae-zalbin%e2%84%a2.html</loc>
		<lastmod>2009-12-15T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fenwal-receives-fda-approval-for-new-solution-used-to-store-donated-blood-platelets.html</loc>
		<lastmod>2009-12-15T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/india-says-it-has-joined-personal-genome-sequencing-club.html</loc>
		<lastmod>2009-12-14T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/big-pharma-adopting-orphan-drug-strategy.html</loc>
		<lastmod>2009-12-14T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alexza-announces-submission-of-az-004-staccator-loxapine-nda.html</loc>
		<lastmod>2009-12-14T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/celsion-announces-treatment-of-first-patient-in-china-in-global-phase-iii-thermodox%c2%ae-trial-for-primary-liver-cancer.html</loc>
		<lastmod>2009-12-14T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/positive-h1n1-swine-flu-virus-initial-pilot-animal-study-may-support-use-of-sinofresh-nasal-spray-as-preventative-measure.html</loc>
		<lastmod>2009-12-14T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genetics-of-asian-migration.html</loc>
		<lastmod>2009-12-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vaaldiam-resources-ltd-private-placement.html</loc>
		<lastmod>2009-12-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-nu-bite-block-%e2%80%93-a-better-endotracheal-solution-for-ventilators-10-02.html</loc>
		<lastmod>2009-12-11T06:24:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lannett-receives-fda-approvals-for-hydromorphone-hydrochloride-tablets-usp-2-mg-4-mg-and-8-mg-strengths.html</loc>
		<lastmod>2009-12-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/azaya-therapeutics-receives-fda-authorization-to-start-phase-i-cancer-trial.html</loc>
		<lastmod>2009-12-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-grants-cequent-ind-clears-way-for-first-ever-clinical-trial-of-orally-delivered-rnai-therapeutic-ceq508-a-tkrnai-drug-candidate-in-oncology.html</loc>
		<lastmod>2009-12-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/protalix-completes-nda-submission-for-taliglucerase-alfa-for-the-treatment-of-gaucher%e2%80%99s-disease.html</loc>
		<lastmod>2009-12-09T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/goldsource-commences-drilling-on-manitoba-coal-permits.html</loc>
		<lastmod>2009-12-08T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/timminco-settles-outstanding-payable-through-issuance-of-shares.html</loc>
		<lastmod>2009-12-08T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neoprobe-files-phase-3-report-with-fda.html</loc>
		<lastmod>2009-12-08T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dextromethorphan-sr-suspension-30mg.html</loc>
		<lastmod>2009-12-08T06:03:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/slimminganti-obesity-capsule.html</loc>
		<lastmod>2009-12-08T06:03:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clinical-trial-supply-services.html</loc>
		<lastmod>2009-12-08T06:03:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nxa-inc-appoints-new-directors-and-senior-officers.html</loc>
		<lastmod>2009-12-07T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/somaxon-receives-complete-response-letter-from-the-fda-for-silenor%c2%ae-nda.html</loc>
		<lastmod>2009-12-07T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/getz-industry-trends-suggest-more-trials-will-go-to-top-sites.html</loc>
		<lastmod>2009-12-07T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/chinese-group-plans-third-gen-sequencing-instrument.html</loc>
		<lastmod>2009-12-07T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biogen-raises-bid-for-facet.html</loc>
		<lastmod>2009-12-07T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/carfilzomib-safety-data-from-ongoing-phase-2b-pivotal-trial-in-relapsed-and-refractory-multiple-myeloma-show-promising-safety-and-tolerability.html</loc>
		<lastmod>2009-12-06T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eczema-cream.html</loc>
		<lastmod>2009-12-05T05:17:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dry-mouth-spray.html</loc>
		<lastmod>2009-12-05T05:17:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bladder-infection-capsule.html</loc>
		<lastmod>2009-12-05T05:17:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anal-fissure-wipes.html</loc>
		<lastmod>2009-12-05T05:17:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/drape-adhesive-plus-antimicrobial-eg-p-iodine-or-other-antimicrobial.html</loc>
		<lastmod>2009-12-05T05:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/wart-removal-pen.html</loc>
		<lastmod>2009-12-05T05:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vaginal-discomfort-capsules.html</loc>
		<lastmod>2009-12-05T05:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nail-fungus-pen.html</loc>
		<lastmod>2009-12-05T05:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-approves-initiation-of-clinical-studies-in-the-u-s-for-t2000-taro%e2%80%99s-proprietary-non-sedating-barbiturate-compound.html</loc>
		<lastmod>2009-12-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/santarus-receives-fda-approval-for-immediate-release-omeprazole-tablet-with-dual-buffers.html</loc>
		<lastmod>2009-12-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/crown-minerals-announces-500000-non-brokered-private-placement.html</loc>
		<lastmod>2009-12-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/st-jude-medical-receives-fda-approval-for-industry-first-five-column-neurostimulation-lead-to-manage-chronic-pain.html</loc>
		<lastmod>2009-12-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/us-fda-approves-seroquel-xrr-for-add-on-treatment-of-major-depressive-disorder.html</loc>
		<lastmod>2009-12-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-intestinal-regions-and-characterized-subcellular-factions-from-duodenum-small-intestine-and-the-colon-99-22.html</loc>
		<lastmod>2009-12-04T05:03:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/secreting-products-from-skin-by-adeno-associated-virus-aav-gene-transfer-99-29.html</loc>
		<lastmod>2009-12-04T05:03:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-of-producing-infectious-papillomavirus-in-placental-cells-00-20.html</loc>
		<lastmod>2009-12-04T05:03:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-for-screening-a-therapeutic-agent-of-heart-failure-fibrosis-and-inflammation-and-compositions-comprising-the-same.html</loc>
		<lastmod>2009-12-04T05:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/total-heeling-topical-for-heel-fissures-xerosis-cracked-or-dry-skin.html</loc>
		<lastmod>2009-12-04T05:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-method-of-human-therapy-using-wildtype-adeno-associated-viral-aav-vectors-96-11.html</loc>
		<lastmod>2009-12-04T05:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mast-r-calc-psoriasis-topical-with-calcipotriene.html</loc>
		<lastmod>2009-12-04T05:03:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/istodax%c2%ae-incorporated-into-nccn-clinical-practice-guidelines-in-oncology%e2%84%a2-for-the-treatment-of-cutaneous-t-cell-lymphoma-ctcl.html</loc>
		<lastmod>2009-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/radient-pharmaceuticals-receives-korean-fda-approval-for-routine-clinical-testing-and-government-reimbursement-for-its-onko-suretm-in-vitro-diagnostic-cancer-test.html</loc>
		<lastmod>2009-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amneal-receives-fda-approval-for-nizatidine-oral-solution-the-first-generic-oral-solution-for-axid%c2%ae-in-the-market.html</loc>
		<lastmod>2009-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-patient-advocacy-coalition-led-by-the-international-myeloma-foundation-and-the-mds-foundation-says-its-cancer-patient-statement-of-principles-gains-momentum-going-into-the-ash-cancer-conference.html</loc>
		<lastmod>2009-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/celsion-provides-update-on-progress-of-thermodox%c2%ae-phase-iii-study-for-primary-liver-cancer.html</loc>
		<lastmod>2009-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/devices-for-sexual-well-being-2.html</loc>
		<lastmod>2009-12-03T04:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/consumer-diagnostics.html</loc>
		<lastmod>2009-12-03T04:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/barrier-protection.html</loc>
		<lastmod>2009-12-03T04:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-to-treat-warts-and-verrucae-2.html</loc>
		<lastmod>2009-12-03T04:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-to-treat-foot-infections-2.html</loc>
		<lastmod>2009-12-03T04:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-treating-problems-with-the-foot-and-leg-2.html</loc>
		<lastmod>2009-12-03T04:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microbicides.html</loc>
		<lastmod>2009-12-03T04:49:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/intimate-lubricants-and-massage.html</loc>
		<lastmod>2009-12-03T04:49:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/intimate-hygiene.html</loc>
		<lastmod>2009-12-03T04:49:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sexual-performance-enhancement-products.html</loc>
		<lastmod>2009-12-03T04:49:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/iambiotech-interviews-ricardo-llamas-at-san-diego-biotechnology-network-event.html</loc>
		<lastmod>2009-12-02T17:14:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sequencer-market-heats-up.html</loc>
		<lastmod>2009-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lilly-and-jubilant-extend-partnership.html</loc>
		<lastmod>2009-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/javelin-pharmaceuticals-submits-dyloject%e2%84%a2-new-drug-application-to-fda-for-management-of-acute-moderate-to-severe-pain-in-adults.html</loc>
		<lastmod>2009-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/study-finds-logging-effects-vary-based-on-a-forests-history-climate.html</loc>
		<lastmod>2009-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/some-birds-listen-instead-of-look-for-mates.html</loc>
		<lastmod>2009-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/iambiotech-interviews-ivan-tesic-at-san-diego-biotechnology-network-october-29th-event.html</loc>
		<lastmod>2009-12-01T17:59:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/smarter-cancer-strategies.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/smarter-cancer-strategies.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dyax-announces-fda-approval-of-kalbitor%c2%ae-ecallantide-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-in-patients-16-years-of-age-and-older.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/santarus-announces-fda-approval-of-schering-plough-healthcare-products%e2%80%99-zegerid-otc.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/harvest-technologies-announces-trial-results-in-its-india-study-using-bmac-to-treat-patients-with-non-reconstructable-critical-limb-ischemia.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/firstgold-satisfies-working-capital-financing-condition.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ecometals-announces-drilling-to-start-at-rio-zarza-gold-project-ecuador.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/teva-announces-the-submission-of-a-biologics-license-application-bla-for-xm02-for-the-treatment-of-chemotherapy-induced-neutropenia.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/osteotechs-plexur-mr-innovative-grafting-now-approved-for-use-at-50-u-s-hospitals.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/avioq-receives-fda-approval-for-anti-hiv-1-microelisa-system-for-detection-of-antibodies-to-hiv-1-in-serum-plasma-dried-blood-spots-or-oral-fluid-specimens-obtained-with-the-orasure%c2%ae-hiv-1-ora.html</loc>
		<lastmod>2009-12-01T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-detoxification-method.html</loc>
		<lastmod>2009-12-01T04:10:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amylin-amazon-and-the-cloud.html</loc>
		<lastmod>2009-11-30T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cytoplasmic-transduction-peptide-and-its-uses.html</loc>
		<lastmod>2009-11-30T03:51:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/crown-minerals-increases-size-of-non-brokered-private-placement.html</loc>
		<lastmod>2009-11-27T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/theravance-receives-complete-response-letter-on-the-telavancin-nda-for-the-treatment-of-nosocomial-pneumonia.html</loc>
		<lastmod>2009-11-27T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/risk%e2%80%93adapted-therapy-for-multiple-myeloma-patents-harboring-the-tp53-deletion-the-adverse-consequences-in-total-therapy-2-are-overcome-by-addition-of-bortezomib-in-total-therapy-3-to-treat-t.html</loc>
		<lastmod>2009-11-27T03:21:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-of-testing-ppar-gamma-modulators-for-their-effects-on-bone-04-02.html</loc>
		<lastmod>2009-11-27T03:21:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/manufacture-microbubble-with-very-homogeneous-diameters-and-distinct-shell-thicknessstrength-07-46.html</loc>
		<lastmod>2009-11-27T03:21:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nanowires-key-to-future-transistors-electronics.html</loc>
		<lastmod>2009-11-26T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/han-chinese-genome-published.html</loc>
		<lastmod>2009-11-26T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/han-chinese-genome-published.html</loc>
		<lastmod>2009-11-26T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tough-time-wisdom-part-i.html</loc>
		<lastmod>2009-11-25T17:27:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/poniard%e2%80%99s-fortunes-likely-rest-on-picoplatin.html</loc>
		<lastmod>2009-11-25T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-genome-sciences-submits-biologics-license-application-to-fda-for-zalbin%e2%84%a2.html</loc>
		<lastmod>2009-11-25T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clear-forecast-for-ibm%e2%80%99s-%e2%80%98smarter-planet%e2%80%99.html</loc>
		<lastmod>2009-11-25T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmas-early-cloud-adopters.html</loc>
		<lastmod>2009-11-25T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cloud-storage-the-parascale-way.html</loc>
		<lastmod>2009-11-25T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cloud-storage-the-parascale-way-2.html</loc>
		<lastmod>2009-11-25T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/stephan-ignites-a-medical-revolution-in-northern-virginia.html</loc>
		<lastmod>2009-11-25T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/stephan-ignites-a-medical-revolution-in-northern-virginia.html</loc>
		<lastmod>2009-11-25T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/evi27-gene-sequence-and-protein-encoded-thereby-cancer-diagnostics-98-18.html</loc>
		<lastmod>2009-11-25T00:09:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mri-stereotactic-system-00-07.html</loc>
		<lastmod>2009-11-25T00:09:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/multi-epitope-peptide-loaded-dendritic-cell-immunotherapy-for-cancer-07-09.html</loc>
		<lastmod>2009-11-25T00:09:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mutated-herpes-simplex-virus-type-i-thymidine-kinases-98-19.html</loc>
		<lastmod>2009-11-25T00:09:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-for-treating-ovarian-cancer-04-10_97-07.html</loc>
		<lastmod>2009-11-25T00:09:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/molecular-diagnosis-of-atypical-mycobacterial-infections-02-23.html</loc>
		<lastmod>2009-11-25T00:09:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dynamic-radiation-therapy-simulation-system-port-sim%c2%a9-05-23.html</loc>
		<lastmod>2009-11-25T00:09:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/efficient-gene-silencing-using-trna-promoter-in-a-herpes-virus-vector-to-deliver-small-interference-rnas-05-07.html</loc>
		<lastmod>2009-11-25T00:09:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/advanced-cell-technology-to-present-at-ld-micro-conference-in-los-angeles.html</loc>
		<lastmod>2009-11-24T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biolaxy-secures-ind-approval-for-oral-insulin.html</loc>
		<lastmod>2009-11-24T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/linda-avey-on-an-alzheimer%e2%80%99s-brainstorm.html</loc>
		<lastmod>2009-11-24T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ym-biosciences-reports-first-patient-in-phase-iii-trial-of-jak1jak2-inhibitor-cyt387-enrolled-by-cytopia.html</loc>
		<lastmod>2009-11-23T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/transcept-pharmaceuticals-scheduled-to-meet-with-fda-to-discuss-intermezzor-complete-response-letter.html</loc>
		<lastmod>2009-11-23T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seattle-genetics-and-agensys-an-affiliate-of-astellas-expand-antibody-drug-conjugate-collaboration.html</loc>
		<lastmod>2009-11-23T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/receptos-completes-25m-series-a-financing.html</loc>
		<lastmod>2009-11-23T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology/</loc>
		<lastmod>2009-11-21T06:16:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pfizer-receives-fda-approval-for-geodon%c2%ae-ziprasidone-hci-capsules-for-the-adjunctive-maintenance-treatment-of-bipolar-disorder-in-adults.html</loc>
		<lastmod>2009-11-20T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/company-profile-for-amneal-pharmaceuticals-llc.html</loc>
		<lastmod>2009-11-20T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-extends-review-of-nda-for-exalgo%e2%84%a2.html</loc>
		<lastmod>2009-11-20T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-extends-nda-review-for-exalgo%e2%84%a2-extended-release-tablets.html</loc>
		<lastmod>2009-11-20T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dendreon-receives-fda-acknowledgement-of-complete-response.html</loc>
		<lastmod>2009-11-20T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/original-sulfonylureas-as-promising-antiplatelet-or-antiasthmatic-agents.html</loc>
		<lastmod>2009-11-19T23:06:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/qustream-corporation-announces-grant-of-stock-options.html</loc>
		<lastmod>2009-11-19T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/astellas-and-xenoport-announce-submission-of-a-new-drug-application-in-japan-requesting-pmda-approval-of-asp8825xp13512-for-restless-legs-syndrome.html</loc>
		<lastmod>2009-11-19T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pivotal-study-for-psd502-the-first-potential-treatment-for-premature-ejaculation.html</loc>
		<lastmod>2009-11-19T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/maize-cell-wall-genes-identified-giving-boost-to-biofuel-research.html</loc>
		<lastmod>2009-11-19T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/drug-studied-as-possible-treatment-for-spinal-injuries.html</loc>
		<lastmod>2009-11-19T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/arizona-medtech-companys-technology-breakthrough-the-first-to-achieve-fda-approval-for-seetreat-ultrasound.html</loc>
		<lastmod>2009-11-18T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/crown-minerals-clarifies-300000-non-brokered-private-placement.html</loc>
		<lastmod>2009-11-18T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/common-pain-relief-medication-may-encourage-cancer-growth.html</loc>
		<lastmod>2009-11-18T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-advisory-committee-finds-data-support-the-safety-and-effectiveness-of-prevnar-13%e2%84%a2-vaccine-for-the-prevention-of-invasive-pneumococcal-disease-in-infants-and-young-children.html</loc>
		<lastmod>2009-11-18T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cycle-computings-tour-de-cloud.html</loc>
		<lastmod>2009-11-18T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/warm-wellcome-for-cloud-computing.html</loc>
		<lastmod>2009-11-18T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/warm-wellcome-for-cloud-computing.html</loc>
		<lastmod>2009-11-18T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-grants-geovax-labs-inc-request-for-pre-ind-meeting.html</loc>
		<lastmod>2009-11-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neurogesx-to-hold-conference-call-to-discuss-fda-approval-of-qutenzatm-capsaicin-8-patch-for-treatment-of-postherpetic-neuralgia-phn.html</loc>
		<lastmod>2009-11-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ym-biosciences-reports-cyt997-oral-vascular-disrupting-agent-results-presented-at-aacr-nci-eortc-meeting.html</loc>
		<lastmod>2009-11-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/knome-expands-sequence-service-to-research-community.html</loc>
		<lastmod>2009-11-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microsoft%e2%80%99s-hpc-hopes-at-supercomputing-2009.html</loc>
		<lastmod>2009-11-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/decode-files-for-bankruptcy.html</loc>
		<lastmod>2009-11-17T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antimicrobials-to-treat-fungi-and-parasites-infections.html</loc>
		<lastmod>2009-11-16T22:24:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/thiadiazine-derivatives-for-treatment-of-chagas-disease.html</loc>
		<lastmod>2009-11-16T22:24:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mgd3-monoclonal-antibody-for-treatment-of-inflammatory-diseases.html</loc>
		<lastmod>2009-11-16T22:24:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/arca-biopharma-announces-corporate-and-gencarotm-development-update.html</loc>
		<lastmod>2009-11-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/advanced-cell-technologies-strengthens-balance-sheet-through-completion-of-private-placements.html</loc>
		<lastmod>2009-11-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-discusses-neuromed-nda-application-for-exalgo.html</loc>
		<lastmod>2009-11-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-genome-sciences-receives-complete-response-letter-from-fda-for-raxibacumab-biologics-license-application.html</loc>
		<lastmod>2009-11-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-directions-for-bioit-alliance.html</loc>
		<lastmod>2009-11-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gina-takes-effect.html</loc>
		<lastmod>2009-11-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genetic-testing-for-sudden-death.html</loc>
		<lastmod>2009-11-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech-prices-going-up-for-pharma.html</loc>
		<lastmod>2009-11-16T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oculus-innovative-sciences%e2%80%99-development-partner-bayer-animal-health-receives-regulatory-approvals-to-market-microcyn%c2%ae-based-vetericyn%e2%84%a2-animal-healthcare-products-in-china-and-ta.html</loc>
		<lastmod>2009-11-13T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biologic-entities-in-clinical-development-registered-novel-or-bio-genericfollow-on.html</loc>
		<lastmod>2009-11-12T21:58:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-biomarker-for-evaluating-immune-system-dysfunction-under-chronic-diseases.html</loc>
		<lastmod>2009-11-12T21:58:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microparticles-for-oral-drug-delivery.html</loc>
		<lastmod>2009-11-12T21:58:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/atherosclerosis-prevention-and-treatment-by-inhibiting-carbamylation-02-04.html</loc>
		<lastmod>2009-11-12T21:58:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novafrontline-harvest-of-fear-112.html</loc>
		<lastmod>2009-11-12T17:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/advanced-cell-technologys-chief-scientific-officer-robert-lanza-opening-plenary-speaker-at-the-3rd-international-conference-on-cell-therapy.html</loc>
		<lastmod>2009-11-12T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/schering-plough%e2%80%99s-search-for-biomarkers.html</loc>
		<lastmod>2009-11-12T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/forum-shows-pharma-biotech-need-each-other.html</loc>
		<lastmod>2009-11-12T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sequencing-sequencing-sequencing.html</loc>
		<lastmod>2009-11-12T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/safe-and-smart-handwashing-solution-dispenser.html</loc>
		<lastmod>2009-11-11T21:56:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/london-science-museum-biotech-section.html</loc>
		<lastmod>2009-11-11T17:16:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/iowa-state-engineers-develop-3-d-software-to-give-doctors-students-a-view-inside-the-body.html</loc>
		<lastmod>2009-11-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/skyepharma-plc-interim-management-statement.html</loc>
		<lastmod>2009-11-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cloud-computing-for-life-sciences.html</loc>
		<lastmod>2009-11-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/isolation-of-inner-cell-mass-in-mammal-blastocysts.html</loc>
		<lastmod>2009-11-10T21:47:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/composition-for-pathological-processes-associated-with-cell-proliferation-and-angiogenesis.html</loc>
		<lastmod>2009-11-10T21:47:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mesenchymal-stem-cells-composition-for-use-in-cell-therapy.html</loc>
		<lastmod>2009-11-10T21:47:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kit-for-immunological-analysis.html</loc>
		<lastmod>2009-11-10T21:47:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/metal-nanoparticles-functionalized-with-the-neuropeptide-vip.html</loc>
		<lastmod>2009-11-10T21:47:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/artificial-tissue-for-transplantation-or-clinical-screening.html</loc>
		<lastmod>2009-11-10T21:47:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/primers-procedure-and-set-of-tools-for-determining-the-functionallity-of-the-human-thymus.html</loc>
		<lastmod>2009-11-10T21:47:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/incubator-for-premature-babies.html</loc>
		<lastmod>2009-11-10T21:47:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/progressive-surgical-distractor-for-atraumatic-access.html</loc>
		<lastmod>2009-11-10T21:47:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/multipotential-stem-cells-obtained-from-mammal-thymus.html</loc>
		<lastmod>2009-11-10T21:47:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/correcting-and-replacing-glaxosmithkline-and-xenoport-announce-extension-of-gsk1838262-xp13512-fda-review-date-to-february-9-2010.html</loc>
		<lastmod>2009-11-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/teva-receives-favorable-court-decision-regarding-generic-prevacid%c2%ae-solutab.html</loc>
		<lastmod>2009-11-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/depomed-receives-notice-of-paragraph-iv-certification-against-patents-for-glumetza%c2%ae.html</loc>
		<lastmod>2009-11-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-finfets-promising-for-smaller-transistors-more-powerful-chips.html</loc>
		<lastmod>2009-11-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/teva-receives-final-approval-for-generic-prevacid%c2%ae-delayed-release-capsules.html</loc>
		<lastmod>2009-11-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/d-pharm-enters-into-collaboration-with-wanbang-biopharmaceuticals-to-increase-the-potential-market-for-its-stroke-drug-candidate-dp-b99.html</loc>
		<lastmod>2009-11-09T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/chemgenex-announces-fda-accepts-nda-for-omapro%e2%84%a2-omacetaxine-mepesuccinate-and-grants-the-filing-priority-review-status.html</loc>
		<lastmod>2009-11-09T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/findings-show-nanomedicine-promising-for-treating-spinal-cord-injuries.html</loc>
		<lastmod>2009-11-08T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vaccine-to-substantially-prevent-bovine-mastitis-caused-by-staphylococci.html</loc>
		<lastmod>2009-11-07T20:19:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisition-of-uk-hospital-established-brands.html</loc>
		<lastmod>2009-11-06T19:39:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/charles-craig.html</loc>
		<lastmod>2009-11-06T17:18:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genetix-pharmaceuticals-announces-global-clinical-plans-to-treat-adrenoleukodystrophy-ald.html</loc>
		<lastmod>2009-11-06T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/glaxosmithkline-and-xenoport-announce-extension-of-gsk1838262-xp13512-fda-review-date-to-february-9-2010.html</loc>
		<lastmod>2009-11-06T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/theratechnologies-nda-for-tesamorelin-to-be-reviewed-by-an-fda-advisory-committee.html</loc>
		<lastmod>2009-11-05T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/symmetry-medical-reports-third-quarter-2009-financial-results.html</loc>
		<lastmod>2009-11-05T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/insect-scientists-converge-in-indianapolis.html</loc>
		<lastmod>2009-11-05T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/autism-consortium-symposium-draws-record-number-of-researchers-advocates-parents-for-autism-update.html</loc>
		<lastmod>2009-11-05T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-approves-gloucester-pharmaceuticals%e2%80%99-istodax%c2%ae-for-patients-with-cutaneous-t-cell-lymphoma.html</loc>
		<lastmod>2009-11-05T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/testosterone-tts-lts.html</loc>
		<lastmod>2009-11-04T18:37:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tulobuterol-tts.html</loc>
		<lastmod>2009-11-04T18:37:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/intermune-announces-submission-of-nda-for-pirfenidone-for-the-treatment-of-patients-with-ipf.html</loc>
		<lastmod>2009-11-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-grants-priority-review-for-shires-velaglucerase-alfa-for-type-1-gaucher-disease.html</loc>
		<lastmod>2009-11-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kit-for-the-diagnosis-of-diseases-involving-alteration-of-the-inflammatory-response.html</loc>
		<lastmod>2009-11-03T18:34:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gripping-device-for-the-extraction-of-fixation-elements.html</loc>
		<lastmod>2009-11-03T18:34:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-mouse-model-of-cutaneous-inflammation-and-hyperpigmentation.html</loc>
		<lastmod>2009-11-03T18:34:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-of-differentiation-of-pluripotent-stem-cells-to-definitive-endoderm-cells.html</loc>
		<lastmod>2009-11-03T18:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-and-kit-for-rapid-detection-of-brucella-spp.html</loc>
		<lastmod>2009-11-03T18:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/frame-for-securing-thermoplastic-mask.html</loc>
		<lastmod>2009-11-03T18:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dummy-for-calibration-and-quality-control-of-virtual-simulation-devices.html</loc>
		<lastmod>2009-11-03T18:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diaphragmatic-and-abdominal-compression-system.html</loc>
		<lastmod>2009-11-03T18:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/surgical-retraction-device-for-the-deep-disection-of-pelvis.html</loc>
		<lastmod>2009-11-03T18:34:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pyrazoles-derivatives-as-specific-activators-of-ppar-alpha-receptors.html</loc>
		<lastmod>2009-11-03T18:34:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alnara-pharmaceuticals-announces-appointment-of-lee-r-brettman-m-d-facp-to-chief-medical-officer.html</loc>
		<lastmod>2009-11-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gamma-rho-chapter-sigma-theta-tau-international-receives-chapter-key-award.html</loc>
		<lastmod>2009-11-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-high-yield-enzymatic-synthesis-of-non-ionic-biosurfactants-l-10269.html</loc>
		<lastmod>2009-11-02T18:05:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-high-yield-enzymatic-synthesis-of-non-ionic-biosurfactants-l-10269.html</loc>
		<lastmod>2009-11-02T18:05:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/identification-of-molecular-formula-of-small-molecules-by-mass-spectrometry-l-11740.html</loc>
		<lastmod>2009-11-02T18:05:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/identification-of-molecular-formula-of-small-molecules-by-mass-spectrometry-l-11740.html</loc>
		<lastmod>2009-11-02T18:05:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/simple-and-efficient-method-for-the-large-scale-production-of-e1-deficient-adenovirus-l-10624.html</loc>
		<lastmod>2009-11-02T18:05:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/retractable-bivalent-polypeptide-inhibitors-l-11615.html</loc>
		<lastmod>2009-11-02T18:05:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/retractable-bivalent-polypeptide-inhibitors-l-11615.html</loc>
		<lastmod>2009-11-02T18:05:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gtx-receives-complete-response-letter-from-fda-for-toremifene-80-mg-new-drug-application.html</loc>
		<lastmod>2009-11-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dendreon-completes-submission-of-biologics-license-application-for-provenge.html</loc>
		<lastmod>2009-11-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/discovery-offers-potential-new-pancreatic-cancer-treatment.html</loc>
		<lastmod>2009-11-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genetically-modified-human-stem-cells-for-clinical-screening-of-oncogenesis-inhibitors.html</loc>
		<lastmod>2009-10-31T15:39:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/composition-for-the-treatment-and-prevention-of-diabetes-mellitus.html</loc>
		<lastmod>2009-10-31T15:39:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fast-and-high-yield-recombinant-proteins-production-by-large-scale-transfection-of-suspension-growing-mammalian-cells-l-11266.html</loc>
		<lastmod>2009-10-31T15:39:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cumate-inducible-expression-system-in-eukaryotic-cells-l-11648-11225.html</loc>
		<lastmod>2009-10-31T15:39:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-and-kit-for-rapid-detection-and-differenciation-of-brucela-spp-and-mycobacterium-tuberculosis.html</loc>
		<lastmod>2009-10-31T15:39:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/covidien-receives-fda-approval-for-oral-transmucosal-fentanyl-citrate-product.html</loc>
		<lastmod>2009-10-30T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-and-schering-plough-receive-approvals-from-u-s-federal-trade-commission-swiss-competition-commission-and-canadian-competition-bureau-for-merger.html</loc>
		<lastmod>2009-10-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/safeguard-scientifics-leads-17-4-million-series-b-financing-for-quinnova-pharmaceuticals.html</loc>
		<lastmod>2009-10-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gossip-in-the-workplace-a-weapon-or-gift-new-research-from-iu.html</loc>
		<lastmod>2009-10-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/imaging3-to-host-conference-call-regarding-fda-approval-progress.html</loc>
		<lastmod>2009-10-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/zimmer-holdings-announces-omega-graduate-medical-education-grant-recipients.html</loc>
		<lastmod>2009-10-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rio-alto-mining-limited-lima-stock-exchange-listing.html</loc>
		<lastmod>2009-10-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/polymedix-completes-successful-phase-1b-clinical-study-of-heparin-antagonist-pmx-60056.html</loc>
		<lastmod>2009-10-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biosphere-medical-submits-investigational-device-exemption-to-fda-for-quadrasphere%c2%ae-microspheres-for-use-with-doxorubicin-for-the-treatment-of-primary-liver-cancer.html</loc>
		<lastmod>2009-10-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/potential-of-lux-biosciences%e2%80%99-luveniq-lx211-as-first-disease-modifying-treatment-for-sight-threatening-non-infectious-uveitis-highlighted-at-american-academy-of-ophthalmology.html</loc>
		<lastmod>2009-10-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cephalon-signs-option-agreement-to-acquire-bioassets-development-corporation.html</loc>
		<lastmod>2009-10-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lx211-highlighted-as-potential-disease-modifying-therapy-for-non-infectious-uveitis.html</loc>
		<lastmod>2009-10-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/theratechnologies-presents-clinically-relevant-improvements-in-patient-reported-outcome-parameters-at-the-international-workshop-on-adverse-drug-reactions-and-co-morbidities-in-hiv.html</loc>
		<lastmod>2009-10-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-rad-signs-agreement-to-acquire-certain-diagnostics-businesses-of-biotest-ag.html</loc>
		<lastmod>2009-10-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bd-announces-agreement-to-acquire-handylab-inc.html</loc>
		<lastmod>2009-10-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-single-mom-studies-to-be-a-process-technician.html</loc>
		<lastmod>2009-10-22T17:15:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/laparoscopic-magnetic-anchoring-device-2.html</loc>
		<lastmod>2009-10-22T12:46:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acorda-therapeutics-announces-extension-of-fampridine-sr-pdufa-goal-date-to-january-22-2010.html</loc>
		<lastmod>2009-10-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/zimmer-holdings-inc-reports-third-quarter-2009-financial-results.html</loc>
		<lastmod>2009-10-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bloomington-hospital-estimates-2-million-savings-with-new-prime-vendor-supply-agreement-with-medline.html</loc>
		<lastmod>2009-10-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kempharm-inc-announces-initiation-of-phase-1-trial-of-kp106-for-adhd.html</loc>
		<lastmod>2009-10-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/geospatial-technology-brings-surveying-into-the-21st-century.html</loc>
		<lastmod>2009-10-21T17:16:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-issues-complete-response-letter-for-corvue%e2%84%a2.html</loc>
		<lastmod>2009-10-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/shire-targets-fourth-quarter-filing-of-bla-for-replagalr-for-fabry-disease-with-u-s-fda.html</loc>
		<lastmod>2009-10-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sembiosys-provides-an-update-on-botaneco.html</loc>
		<lastmod>2009-10-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cephalon-notified-of-generic-filing-for-armodafinil-tablets.html</loc>
		<lastmod>2009-10-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/atetv-episode-5-process-technology-geospatial-technology-internships.html</loc>
		<lastmod>2009-10-20T17:21:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/inducible-serca2-ko-mouse-model-for-heart-failure.html</loc>
		<lastmod>2009-10-20T12:02:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/international-distributors-for-provocholine%c2%ae-methacholine-chloride-%e2%80%93-for-use-in-the-diagnosis-of-patients-suspected-of-having-asthma.html</loc>
		<lastmod>2009-10-20T12:02:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/digital-based-detection-system-for-optical-tomography.html</loc>
		<lastmod>2009-10-20T12:02:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/improved-fixation-of-orthopedic-and-dental-implants.html</loc>
		<lastmod>2009-10-20T12:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/laparoscopic-magnetic-anchoring-device.html</loc>
		<lastmod>2009-10-20T12:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microarray-based-gene-translocation-assay-for-differential-diagnosis-and-selection-of-treatment-of-cancers.html</loc>
		<lastmod>2009-10-20T12:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/non-invasive-screening-assay-for-early-stage-colorectal-cancer-diagnosis.html</loc>
		<lastmod>2009-10-20T12:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-early-diagnosis-of-alzheimer%e2%80%99s-disease.html</loc>
		<lastmod>2009-10-20T12:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/soft-tissue-implants.html</loc>
		<lastmod>2009-10-20T12:02:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kai-reports-positive-preclinical-results-in-pain-therapeutic-program-targeting-gamma-protein-kinase-c-pkc-pathway.html</loc>
		<lastmod>2009-10-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/internships-and-co-ops-get-students-into-the-workforce.html</loc>
		<lastmod>2009-10-19T17:15:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/distribution-in-licensing-of-niche-hospital-brands-for-usa.html</loc>
		<lastmod>2009-10-19T11:39:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/distribution-in-licensing-of-niche-hospital-brands-for-canada.html</loc>
		<lastmod>2009-10-19T11:39:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aastra-announces-commencement-of-normal-course-issuer-bid.html</loc>
		<lastmod>2009-10-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/peregrine-pharmaceuticals-appoints-former-genentech-senior-executive-dr-robert-garnick-as-head-of-regulatory-affairs.html</loc>
		<lastmod>2009-10-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/teva-comments-on-mylan-paragraph-iv-filing-for-copaxone%c2%ae-files-lawsuit-against-generic-filer-for-patent-infringement.html</loc>
		<lastmod>2009-10-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-approves-gardasil%c2%ae-for-use-in-boys-and-young-men.html</loc>
		<lastmod>2009-10-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/epix-pharmaceuticals-announces-fda-approval-of-a-physician-sponsored-ind-for-fourth-6-month-open-label-extension-of-prx-03140-for-alzheimers-disease-patient.html</loc>
		<lastmod>2009-10-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/atetv-episode-4-industrial-manufacturing-biotechnology-cloud-computing.html</loc>
		<lastmod>2009-10-15T18:10:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/industrial-technology-students-tackle-real-world-problems.html</loc>
		<lastmod>2009-10-14T17:29:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/california-stem-cell-inc-and-families-of-spinal-muscular-atrophy-announce-completion-of-pre-ind-meeting-with-fda-for-stem-cell-derived-therapy-for-the-treatment-of-spinal-muscular-atrophy-type-i.html</loc>
		<lastmod>2009-10-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/atetv-episode-4.html</loc>
		<lastmod>2009-10-13T17:49:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-genetically-modified-bacterial-vector-expressing-an-epithelial-derived-cancer-antibody-for-targeted-delivery-to-tumors.html</loc>
		<lastmod>2009-10-13T07:07:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/assay-for-the-identification-of-therapeutic-agents-that-disrupt-protein-protein-interaction-l-11131.html</loc>
		<lastmod>2009-10-13T07:07:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-delivery-system-of-an-antifungal-agent-to-treat-nail-fungi-infections.html</loc>
		<lastmod>2009-10-13T07:07:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/shire-and-sandoz-settle-all-pending-litigation-concerning-adderall-xrr.html</loc>
		<lastmod>2009-10-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-biotechnology-program-reaches-out-to-the-community.html</loc>
		<lastmod>2009-10-12T17:40:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/takeda-san-francisco-inc-appoints-michael-buckley-ph-d-vice-president-of-process-sciences.html</loc>
		<lastmod>2009-10-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-chemical-entities-and-innovative-therapeutic-targets.html</loc>
		<lastmod>2009-10-11T06:52:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/really-bring-life-to-science-thoughts-from-david-welch.html</loc>
		<lastmod>2009-10-10T17:34:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-state-of-biotech-science-education.html</loc>
		<lastmod>2009-10-09T18:05:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ipsen-acquires-exclusive-marketing-rights-of-bli-800-from-braintree-for-colonic-cleansing-before-colonoscopy.html</loc>
		<lastmod>2009-10-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acorda-therapeutics-announces-posting-of-briefing-documents-for-october-14-fda-advisory-committee-meeting-on-fampridine-sr.html</loc>
		<lastmod>2009-10-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-underappreciated-cost-saving-potential-of-personalized-medicine-in-health-reform-debate.html</loc>
		<lastmod>2009-10-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kilo-announces-debt-settlement-for-shares.html</loc>
		<lastmod>2009-10-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/petro-vista-and-cantrell-announce-financing-and-property-farm-outs.html</loc>
		<lastmod>2009-10-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/isolagen-inc-reorganizes-as-fibrocell-science-inc.html</loc>
		<lastmod>2009-10-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmasset-nominates-psi-879-as-a-new-nucleotide-analog-inhibitor-of-hepatitis-c-for-preclinical-development.html</loc>
		<lastmod>2009-10-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/theratechnologies-announces-financial-results-for-the-third-quarter-2009.html</loc>
		<lastmod>2009-10-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/impax-laboratories-receives-tentative-fda-approval-for-generic-flomax%c2%ae-0-4mg-capsules.html</loc>
		<lastmod>2009-10-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/avi-biopharma-receives-expanded-contract-from-u-s-department-of-defense-to-develop-its-drug-candidate-for-the-treatment-of-junin-virus-infection.html</loc>
		<lastmod>2009-10-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/angiotensin-ii-type-2-receptor-for-the-treatment-of-cardiovascular-disease-07-18.html</loc>
		<lastmod>2009-10-03T05:05:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/skyline-gold-announces-private-placement.html</loc>
		<lastmod>2009-10-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/etna-resources-inc-announces-a-minimum-3-million-financing.html</loc>
		<lastmod>2009-10-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-new-method-for-generating-new-chemical-entities-from-bacteria.html</loc>
		<lastmod>2009-10-01T04:03:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/specific-inhibitors-of-human-udp-glucuronosyltransferases-enhance-the-efficacy-of-selected-antivirals-by-changing-their-pharmacokinetic-profiles-09-24.html</loc>
		<lastmod>2009-10-01T04:03:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mylan-receives-fda-approval-for-generic-version-of-parkinsons-treatment-sinemetr.html</loc>
		<lastmod>2009-09-30T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hinterland-closes-final-tranche-of-622430-private-placement.html</loc>
		<lastmod>2009-09-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/macquarie-power-amp-infrastructure-income-fund-announces-new-distribution-policy-and-corporate-conversion.html</loc>
		<lastmod>2009-09-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sfc-fluidics-llc-receives-funding-from-us-army-for-development-of-traumatic-brain-injury-diagnostic-device.html</loc>
		<lastmod>2009-09-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sfc-fluidics-llc-receives-funding-from-us-army-for-development-of-traumatic-brain-injury-diagnostic-device.html</loc>
		<lastmod>2009-09-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/raptor-pharmaceuticals-and-torreypines-therapeutics-receive-stockholder-approvals-to-merge.html</loc>
		<lastmod>2009-09-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/update-fda-approves-pralatrexate-for-treatment-of-peripheral-t-cell-lymphoma-drug-discovered-and-developed-by-sri-international-memorial-sloan-kettering-cancer-center-and-southern-research-institu.html</loc>
		<lastmod>2009-09-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clinical-trial-failures-further-signal-pancreatic-cancer%e2%80%99s-intractable-nature.html</loc>
		<lastmod>2009-09-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/enzymerx-announces-its-ind-for-uricase-peg-20-becomes-effective.html</loc>
		<lastmod>2009-09-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/capsaicin-patch.html</loc>
		<lastmod>2009-09-25T01:48:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/predictive-medicine-risk-adapted-therapy-in-multiple-myeloma-with-combined-abnormal-chromosomes-1-and-13-confers-resistance-to-thalidomide-in-total-therapy-2-and-is-linked-to-hyper-expression-of-the.html</loc>
		<lastmod>2009-09-25T01:48:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/improved-pharmacokinetic-profiles-of-methylphenidate-for-adhd-09-22.html</loc>
		<lastmod>2009-09-25T01:48:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/reverse-medical-corporation-receives-fda-ide-clinical-study-approval-for-the-restoretm-microcatheter.html</loc>
		<lastmod>2009-09-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amylin-and-lilly-to-present-more-than-20-studies-for-exenatide-at-easd-2009.html</loc>
		<lastmod>2009-09-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-advisory-committee-hears-presentations-and-public-comment-on-exalgo-extended-release-tablets.html</loc>
		<lastmod>2009-09-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/imaging3-state-of-the-company-conference-call-summarizes-progress-of-initiatives.html</loc>
		<lastmod>2009-09-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/combinatorx-stock-trading-halted-today-fda-advisory-committees-meet-to-discuss-exalgo.html</loc>
		<lastmod>2009-09-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lilly-endowment-awards-7-million-grant-to-establish-orthopedics-and-community-initiative-in-kosciusko-county-in.html</loc>
		<lastmod>2009-09-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sangamo-biosciences-announces-plans-to-initiate-a-second-clinical-trial-of-ccr5-zfp-therapeutic-to-treat-hivaids.html</loc>
		<lastmod>2009-09-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biosante-pharmaceuticals-and-cell-genesys-announce-final-exchange-ratio-for-merger.html</loc>
		<lastmod>2009-09-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/advanced-cell-completing-pre-clinical-activities-in-preparation-for-ind-filing.html</loc>
		<lastmod>2009-09-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/combinatorx-and-neuromed-announce-posting-of-briefing-documents-for-fda-advisory-committee.html</loc>
		<lastmod>2009-09-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-multi-use-device-can-shed-light-on-oxygen-intake.html</loc>
		<lastmod>2009-09-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/imaging3-to-host-state-of-the-company-conference-call.html</loc>
		<lastmod>2009-09-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clarian-health-reduces-costs-with-new-prime-vendor-supply-agreement-with-medline.html</loc>
		<lastmod>2009-09-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rexahn-pharmaceuticals-and-teva-pharmaceutical-industries-close-on-a-license-agreement.html</loc>
		<lastmod>2009-09-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/geovax-labs-requests-pre-ind-meeting-with-fda.html</loc>
		<lastmod>2009-09-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/xrc-medical-imaging-announces-rapid-test-results.html</loc>
		<lastmod>2009-09-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merrimack-pharmaceuticals-names-clet-niyikiza-ph-d-senior-vice-president-development.html</loc>
		<lastmod>2009-09-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neuralstem-receives-fda-approval-to-commence-first-als-stem-cell-trial.html</loc>
		<lastmod>2009-09-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hylacare-product-line-with-hylasome%c2%ae-2.html</loc>
		<lastmod>2009-09-19T00:58:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/frosta-technology-fast-dissolving-tablet-fdt-also-called-orally-disintegrating-tablet-technology-of-samyang.html</loc>
		<lastmod>2009-09-19T00:58:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/capsaicin-plaster-for-neuropathic-pains-such-as-post-herpetic-neuralgia-diabetic-neuropathy-and-so-on.html</loc>
		<lastmod>2009-09-19T00:58:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/docetaxel-pm-polymeric-micelle-formulation-of-docetaxel.html</loc>
		<lastmod>2009-09-19T00:58:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cns-target-enzyme-glutaminyl-cyclase-qc-for-neurodegeneration-alzheimers-disease.html</loc>
		<lastmod>2009-09-18T00:46:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/paul-hanle.html</loc>
		<lastmod>2009-09-17T17:37:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pancreatic-and-colorectal-cancer-novel-antibody-developed-from-a-vaccine-to-begin-phase-i-trial.html</loc>
		<lastmod>2009-09-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/photo-novartis-receives-fda-approval-for-valturnar-a-single-pill-combination-of-valsartan-and-aliskiren-to-treat-high-blood-pressure.html</loc>
		<lastmod>2009-09-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/avaya-receives-u-s-and-canadian-court-approvals-to-acquire-nortels-enterprise-solutions-business.html</loc>
		<lastmod>2009-09-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nortel-obtains-u-s-and-canadian-court-approvals-for-sale-agreements-with-avaya-for-enterprise-solutions-business.html</loc>
		<lastmod>2009-09-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kempharm-inc-expands-prodrug-pipeline-with-candidate-for-treatment-of-pain-and-closes-series-b-financing.html</loc>
		<lastmod>2009-09-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/savient-provides-update-on-meeting-with-u-s-food-and-drug-administration-for-krystexxatm.html</loc>
		<lastmod>2009-09-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-010-x-ray-pulse-injector-for-quantitative-angiographic-blood-flow-measurements-2.html</loc>
		<lastmod>2009-09-16T00:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-009-radiotracer-99tc-cysteine-rhenium-colloid-2.html</loc>
		<lastmod>2009-09-16T00:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-liposome-based-microarray-technology.html</loc>
		<lastmod>2009-09-16T00:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-008-ultrasound-system-and-method-for-4d-ultrasound-imaging.html</loc>
		<lastmod>2009-09-16T00:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-007-ultrasound-3d-ultrasound-guided-method-for-prostate-brachytherapy.html</loc>
		<lastmod>2009-09-16T00:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-006-ultrasound-3d-ultrasound-imaging-system-and-process-for-percutaneous-breast-tissue-biopsy-2.html</loc>
		<lastmod>2009-09-16T00:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mdp-006-fetal-health-detection-of-early-changes-in-fetal-eeg-due-to-asphyxia-with-acidemia-during-labour-2.html</loc>
		<lastmod>2009-09-16T00:07:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mdp-002-cancer-single-stage-freezing-and-embedding-system-for-use-in-mohs-surgery-andor-other-tissue-histopathological-procedures-2.html</loc>
		<lastmod>2009-09-16T00:07:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/avayas-purchase-of-nortels-enterprise-business-joint-court-hearing-now-scheduled-for-september-16-2009.html</loc>
		<lastmod>2009-09-15T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/st-jude-medical-announces-fda-approval-of-ensite-velocity-cardiac-mapping-system.html</loc>
		<lastmod>2009-09-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/protalix-completes-pivotal-phase-iii-trial-for-prgcd-for-the-treatment-of-gaucher-disease.html</loc>
		<lastmod>2009-09-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-to-treat-warts-and-verrucae.html</loc>
		<lastmod>2009-09-11T22:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-guanine-nucleotide-analogs-as-antibiotic-agents.html</loc>
		<lastmod>2009-09-11T22:51:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/carvacrol-in-protection-of-neurons-following-brain-injury.html</loc>
		<lastmod>2009-09-11T22:51:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/peptides-for-the-selective-killing-of-hiv-1-infected-cells.html</loc>
		<lastmod>2009-09-11T22:51:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/water-dispersible-powders-composed-of-nanoparticles-of-insoluble-organic-compounds.html</loc>
		<lastmod>2009-09-11T22:51:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/metallo-siderophore-complexes-to-treat-bacterial-infections.html</loc>
		<lastmod>2009-09-11T22:51:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/treating-achondroplasia-with-fgfr3-derived-peptides.html</loc>
		<lastmod>2009-09-11T22:51:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/thiazolidinediones-in-prevention-and-destruction-of-biofilms.html</loc>
		<lastmod>2009-09-11T22:51:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-transmitting-medical-images-via-cell-phones.html</loc>
		<lastmod>2009-09-11T22:51:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/advanced-functional-nylon-fibers.html</loc>
		<lastmod>2009-09-11T22:51:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genspera-receives-fda-approval-for-g-202-phase-i-cancer-trial.html</loc>
		<lastmod>2009-09-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/theravance-and-astellas-announce-fda-approval-of-vibativtm-telavancin-for-the-treatment-of-complicated-skin-and-skin-structure-infections.html</loc>
		<lastmod>2009-09-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-compounds-to-alter-human-udp-glucuronosyltransferase-activity-and-api-pharmacokinetic-properties-09-24.html</loc>
		<lastmod>2009-09-10T22:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/p49strap-is-a-novel-protein-involved-in-gene-regulation-cardiac-development-and-remodeling-04-20.html</loc>
		<lastmod>2009-09-10T22:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology-at-montgomery-college.html</loc>
		<lastmod>2009-09-10T17:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/continental-nickel-reports-grant-of-stock-options.html</loc>
		<lastmod>2009-09-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-issues-complete-response-letter-for-trabectedin-combined-with-doxil.html</loc>
		<lastmod>2009-09-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dynavax-reports-fda-removes-clinical-hold-on-heplisavtm-phase-3-hepatitis-b-vaccine.html</loc>
		<lastmod>2009-09-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dksh-seeks-to-in-license-branded-pharmaceuticals-to-market-in-asia.html</loc>
		<lastmod>2009-09-09T22:41:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mineral-supplements.html</loc>
		<lastmod>2009-09-09T22:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/chemgenex-submits-new-drug-application-for-omapro%e2%84%a2-omacetaxine-mepesuccinate-to-u-s-fda.html</loc>
		<lastmod>2009-09-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/affymax-provides-phase-3-program-update-for-investigational-drug-hematide%e2%84%a2-to-treat-anemia-in-chronic-renal-failure.html</loc>
		<lastmod>2009-09-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/wilmington-pharmaceuticals-receives-fda-approval-for-orally-disintegrating-metoclopramide-tablet.html</loc>
		<lastmod>2009-09-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/model-backs-green-tea-and-lemon-claim-lessens-need-to-test-animals.html</loc>
		<lastmod>2009-09-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-approves-zevalin%c2%ae-expanded-label-as-part-of-first-line-therapy-in-treatment-of-follicular-non-hodgkin%e2%80%99s-lymphoma.html</loc>
		<lastmod>2009-09-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/takeda-receives-fda-complete-response-letter-for-the-investigational-fixed-dose-combination-of-alogliptin-and-actosr-pioglitazone-hcl-for-the-treatment-of-type-2-diabetes.html</loc>
		<lastmod>2009-09-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genetic-reference-materials.html</loc>
		<lastmod>2009-09-03T21:28:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/assay-for-identification-of-diabetic-patients-likely-to-develop-kidney-disease.html</loc>
		<lastmod>2009-09-03T21:28:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/shire-announces-fda-approval-of-once-daily-intunivtm-guanfacine-extended-release-tablets-for-the-treatment-of-adhd-in-children-and-adolescents-aged-6-to-17.html</loc>
		<lastmod>2009-09-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-launches-saflutan%c2%ae-tafluprost-in-international-markets.html</loc>
		<lastmod>2009-09-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/china-aoxing-pharmaceutical-company-announces-submission-of-nda-of-its-leading-narcotic-drug-for-the-treatment-of-acute-moderate-to-severe-cough.html</loc>
		<lastmod>2009-09-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/epicept%e2%80%99s-ceplene%c2%ae-highlighted-in-two-2008-european-union-drug-approval-reports.html</loc>
		<lastmod>2009-09-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/world-first-swine-flu-vaccine-trial-reveals-one-dose-provides-strong-immune-response.html</loc>
		<lastmod>2009-09-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cytopias-cyt387-receives-fda-clearance-to-start-us-clinical-trials.html</loc>
		<lastmod>2009-09-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-advisory-committee-recommends-gloucester-pharmaceuticals%e2%80%99-romidepsin-for-approval-for-cutaneous-t-cell-lymphoma.html</loc>
		<lastmod>2009-09-02T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oculus-ventures-announces-agreement-in-principle-for-proposed-qualifying-transaction-with-powerbase-companies.html</loc>
		<lastmod>2009-09-02T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/meda-fda-approval-of-the-first-once-daily-nasal-antihistamine.html</loc>
		<lastmod>2009-09-02T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-computer-models-aim-to-classify-help-reduce-injury-accidents.html</loc>
		<lastmod>2009-09-02T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/buyer-beware-estrogen-supplements-not-as-effective-as-claimed.html</loc>
		<lastmod>2009-09-02T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tendoactive-%c2%ae.html</loc>
		<lastmod>2009-09-01T21:24:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hyal-rub-%c2%ae.html</loc>
		<lastmod>2009-09-01T21:24:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-licensing-cyclizine.html</loc>
		<lastmod>2009-08-31T21:23:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pozen-announces-fda-acceptance-of-nda-for-vimovo%e2%84%a2.html</loc>
		<lastmod>2009-08-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/skyepharma-plc-research-update.html</loc>
		<lastmod>2009-08-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/shire-completes-submission-of-nda-for-velaglucerase-alfa-for-type-1-gaucher-disease-and-reports-positive-results-for-remaining-two-phase-iii-trials.html</loc>
		<lastmod>2009-08-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/basilea-pharmaceutica-ltd-fda-accepts-for-review-the-complete-response-submission-to-ceftobiprole-nda.html</loc>
		<lastmod>2009-08-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/3-substituted-quinolinium-and-7h-indolo3-cquinolinium-salts-as-new-anti-infectives.html</loc>
		<lastmod>2009-08-28T20:00:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/portable-vital-statistics-monitoring-and-medication-dispensing-system-vmonitor.html</loc>
		<lastmod>2009-08-27T19:54:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/synthetic-flavonoids-and-pharmaceutical-compositions-and-therapeutic-methods-of-treatment-of-cancer-and-other-pathologies.html</loc>
		<lastmod>2009-08-27T19:54:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/geron-comments-on-fda-hold-on-spinal-cord-injury-trial.html</loc>
		<lastmod>2009-08-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ohsu-primate-center-scientists-develop-gene-therapy-method-to-prevent-some-inherited-diseases.html</loc>
		<lastmod>2009-08-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vitamin-c-500mg-controlled-release-and-vitamin-c-500mg-controlled-release-5mg-zinc.html</loc>
		<lastmod>2009-08-25T19:36:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/levocetirizine-orodispersible-tablets-2-5mg-and-5mg.html</loc>
		<lastmod>2009-08-25T19:36:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ropinirole-extended-release-tablets-in-2mg-4mg-and-8mg-strengths.html</loc>
		<lastmod>2009-08-25T19:36:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-capacitor-based-single-molecule-motion-detector.html</loc>
		<lastmod>2009-08-25T19:36:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-rapid-and-sensitive-onoff-switch-regulated-by-coumarin-for-gene-expression-in-mammalian-cells-l-11444.html</loc>
		<lastmod>2009-08-25T19:36:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-composition-for-treating-or-preventing-a-ryanodine-receptor-associated-disorder.html</loc>
		<lastmod>2009-08-25T19:36:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/teikoku-pharma-usa-focused-on-innovative-drug-delivery-technology.html</loc>
		<lastmod>2009-08-25T19:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nces-new-patented-formulations-and-products.html</loc>
		<lastmod>2009-08-25T19:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/supersonic-imagine-receives-fda-approval-for-aixplorer-ultrasound-system.html</loc>
		<lastmod>2009-08-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acorda-therapeutics-reports-date-of-fda-advisory-committee-review-of-fampridine-sr-for-improvement-of-walking-ability-in-people-with-ms.html</loc>
		<lastmod>2009-08-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amorphous-spherical-nano-particles.html</loc>
		<lastmod>2009-08-24T19:19:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/salix-pharmaceuticals-announces-fda-acceptance-for-filing-and-priority-review-designation-for-rifaximin-nda-for-the-maintenance-of-remission-of-hepatic-encephalopathy.html</loc>
		<lastmod>2009-08-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-microrna-for-the-treatment-of-copd.html</loc>
		<lastmod>2009-08-22T19:13:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/e-ll-01-clinically-proven-formula-for-lipid-lowering.html</loc>
		<lastmod>2009-08-21T18:40:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/e-us-01-clinically-proven-formula-to-support-kidney-health.html</loc>
		<lastmod>2009-08-21T18:40:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dendreon%e2%80%99s-70m-investment-in-production-capabilities-could-woo-firms-without-similar-expertise.html</loc>
		<lastmod>2009-08-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lundbeck-inc-announces-fda-marketing-approval-for-sabril-for-the-treatment-of-two-difficult-to-treat-epilepsies.html</loc>
		<lastmod>2009-08-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/intelgenx-corp-comments-on-cpi-300-patent-infringement-complaint.html</loc>
		<lastmod>2009-08-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-issues-complete-response-letter-for-carisbamate.html</loc>
		<lastmod>2009-08-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/3d-matrices-for-growing-and-differentiating-progenitor-and-stem-cells.html</loc>
		<lastmod>2009-08-20T18:13:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/investigating-immune-regulatory-properties-of-drug-candidates.html</loc>
		<lastmod>2009-08-19T18:09:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biomarkers.html</loc>
		<lastmod>2009-08-19T18:09:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/active-compound-to-drug-provided-by-bioneerfarma.html</loc>
		<lastmod>2009-08-19T18:09:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/formulation-method-for-improved-delivery-to-the-lung-using-pressurized-metered-dose-inhalers.html</loc>
		<lastmod>2009-08-19T18:09:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eudracol%e2%84%a2.html</loc>
		<lastmod>2009-08-19T18:09:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/teva-provides-update-on-generic-singulair%c2%ae-litigation.html</loc>
		<lastmod>2009-08-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-wins-singulair%c2%ae-patent-infringement-lawsuit.html</loc>
		<lastmod>2009-08-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bioalliance-pharma-fda-accepts-drug-application-for-miconazole-lauriad%c2%ae-loramyc%c2%ae-to-treat-oropharyngeal-candidiasis.html</loc>
		<lastmod>2009-08-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tobacco-plants-yield-the-first-vaccine-for-the-dreaded-cruise-ship-virus.html</loc>
		<lastmod>2009-08-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/helixate-fs-receives-fda-approval-for-routine-prophylaxis-in-children-with-hemophilia-a.html</loc>
		<lastmod>2009-08-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vasogen-and-intellipharmaceutics-to-combine-to-create-publicly-traded-specialty-pharmaceutical-company.html</loc>
		<lastmod>2009-08-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dr-wach-sees-district-9-district9facts-com.html</loc>
		<lastmod>2009-08-16T17:18:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-eco-friendly-self-cleaning-material-tough-on-stains-light-on-effort.html</loc>
		<lastmod>2009-08-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/district-9-facts-teaser-hd.html</loc>
		<lastmod>2009-08-14T17:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ghrelin-analogues-as-molecular-imaging-probes.html</loc>
		<lastmod>2009-08-14T17:48:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/electrochemical-biosensor-for-the-detection-of-hiv-enzymes.html</loc>
		<lastmod>2009-08-14T17:48:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gastem-signs-new-loi-with-utica-energy-for-nys-properties.html</loc>
		<lastmod>2009-08-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tianyin-pharmaceutical-co-inc-receives-chinese-sfda-approval-for-sanqi-tablets-and-yinqiao-jiedu-tablets.html</loc>
		<lastmod>2009-08-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/agi-therapeutics-announces-termination-of-agreement-with-axcan-for-agi-010.html</loc>
		<lastmod>2009-08-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cannabis-science-reports-on-two-cannabis-based-drug-release-programs.html</loc>
		<lastmod>2009-08-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/theratechnologies-to-receive-a-milestone-payment-of-us-10-million-associated-with-the-fda-acceptance-to-file-tesamorelin-nda.html</loc>
		<lastmod>2009-08-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genome-duplication-responsible-for-more-plant-species-than-previously-thought.html</loc>
		<lastmod>2009-08-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genosys-announces-consulting-agreement.html</loc>
		<lastmod>2009-08-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/denosumab-increases-bone-density-cuts-fracture-risk-in-prostate-cancer-survivors.html</loc>
		<lastmod>2009-08-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/wyeth-provides-regulatory-update-on-prevnar-13-in-the-united-states.html</loc>
		<lastmod>2009-08-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/edmund-mickunas-named-vice-president-of-regulatory-for-advanced-cell-technologies.html</loc>
		<lastmod>2009-08-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clinical-data-inc-reports-first-quarter-fiscal-2009-results.html</loc>
		<lastmod>2009-08-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nycomed-and-forest-laboratories-to-collaborate-on-daxas%c2%ae-roflumilast-for-copd.html</loc>
		<lastmod>2009-08-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clonacell%c2%ae-hy-96-well-protocol-selection-and-cloning-stemcell-technologies.html</loc>
		<lastmod>2009-08-07T21:08:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/molecular-insight-pharmaceuticals-inc-advances-azedra-program-into-pivotal-phase-2-therapeutic-trial-in-neuroendocrine-cancer-patients.html</loc>
		<lastmod>2009-08-07T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-serono.html</loc>
		<lastmod>2009-08-06T20:46:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alnylam-pharmaceuticals-reports-second-quarter-2009-financial-results.html</loc>
		<lastmod>2009-08-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vabio-exclusive-bioscience-financial-markets-briefing-with-jp-morgan.html</loc>
		<lastmod>2009-08-05T18:17:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/traditional-chinese-medicine-database.html</loc>
		<lastmod>2009-08-05T09:43:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cell-therapeutics-second-quarter-net-loss-decreases-54-pixantrone-nda-submitted-to-the-fda-for-approval.html</loc>
		<lastmod>2009-08-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neurogesx-announces-new-pdufa-date-for-qutenzatm-new-drug-application.html</loc>
		<lastmod>2009-08-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/impax-laboratories-receives-final-fda-approval-for-generic-depakote%c2%ae-extended-release-500mg-tablets.html</loc>
		<lastmod>2009-08-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/exciton-technologies-receives-fda-approval-to-market-exsalttm.html</loc>
		<lastmod>2009-08-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kane-biotech-announces-amendment-to-warrant-terms-and-early-exercise-warrant-incentive-program.html</loc>
		<lastmod>2009-08-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aldagen-reaches-agreement-with-fda-on-a-special-protocol-assessment-spa-for-phase-3-trial-of-ald-301-for-critical-limb-ischemia.html</loc>
		<lastmod>2009-08-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/chemical-abstracts-service-and-scifinder.html</loc>
		<lastmod>2009-08-04T21:27:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/requirements-for-china-to-globalize-success-seen-in-domestic-biosimilars-market.html</loc>
		<lastmod>2009-08-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/adventrx-narrows-prior-guidance-on-nda-submission-timeline.html</loc>
		<lastmod>2009-08-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kamadas-biologics-license-application-for-iv-aat-to-treat-alpha-1-antitrypsin-deficiency-is-accepted-for-review-by-the-us-food-and-drug-administration.html</loc>
		<lastmod>2009-08-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clonacell%c2%ae-hy-96-well-protocol-stemcell-technologies.html</loc>
		<lastmod>2009-08-03T17:14:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dysport-proves-safe-effective-anti-wrinkle-treatment-ut-southwestern-plastic-surgeons-find.html</loc>
		<lastmod>2009-08-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/xenoport-announces-astellas%e2%80%99-plans-to-file-an-nda-for-xp13512-in-japan.html</loc>
		<lastmod>2009-08-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/video-fda-approves-invegar-sustennatm-for-the-acute-and-maintenance-treatment-of-schizophrenia.html</loc>
		<lastmod>2009-08-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/medivir-the-us-fda-approves-lipsovir%c2%ae-for-marketing-and-sales-in-us.html</loc>
		<lastmod>2009-08-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/special-effects-and-simulation-used-for-medical-training.html</loc>
		<lastmod>2009-08-03T05:53:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/medicon-valley-www-mva-org-medicon-valley-alliance.html</loc>
		<lastmod>2009-08-03T05:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biocair-cambridge-hls-supplier-protest.html</loc>
		<lastmod>2009-08-03T05:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/were-life-texas-am-college-of-agriculture-and-life-sciences-slideshow.html</loc>
		<lastmod>2009-08-03T05:52:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/purdue-pharmaceutical-products-l-p-and-transcept-pharmaceuticals-inc-sign-exclusive-agreement-to-commercialize-intermezzor-in-the-united-states.html</loc>
		<lastmod>2009-08-02T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/124-benzothiadiazine-derivatives.html</loc>
		<lastmod>2009-07-31T12:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/metabolic-profiling-methods-and-compositions-to-control-warfarin-therapy-personalized-medicine-for-control-of-coagulation-therapy-09-26.html</loc>
		<lastmod>2009-07-24T09:43:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/two-pharmas-better-than-one.html</loc>
		<lastmod>2009-07-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/health-care-vs-biotech.html</loc>
		<lastmod>2009-07-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/boosting-adaptive-clinical-trials.html</loc>
		<lastmod>2009-07-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pulsys%c2%ae-drug-delivery-technology.html</loc>
		<lastmod>2009-07-22T08:12:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bms-to-acquire-medarex.html</loc>
		<lastmod>2009-07-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/miglustat-shows-promise-in-treatment-for-cystic-fibrosis.html</loc>
		<lastmod>2009-07-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/jumping-on-next-gen-sequence-data-analysis.html</loc>
		<lastmod>2009-07-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/carpenter-builds-open-source-imaging-software.html</loc>
		<lastmod>2009-07-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/elsevier-cell-press-demo-the-%e2%80%9carticle-of-the-future%e2%80%9d.html</loc>
		<lastmod>2009-07-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hypertension-genes-found-in-black-americans.html</loc>
		<lastmod>2009-07-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/celera-pushes-boundaries-with-automated-workflows.html</loc>
		<lastmod>2009-07-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/were-life-2008.html</loc>
		<lastmod>2009-07-16T18:56:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-revealing-study-on-genetic-testing-for-alzheimer%e2%80%99s-disease.html</loc>
		<lastmod>2009-07-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pathway-genomics-joins-the-direct-to-consumer-genomics-parade.html</loc>
		<lastmod>2009-07-15T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/were-life-at-texas-am.html</loc>
		<lastmod>2009-07-14T17:15:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/apoe-variants-may-predict-age-of-onset-in-alzheimers.html</loc>
		<lastmod>2009-07-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lilly-innovation-and-drug-delivery-technology.html</loc>
		<lastmod>2009-07-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/roche-begins-cutting-jobs-at-genentech.html</loc>
		<lastmod>2009-07-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology-program-health-sciences-3-blog-nights-thu-10am.html</loc>
		<lastmod>2009-07-07T21:03:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/transdermal-fentanyl.html</loc>
		<lastmod>2009-07-07T09:20:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology-an-introduction.html</loc>
		<lastmod>2009-07-01T17:36:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-to-in-license-late-stage-or-marketed-products-for-commercialization-though-solvay%e2%80%99s-strong-commercial-presence-in-emerging-markets.html</loc>
		<lastmod>2009-06-29T21:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/idbs-acquires-inforsense-in-uk-software-merger.html</loc>
		<lastmod>2009-06-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/i%e2%80%99m-a-celebrity-diagnosis-get-me-a-teachable-moment.html</loc>
		<lastmod>2009-06-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vaccination-for-treating-psychological-disorder.html</loc>
		<lastmod>2009-06-25T20:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pon1-for-treatment-of-atherosclerosis.html</loc>
		<lastmod>2009-06-25T20:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dynamic-proteomics-methods-for-discovering-drug-targets-by-analysis-of-individual-cells.html</loc>
		<lastmod>2009-06-25T20:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/parp-inhibitors-show-promise-treating-hereditary-breast-cancer.html</loc>
		<lastmod>2009-06-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lo2a-lacrycon-dropyal-moisturizing-eye-drops.html</loc>
		<lastmod>2009-06-23T20:19:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/will-regulated-product-submission-rps-trump-ectd.html</loc>
		<lastmod>2009-06-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cloud-storage-alternatives-to-amazon-and-google.html</loc>
		<lastmod>2009-06-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clc-bio-to-launch-high-performance-computing-%e2%80%98genomics-machine%e2%80%99-at-ismb.html</loc>
		<lastmod>2009-06-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/parascale.html</loc>
		<lastmod>2009-06-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-approval-of-novartis-ilaris-validates-drug-repositioning.html</loc>
		<lastmod>2009-06-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-cosmetic-footcare.html</loc>
		<lastmod>2009-06-19T17:02:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-consumer-healthcare.html</loc>
		<lastmod>2009-06-19T17:02:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-pain-relief.html</loc>
		<lastmod>2009-06-19T17:02:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microsoft-names-les-jordan-as-bioit-alliance-director.html</loc>
		<lastmod>2009-06-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-licensing-the-products-mentioned-to-goldshield-for-europe-markets.html</loc>
		<lastmod>2009-06-17T16:43:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/virus-halts-orphan-drug-production-at-genzyme-plant.html</loc>
		<lastmod>2009-06-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/boston-hospital-to-collect-patient-genomic-data.html</loc>
		<lastmod>2009-06-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ors-effervescent-tablet-oral-rehydration-salts.html</loc>
		<lastmod>2009-06-13T09:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/world-science-festival-takes-manhattan.html</loc>
		<lastmod>2009-06-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/illumina-to-offer-48000-personal-genome-sequencing-service.html</loc>
		<lastmod>2009-06-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microparticle-based-topical-formulations.html</loc>
		<lastmod>2009-06-11T01:33:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/four-pharmas-invest-in-aileron-biotech.html</loc>
		<lastmod>2009-06-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gq-names-rock-stars-of-science.html</loc>
		<lastmod>2009-06-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/got-pubmed-pubget-searches-and-delivers-scientific-pdfs.html</loc>
		<lastmod>2009-06-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/consumer-genomics-takes-off.html</loc>
		<lastmod>2009-06-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/scientists-predict-1000-genome-in-2011.html</loc>
		<lastmod>2009-06-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sd-281-an-immunomodulatory-compound-with-a-novel-anti-inflammatory-profile.html</loc>
		<lastmod>2009-06-04T21:19:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sd-208-an-anti-inflammatory-prodrug-near-phase-i-moderate-to-severe-psoriasis.html</loc>
		<lastmod>2009-06-04T21:19:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/srni-compounds-ad-337-phase-iib-fibromyalgia-sd-726-phase-i-neuropathic-pain-and-analogues.html</loc>
		<lastmod>2009-06-04T21:19:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aamc-hhmi-issue-report-on-physician-scientific-literarcy-in-the-21st-century.html</loc>
		<lastmod>2009-06-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/scientists-engineer-counting-networks-in-bacteria.html</loc>
		<lastmod>2009-06-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/information-you-can-bank-on.html</loc>
		<lastmod>2009-06-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/uses-for-human-ugt-glucuronosyltransferases-to-enhance-pain-control-by-cannabinoids-and-possible-activation-of-classical-cannabinoids-a-new-class-api-derivatives-09-23.html</loc>
		<lastmod>2009-06-03T20:34:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ucsf-opens-new-135-million-cancer-research-center.html</loc>
		<lastmod>2009-06-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microsoft-acquires-rosetta-biosoftware-to-aid-amalga-life-sciences.html</loc>
		<lastmod>2009-06-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sdbns-social-media-for-scientists-event-presentation-may-28th-2009.html</loc>
		<lastmod>2009-05-30T19:37:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-drug-targets-identified-in-kras-cancers.html</loc>
		<lastmod>2009-05-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pacific-biosciences-nets-eric-schadt-as-chief-scientific-officer.html</loc>
		<lastmod>2009-05-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/exclusive-stephen-friend-on-the-road-from-merck-to-sage.html</loc>
		<lastmod>2009-05-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/specific-inhibition-of-adam-proteases.html</loc>
		<lastmod>2009-05-27T10:03:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pravafen%c2%ae-%e2%80%93-for-treatment-of-mixed-dyslipidemia.html</loc>
		<lastmod>2009-05-27T10:03:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biovista%e2%80%99s-unusual-brand-of-in-silico-drug-discovery.html</loc>
		<lastmod>2009-05-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/isilon%e2%80%99s-data-storage-odyssey.html</loc>
		<lastmod>2009-05-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibody-docking-on-the-amazon-cloud.html</loc>
		<lastmod>2009-05-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/swine-flus-long-history.html</loc>
		<lastmod>2009-05-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-vagaries-of-genome-variation-do-you-copy.html</loc>
		<lastmod>2009-05-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/will-consumers-sustain-direct-to-consumer-genomics.html</loc>
		<lastmod>2009-05-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/what%e2%80%99s-on-life-sciences-tv.html</loc>
		<lastmod>2009-05-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/putting-the-alpha-in-alabama.html</loc>
		<lastmod>2009-05-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genetically-engineered-t-regs-for-use-in-suppression-of-autoimmune-and-inflammatory-diseases.html</loc>
		<lastmod>2009-05-23T01:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genomic-tagging-strategy-for-localization-of-mrna-within-living-cells.html</loc>
		<lastmod>2009-05-23T01:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cten-a-novel-target-of-egfr-which-mediates-cell-migration.html</loc>
		<lastmod>2009-05-23T01:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sticky-c.html</loc>
		<lastmod>2009-05-23T01:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/administration-of-reversibly-pegylated-epinephrine-derivative-enhances-repopulation-of-hematopoietic-progenitors.html</loc>
		<lastmod>2009-05-23T01:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/regulation-of-myelination-by-nectin-like-molecules.html</loc>
		<lastmod>2009-05-23T01:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-target-for-regulating-lymphangiogenesis-and-lymph-node-metastasis.html</loc>
		<lastmod>2009-05-23T01:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/multifanctional-albumin-conjugates.html</loc>
		<lastmod>2009-05-23T01:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/increasing-the-efficiency-of-chemotherapy-by-modulating-the-function-of-dna-polymerase-kappa.html</loc>
		<lastmod>2009-05-23T01:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hsp60-biomarker-for-muscle-invasion-in-bladder-cancer.html</loc>
		<lastmod>2009-05-23T01:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-003-cancer-serum-biomarker-system-for-basic-and-pre-clinical-research-in-genetically-engineered-mouse-models-of-prostate-cancer.html</loc>
		<lastmod>2009-05-21T23:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-001-autoimmune-disease-immunomodulation-using-rna-interference.html</loc>
		<lastmod>2009-05-21T23:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/micro-pressure-sensor.html</loc>
		<lastmod>2009-05-21T23:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-004-cancer-novel-sirna-based-strategy-for-treatment-of-cancer-through-silencing-of-genes-involved-in-tumor-protection.html</loc>
		<lastmod>2009-05-21T23:35:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biomedical-field-trip.html</loc>
		<lastmod>2009-05-21T17:19:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clovis-oncology-raises-145-million-on-launch.html</loc>
		<lastmod>2009-05-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nih-plans-new-institute-for-neglected-diseases.html</loc>
		<lastmod>2009-05-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nst0037-anti-epileptic-anticonvulsivant-antioxidant-and-neuroprotective-compound-for-neurodegenerative-and-aging-processes.html</loc>
		<lastmod>2009-05-20T22:32:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/statin-derivatives-for-inhibitingpreventing-the-progression-of-alzheimer%c2%b4s-disease.html</loc>
		<lastmod>2009-05-20T22:32:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mdf004-and-mdf005-polyphenols-with-potent-neuroprotectant-activity-for-the-treatment-of-acute-neuronal-damage-and-disability.html</loc>
		<lastmod>2009-05-20T22:32:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/headlining-bio-sir-elton-john-demands-aids-action.html</loc>
		<lastmod>2009-05-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-the-treatment-of-corns-calluses-and-bunions.html</loc>
		<lastmod>2009-05-19T21:44:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/iressa-instructs-astrazenecas-new-cancer-strategy.html</loc>
		<lastmod>2009-05-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/1000-genomes-project-promises-bespoke-treatment-for-disease.html</loc>
		<lastmod>2009-05-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/out-licensing-of-modified-release-gabapentin-a-non-hormonal-prescription-product-for-the-treatment-of-menopausal-hot-flushesflashes-and-related-symptoms-associated-with-cancer-therapies.html</loc>
		<lastmod>2009-05-18T20:40:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/period-one-table-one-presents-biotech-squad-and-the-immune-response.html</loc>
		<lastmod>2009-05-18T20:40:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/using-its-proprietary-novasperse%e2%84%a0-nanoparticle-technology-pharmanova-seeks-partners-for-the-development-of-client-sponsored-apis-and-also-for-the-partnered-development-of-a-series-of-new-prod.html</loc>
		<lastmod>2009-05-18T20:40:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/wolfram-alphas-computational-knowledge-engine.html</loc>
		<lastmod>2009-05-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/for-1-per-gene-knome-launches-24500-genome-sequencing-service.html</loc>
		<lastmod>2009-05-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-and-use-of-glycoprotein-vi-gpvi-receptor-inhibitors-to-inhibit-arthritis-and-other-inflammatory-disorders-09-16.html</loc>
		<lastmod>2009-05-16T13:05:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/synthesis-of-glycoconjugates-of-the-lewis-y-epitope-and-uses-thereof.html</loc>
		<lastmod>2009-05-15T10:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/transformation-progression-related-genes-and-their-use.html</loc>
		<lastmod>2009-05-15T10:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/compositions-and-methods-for-detecting-and-treating-prostate-cancer.html</loc>
		<lastmod>2009-05-15T10:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-for-modulating-angiogenesis.html</loc>
		<lastmod>2009-05-15T10:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/compositions-and-methods-for-detecting-and-treating-breast-cancer.html</loc>
		<lastmod>2009-05-15T10:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/differentiation-associated-sequences-and-methods-of-use-therefor.html</loc>
		<lastmod>2009-05-15T10:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/photocleavable-fluorescent-nucleotides-for-dna-and-rna-sequencing-on-a-chip.html</loc>
		<lastmod>2009-05-15T10:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/unique-composition-of-matter-liposome-carrier-for-site-specific-delivery-of-chemotheraprtic-polypeptides-toxins-radiotherapeutic-and-radiosensitizing-agents-09-07.html</loc>
		<lastmod>2009-05-15T10:48:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/surgical-device-alarm-to-report-availability-of-balanced-salt-irrigation-solution-during-surgical-procedures-07-28.html</loc>
		<lastmod>2009-05-14T10:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/system-for-minimally-invasive-same-day-treatment-of-breast-cancer-01-19.html</loc>
		<lastmod>2009-05-14T10:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/target-peptides-for-ovarian-cancer-immunotherapy-07-02.html</loc>
		<lastmod>2009-05-14T10:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/toxicity-reduction-of-radiation-toxicity-97-17.html</loc>
		<lastmod>2009-05-14T10:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tuberculosis-diagnostic-testing-90-01.html</loc>
		<lastmod>2009-05-14T10:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tumor-therapeutic-targets-97-07.html</loc>
		<lastmod>2009-05-14T10:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ultrasonic-guided-catheter-deployment-system-02-14.html</loc>
		<lastmod>2009-05-14T10:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-statins-in-disorders-associated-with-reduced-endothelial-thrombomodulin-03-03.html</loc>
		<lastmod>2009-05-14T10:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/staphylococcus-aureus-binding-sites-for-sara-99-23.html</loc>
		<lastmod>2009-05-14T10:36:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/british-scientists-define-possible-origin-of-rna-world.html</loc>
		<lastmod>2009-05-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/inhibitors-of-platelet-glycoprotein-iba-as-anti-tumor-agents-07-07.html</loc>
		<lastmod>2009-05-13T07:50:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/increasing-bone-strength-with-selected-biophosphonates-99-09.html</loc>
		<lastmod>2009-05-13T07:50:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-vitro-and-in-vivo-models-for-screening-compounds-to-prevent-glucocorticoid-induced-bone-destruction-99-01.html</loc>
		<lastmod>2009-05-13T07:50:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lung-volume-in-infants-measuring-residual-99-11.html</loc>
		<lastmod>2009-05-13T07:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/locomotion-induction-by-electrical-stimulation-of-the-spinal-cord-88-07.html</loc>
		<lastmod>2009-05-13T07:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ipump%c2%ae-the-image-pumping-utility-to-bridge-the-gap-between-igrt-and-rv-systems-in-radiation-therapy-08-05.html</loc>
		<lastmod>2009-05-13T07:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/intraocular-fibrin-and-inflammation-prevention-94-08.html</loc>
		<lastmod>2009-05-13T07:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/inhibitors-of-staphylococcus-sara-protein-function-involved-in-the-expression-of-stahpylococcal-virulence-factors-and-the-use-thereof-in-treating-staphylococcal-infections-99-23.html</loc>
		<lastmod>2009-05-13T07:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/maintenance-and-propagation-of-mesenchymal-stem-cells-07-12.html</loc>
		<lastmod>2009-05-13T07:50:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/malaysian-prime-minister-454-celebrate-oil-palm-genome.html</loc>
		<lastmod>2009-05-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/skin-care-ingredients.html</loc>
		<lastmod>2009-05-12T07:02:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microsoft-%e2%80%9ccommitted%e2%80%9d-to-bioit-alliance-despite-pharma-group-cuts.html</loc>
		<lastmod>2009-05-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/are-mexicans-genetically-susceptible-to-the-h1n1-virus.html</loc>
		<lastmod>2009-05-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cancer-patients-challenge-myriads-brca-gene-patents.html</loc>
		<lastmod>2009-05-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bipodal-peptide-binder.html</loc>
		<lastmod>2009-05-11T07:01:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-biological-surfactant-as-anti-flammatory-agent-and-tissue-preservative-solution.html</loc>
		<lastmod>2009-05-11T07:01:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-better-g-csf-offers-a-flexible-and-patient-friendly-approach-to-neutropenia-in-dose-dense-chemotherapy-schemes.html</loc>
		<lastmod>2009-05-08T23:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/op-145-novel-topical-therapeutic-for-the-treatment-of-chronic-middle-ear-infection.html</loc>
		<lastmod>2009-05-08T23:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/temperature-sensitive-nanocarriers.html</loc>
		<lastmod>2009-05-08T23:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-trim72-as-a-target-for-muscle-and-heart-enhancer.html</loc>
		<lastmod>2009-05-08T23:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-inhibitors-of-leukotriene-b4-receptor-blt2-for-treating-human-cancers.html</loc>
		<lastmod>2009-05-08T23:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/longer-acting-tacrolimus-for-predictable-and-patient-friendly-immune-suppression-in-transplant-recipients.html</loc>
		<lastmod>2009-05-08T23:03:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/etrials-purchase-would-make-bioclinica-number-three-edc-player.html</loc>
		<lastmod>2009-05-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novartis-leases-more-space-from-mit-for-expansion.html</loc>
		<lastmod>2009-05-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibodies-available.html</loc>
		<lastmod>2009-05-07T22:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ttbk1-transgenic-mouse-model.html</loc>
		<lastmod>2009-05-07T22:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/muc1-expressing-pancreatic-tumor-cell-line.html</loc>
		<lastmod>2009-05-07T22:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ahec-database-system.html</loc>
		<lastmod>2009-05-07T22:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/impression-orientation-guide.html</loc>
		<lastmod>2009-05-07T22:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-the-treatment-of-obesity.html</loc>
		<lastmod>2009-05-07T22:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ventilating-push-rod.html</loc>
		<lastmod>2009-05-07T22:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/animal-intravascular-catheter-2.html</loc>
		<lastmod>2009-05-07T22:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/chemoenzymatic-synthesis-of-tamiflu-oseltamivir-andor-tamiflu-derivatives.html</loc>
		<lastmod>2009-05-07T22:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/devices-for-sexual-well-being.html</loc>
		<lastmod>2009-05-07T22:59:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/canada-lab-claims-h1n1-virus-sequenced.html</loc>
		<lastmod>2009-05-07T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/wolfram-alpha-vs-google.html</loc>
		<lastmod>2009-05-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/medicare-refuses-to-pay-for-warfarin-test.html</loc>
		<lastmod>2009-05-05T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/an-improved-medical-laser-for-dermal-applications-personalized-interactive-laser-therapy-pilt-of-port-wine-stain-and-other-surface-applications-09-14.html</loc>
		<lastmod>2009-05-01T15:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cancer-metastasis-therapeutics-which-block-cancer-cell-surface-transport-and-tissue-distribution-06-14-cip-09-06.html</loc>
		<lastmod>2009-05-01T15:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hesylation.html</loc>
		<lastmod>2009-05-01T15:36:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cellophiltm-biomedical-polymer-new-and-superior-biomedical-polymers-for-a-new-standard-in-the-medical-device-industry.html</loc>
		<lastmod>2009-05-01T15:36:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diclofenac-potassium-oral-drops-at-5.html</loc>
		<lastmod>2009-05-01T15:36:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ketoprofen-patch.html</loc>
		<lastmod>2009-05-01T15:36:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/glucosamine-sulphate-ctd-dossier-for-treatment-of-osteoarthritis-ready-for-registration.html</loc>
		<lastmod>2009-05-01T15:36:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genome-study-illuminates-africa.html</loc>
		<lastmod>2009-05-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kode%e2%84%a2-biosurface-engineering-technology-part-2-applications-of-kode-technology.html</loc>
		<lastmod>2009-04-30T02:07:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antioxidants-reactive-oxygen-species-and-oxidative-stress.html</loc>
		<lastmod>2009-04-29T10:46:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-center-for-genomic-technologies.html</loc>
		<lastmod>2009-04-29T10:46:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-center-for-process-development.html</loc>
		<lastmod>2009-04-29T10:46:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-parasitology-laboratory.html</loc>
		<lastmod>2009-04-29T10:46:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biofilm-research-laboratory.html</loc>
		<lastmod>2009-04-29T10:46:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/organic-and-organometallic-synthesis-laboratory.html</loc>
		<lastmod>2009-04-29T10:46:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/allergy-and-immunopharmacology-laboratory.html</loc>
		<lastmod>2009-04-29T10:46:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/traumatic-brain-injury-laboratory.html</loc>
		<lastmod>2009-04-29T10:46:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rubinstein-services-animal-models-for-colon-cancer.html</loc>
		<lastmod>2009-04-29T10:46:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/combined-test-for-microrna-target-identification-and-validation.html</loc>
		<lastmod>2009-04-29T10:46:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microsoft-launches-amalga-life-sciences.html</loc>
		<lastmod>2009-04-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/immunotherapies-creating-new-tools-to-fight-cancer-and-other-diseases.html</loc>
		<lastmod>2009-04-28T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tds%c2%ae-liquid-transdermal-delivery-system.html</loc>
		<lastmod>2009-04-28T10:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/proprietary-drug-delivery-systems-octodex-polyactive-and-synbiosys.html</loc>
		<lastmod>2009-04-28T10:07:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/op-145-a-novel-approach-to-treat-chronic-middle-ear-infection.html</loc>
		<lastmod>2009-04-28T10:07:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-childrens-medicines.html</loc>
		<lastmod>2009-04-28T10:07:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-coughs-and-colds.html</loc>
		<lastmod>2009-04-28T10:07:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/corey-goodman-resigns-as-pfizer-bbc-chief.html</loc>
		<lastmod>2009-04-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-it-world-expo-2009-the-dagdigian-doctrine.html</loc>
		<lastmod>2009-04-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kode%e2%84%a2-live-cell-surface-modification-technology-now-outdated-2.html</loc>
		<lastmod>2009-04-25T17:16:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cyclic-heat-%e2%80%93-cold-thermal-therapy-device-for-improved-solid-tumor-ablation-09-17.html</loc>
		<lastmod>2009-04-25T06:48:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-%ce%b1-bisabolol.html</loc>
		<lastmod>2009-04-25T06:48:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/utilization-of-fluorescent-dye-for-identification-and-preservation-of-the-facial-nerve-and-semicircular-canals-for-safe-mastoidectomy-09-11.html</loc>
		<lastmod>2009-04-25T06:48:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-68000-question-knome-auctions-genome-on-ebay.html</loc>
		<lastmod>2009-04-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kode%e2%84%a2-biosurface-engineering-technology-part-1-about-kode-technology.html</loc>
		<lastmod>2009-04-24T18:59:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/now-patients-can-tweet-for-trials.html</loc>
		<lastmod>2009-04-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/liposome-gene-therapy-offers-hope-for-cystic-fibrosis.html</loc>
		<lastmod>2009-04-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/repeat-sequences-of-the-ca125-gene-and-their-use-for-diagnostic-and-therapeutic-interventions-01-07-dcv.html</loc>
		<lastmod>2009-04-23T23:36:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biosurface-engineering-using-kode%e2%84%a2-constructs-part-1-about-the-technology.html</loc>
		<lastmod>2009-04-23T19:04:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genomes-on-ebay.html</loc>
		<lastmod>2009-04-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ensembl-genomes-expands-and-tackles-growing-sequencing-data.html</loc>
		<lastmod>2009-04-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dominant-cd8-t-cell-epitope-that-blocks-infection-by-hpv-06-06-05-13.html</loc>
		<lastmod>2009-04-21T22:18:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oracle-buys-sun.html</loc>
		<lastmod>2009-04-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gene-therapy-for-cystic-fibrosis.html</loc>
		<lastmod>2009-04-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amgens-new-angiogenesis-website.html</loc>
		<lastmod>2009-04-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mark-boguskis-resounding-health.html</loc>
		<lastmod>2009-04-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gsk-pfizer-merge-hiv-portfolios.html</loc>
		<lastmod>2009-04-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/geneticists-debate-the-value-of-genome-wide-association-studies.html</loc>
		<lastmod>2009-04-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ensemble-partners-with-bristol-myers-squibb-in-chemical-space-exploration.html</loc>
		<lastmod>2009-04-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/infinity-falls-to-earth-as-lead-cancer-drug-trial-halted.html</loc>
		<lastmod>2009-04-15T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/parkinson%c2%b4s-transdermal-patch.html</loc>
		<lastmod>2009-04-14T17:42:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alzheimer%c2%b4s-transdermal-patch.html</loc>
		<lastmod>2009-04-14T17:42:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pfizers-reorg-focuses-on-biotech.html</loc>
		<lastmod>2009-04-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hhmi-allen-institute-launch-diadem-imaging-challenge.html</loc>
		<lastmod>2009-04-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/force-of-nature-tales-of-the-late-sir-john-maddox.html</loc>
		<lastmod>2009-04-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sympres-and-sympres-xr-for-the-treatment-of-hypertension.html</loc>
		<lastmod>2009-04-13T17:40:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/drug-design-by-cell-origami.html</loc>
		<lastmod>2009-04-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/changes-in-the-expression-of-proteasome-genes-in-tumor-cells-following-short-term-proteasome-inhibitor-therapy-predicts-survival-in-multiple-myeloma-treated-with-bortezomib-containing-multi-agent-chem.html</loc>
		<lastmod>2009-04-10T15:12:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bilisuit-%e2%80%93-a-fiber-optic-led-form-fitting-garment-for-treatment-of-infant-hyperbilirubinemia-09-03.html</loc>
		<lastmod>2009-04-10T15:12:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bortezomib-induces-osteoblast-differentiation-via-wnt-independent-activation-of-beta-catenintcf-signaling-09-04.html</loc>
		<lastmod>2009-04-10T15:12:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mash-multiple-angle-switched-hifu-high-intensity-focused-ultrasound-for-precise-and-localized-drug-delivery-08-25.html</loc>
		<lastmod>2009-04-10T15:12:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/economics-of-personal-genomics.html</loc>
		<lastmod>2009-04-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/beckman-coulter-buys-genomics-unit.html</loc>
		<lastmod>2009-04-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lordy-me-navigenics-names-jonathan-lord-new-ceo.html</loc>
		<lastmod>2009-04-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-it-world-expo-bound-for-europe-and-biotechnica.html</loc>
		<lastmod>2009-04-07T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vaccine-for-protection-against-leishmaniasis-in-animals.html</loc>
		<lastmod>2009-04-06T12:47:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-bourne-commendation-open-access-evangelist-wins-2009-benjamin-franklin-award.html</loc>
		<lastmod>2009-04-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dietrich-stephan-plans-individualized-health-institute-in-virginia.html</loc>
		<lastmod>2009-04-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/codon-devices-closing-as-financing-dwindles.html</loc>
		<lastmod>2009-04-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/monitoring-merrimack-pharmaceutical%e2%80%99s-marathon-run.html</loc>
		<lastmod>2009-04-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clc-bio-enjoys-playing-the-april-fool.html</loc>
		<lastmod>2009-04-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/decode-genetics-in-a-%e2%80%9ctough-spot%e2%80%9d-admits-stefansson.html</loc>
		<lastmod>2009-04-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-drug-discovery-platform-technology-and-early-stage-compounds-for-inflammation-cancer-alzheimers-disease-and-viral-diseases.html</loc>
		<lastmod>2009-03-30T06:09:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hhmi-creates-new-program-for-50-early-career-scientists.html</loc>
		<lastmod>2009-03-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/roche-takeover-of-genentech-final.html</loc>
		<lastmod>2009-03-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-inflammatory-lead-compounds-with-an-entirely-new-mechanism-of-action.html</loc>
		<lastmod>2009-03-27T05:36:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-lead-compounds-targeting-vascular-endothelial-growth-factor-vegf-for-inflammatory-and-autoimmune-disorders.html</loc>
		<lastmod>2009-03-27T05:36:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/how-my-genome-was-hacked.html</loc>
		<lastmod>2009-03-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nanofluidics-technology-could-revolutionize-genetic-analysis.html</loc>
		<lastmod>2009-03-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/radiotracers-for-imaging-p-glycoprotein-transporter-function.html</loc>
		<lastmod>2009-03-25T04:41:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dendrimer-conjugates-targeting-adenosine-receptors-p2y-receptors-and-other-receptors-of-the-gpcr-superfamily-for-use-in-the-treatment-of-various-disorders-including-neurodegenerative-diseases-stro.html</loc>
		<lastmod>2009-03-25T04:41:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/integrating-clinical-and-genomics-data.html</loc>
		<lastmod>2009-03-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/treatment-of-schistosomiasis-using-substituted-oxadiazole-2-oxides.html</loc>
		<lastmod>2009-03-21T00:08:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-hepatitis-c-virus-activity-of-the-protein-scytovirin-svn.html</loc>
		<lastmod>2009-03-21T00:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-of-making-a-vaccine.html</loc>
		<lastmod>2009-03-21T00:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-technologies-says-venter-will-assist-on-next-next-generation-sequencer.html</loc>
		<lastmod>2009-03-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/harvard-research-centers-face-drop-in-private-funding.html</loc>
		<lastmod>2009-03-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/agonist-epitopes-for-renal-cell-carcinoma.html</loc>
		<lastmod>2009-03-19T21:49:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/adoptive-t-cell-transfer-after-lymphodepletion-promotes-tumor-regression.html</loc>
		<lastmod>2009-03-19T21:49:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/t-cell-receptor-recognizing-renal-cell-carcinoma.html</loc>
		<lastmod>2009-03-19T21:49:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-human-igf-1-specific-igf-i-and-igf-ii-cross-reactive-human-monoclonal-antibodies-as-potential-anti-tumor-agents.html</loc>
		<lastmod>2009-03-19T21:49:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/immortal-human-prostate-epithelial-cell-cultures-as-a-prostate-cancer-model.html</loc>
		<lastmod>2009-03-19T21:49:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hybrid-t-cell-receptors-for-the-development-of-improved-vaccines.html</loc>
		<lastmod>2009-03-19T21:49:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/humanized-anti-carcinoma-cc49-monoclonal-antibodies.html</loc>
		<lastmod>2009-03-19T21:49:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diagnostic-and-therapeutic-strategies-for-metastatic-hepatocellular-carcinoma-by-targeting-osteopontin.html</loc>
		<lastmod>2009-03-19T21:49:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-cripto-1-as-a-biomarker-for-neurodegenerative-disease-and-method-of-inhibiting-progression-thereof.html</loc>
		<lastmod>2009-03-19T21:49:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hhmi-funds-hiv-tuberculosis-institute-in-south-africa.html</loc>
		<lastmod>2009-03-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ibm-in-talks-to-buy-sun-microsystems.html</loc>
		<lastmod>2009-03-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/contrast-agents-for-use-with-computer-tomography-radiography-and-magnetic-resonance-imaging.html</loc>
		<lastmod>2009-03-17T20:41:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/iron-sucrose.html</loc>
		<lastmod>2009-03-17T20:41:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/azithromycin.html</loc>
		<lastmod>2009-03-17T20:41:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/googles-sergey-brin-backs-23andme-parkinsons-study-2.html</loc>
		<lastmod>2009-03-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/data-from-alzheimers-genome-wide-study-to-be-released.html</loc>
		<lastmod>2009-03-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/twinject%c2%ae-epinephrine-auto-injector-licensing-opportunity-for-territories-outside-of-north-america.html</loc>
		<lastmod>2009-03-14T13:49:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/googles-sergey-brin-backs-23andme-parkinsons-study.html</loc>
		<lastmod>2009-03-12T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/entelos-prognosis-test-plugged-on-nbc.html</loc>
		<lastmod>2009-03-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/454-next-gen-sequencing-identifies-type-1-diabetes-protective-gene.html</loc>
		<lastmod>2009-03-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-to-buy-schering-plough-in-41-billion-deal.html</loc>
		<lastmod>2009-03-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/obama-links-stem-cell-research-and-scientific-integrity.html</loc>
		<lastmod>2009-03-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lasonolide-compounds-as-reagents-for-inducing-premature-chromosome-condensation-and-methods-of-treating-cancer.html</loc>
		<lastmod>2009-03-07T07:39:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/increased-image-quality-for-early-colon-polyp-detection.html</loc>
		<lastmod>2009-03-07T07:39:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gene-signature-for-predicting-hepatocellular-carcinoma-patient-prognosis.html</loc>
		<lastmod>2009-03-07T07:39:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/adoptive-immunotherapy-with-autologous-natural-killer-cells.html</loc>
		<lastmod>2009-03-07T07:39:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/adoptive-immunotherapy-with-t-lymphocytes-engineered-for-enhanced-survival.html</loc>
		<lastmod>2009-03-07T07:39:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-anthrax-lethal-factor-to-treat-cancer-and-screening-methods-for-mapk-kinase-protease-activity.html</loc>
		<lastmod>2009-03-07T07:39:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/crix-is-operating-and-launching-firebird-pilot.html</loc>
		<lastmod>2009-03-06T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/helicos-founder-steve-quake-sequences-his-genome.html</loc>
		<lastmod>2009-03-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/with-genomes-bigger-may-really-be-better.html</loc>
		<lastmod>2009-03-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mass-general-to-use-genetics-to-personalize-cancer-care.html</loc>
		<lastmod>2009-03-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-execs-see-%e2%80%98sage%e2%80%99-as-key-ingredient-for-disease-biology.html</loc>
		<lastmod>2009-03-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/complete-genomics-broad-institute-forge-cancer-sequencing-collaboration.html</loc>
		<lastmod>2009-03-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mercks-friend-schadt-launch-open-source-drug-development-enterprise.html</loc>
		<lastmod>2009-03-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gene-therapy-moves-closer-to-a-cure.html</loc>
		<lastmod>2009-03-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/stem-cell-breakthrough-could-end-ethical-dilemma.html</loc>
		<lastmod>2009-03-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/multiple-acne-formulations.html</loc>
		<lastmod>2009-02-27T00:03:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/technology-for-treatment-of-melasma-and-hyperpigmentation.html</loc>
		<lastmod>2009-02-27T00:03:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-tetracyclines-as-anti-cancer-agents.html</loc>
		<lastmod>2009-02-25T23:32:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prevention-of-head-and-neck-cancer-using-rapamycin-and-its-analogs.html</loc>
		<lastmod>2009-02-25T23:32:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/glutathione-s-transferase-clones-for-members-of-the-ubiquitin-dependent-protein-degradation-pathway.html</loc>
		<lastmod>2009-02-25T23:32:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kode%e2%84%a2-live-cell-surface-modification-technology-now-outdated.html</loc>
		<lastmod>2009-02-21T19:20:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-opportunities-for-consumer-healthcare-products-and-molecules-with-rx-to-otc-switch-potential.html</loc>
		<lastmod>2009-02-20T20:22:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-development-opportunities-with-novel-delivery-technologies-for-oral-topical-and-transdermal-products.html</loc>
		<lastmod>2009-02-20T20:22:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/transgenic-mice-as-models-of-human-pathologies-for-the-screening-of-new-therapeutic-targets.html</loc>
		<lastmod>2009-02-20T20:22:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech-boom-hits-boston-necn.html</loc>
		<lastmod>2009-02-20T17:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/computational-analysis-of-nucleic-acid-information-defines-binding-sites.html</loc>
		<lastmod>2009-02-19T20:03:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-gift-of-health.html</loc>
		<lastmod>2009-02-17T17:15:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/virtual-reality-medical-center.html</loc>
		<lastmod>2009-02-14T23:08:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kode%e2%84%a2-live-cell-surface-modification-technology.html</loc>
		<lastmod>2009-02-13T17:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/system-for-synergistic-combination-of-multiple-automatic-induction-methods-and-automatic-re-representation-of-data.html</loc>
		<lastmod>2009-02-13T16:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/immlabs-primary-product-a-therapeutic-staphylococcal-lysate-sl-as-described-in-our-patent-6929798-and-7329409-granted-by-the-us-patent-and-trademark-office.html</loc>
		<lastmod>2009-02-12T14:13:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/quantitative-real-time-rt-pcr-array-for-detection-of-human-herpesvirus-6a-gene-expression.html</loc>
		<lastmod>2009-02-12T14:13:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mammalian-%ce%b2-galctosidase-reporter-genes.html</loc>
		<lastmod>2009-02-11T14:12:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hiv-1-gag-monoclonal-antibodies.html</loc>
		<lastmod>2009-02-11T14:12:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/web-portal-aids-teamwork-workflow-of-cystic-fibrosis-research.html</loc>
		<lastmod>2009-02-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/medidata-on-avoiding-the-pitfalls-of-edc-training.html</loc>
		<lastmod>2009-02-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/wow-uw-research-labs.html</loc>
		<lastmod>2009-02-07T17:27:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/deazaflavin-compounds-and-methods-of-use-thereof.html</loc>
		<lastmod>2009-02-07T09:26:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-006-infectious-diseases-compositions-and-methods-for-passive-immunity.html</loc>
		<lastmod>2009-02-07T09:26:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/what-is-biotechnology.html</loc>
		<lastmod>2009-02-04T17:26:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/unichem-laboratories-ltd-india-seeks-opportunities-for-in-licensing-of-ndds-and-regular-versions-of-pharmaceutical-formulations-for-the-high-potential-indian-market.html</loc>
		<lastmod>2009-02-04T07:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/constructs-for-measuring-activated-arf5-in-cells.html</loc>
		<lastmod>2009-02-04T07:22:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hmgn-polypeptides-as-immune-enhancers-and-hmgn-antagonists-as-immune-suppressants.html</loc>
		<lastmod>2009-02-04T07:22:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prognostic-test-for-breast-cancer-based-on-a-12-gene-expression-signature.html</loc>
		<lastmod>2009-02-04T07:22:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/adoptive-immunotherapy-for-reestablishing-hiv-specific-cytotoxic-t-cell-cd8-t-cell-function-in-hiv-and-aids-patients-and-methods-for-assessing-the-reestablishment-of-cd8-t-cell-function.html</loc>
		<lastmod>2009-02-04T07:22:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mouse-monoclonal-antibodies-to-mad1-a-human-spindle-assembly-checkpoint-protein-for-maintaining-chromosomal-segregation.html</loc>
		<lastmod>2009-02-04T07:22:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-parameterized-model-for-simulating-microarrays.html</loc>
		<lastmod>2009-02-04T07:22:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amediplase-a-thrombolytic-agent-for-treatment-of-acute-myocardial-infarct.html</loc>
		<lastmod>2009-02-03T06:47:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/unichem-laboratories-ltd-india-seeks-opportunities-for-in-licensing-of-ndds-and-regular-versions-of-pharmaceutical-formulations-2.html</loc>
		<lastmod>2009-02-03T06:47:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/unichem-laboratories-ltd-india-seeks-opportunities-for-in-licensing-of-ndds-and-regular-versions-of-pharmaceutical-formulations.html</loc>
		<lastmod>2009-02-03T06:47:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/making-drug-manufacturing-safer.html</loc>
		<lastmod>2009-02-02T19:35:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hylacare-product-line-with-hylasome%c2%ae.html</loc>
		<lastmod>2009-02-02T06:45:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/opana-er-ex-north-america-only.html</loc>
		<lastmod>2009-01-30T23:04:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-simple-organic-compounds-for-treating-obesity.html</loc>
		<lastmod>2009-01-29T21:06:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/treatment-for-viral-infections-influenza.html</loc>
		<lastmod>2009-01-29T21:06:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/recombinant-antibody-technology.html</loc>
		<lastmod>2009-01-29T21:06:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nucleosides-for-treatment-of-leishmania-infections.html</loc>
		<lastmod>2009-01-28T21:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/generic-version-of-nalbuphine-20-mg2ml-ampoule.html</loc>
		<lastmod>2009-01-27T20:45:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-mimotope-for-treatment-of-inflammation.html</loc>
		<lastmod>2009-01-27T20:45:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/approved-andas.html</loc>
		<lastmod>2009-01-27T20:45:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/l-dopa-amide-derivatives-for-treating-parkinsons-disease.html</loc>
		<lastmod>2009-01-27T20:45:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dermatology-skin-cancer-anti-fungals-dermoceuticals-more.html</loc>
		<lastmod>2009-01-24T19:09:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/generic-version-of-naltrexone-50-mg-film-tablet.html</loc>
		<lastmod>2009-01-22T18:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/generic-version-of-naloxone-04-mg1-ml-ampoule.html</loc>
		<lastmod>2009-01-22T18:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/generic-version-of-an-ultra-short-acting-beta-blocker-esmolol-2500-mg10-ml-ampoule.html</loc>
		<lastmod>2009-01-22T18:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/generic-version-of-an-ultra-short-acting-beta-blocker-esmolol-100mg10-ml-vial.html</loc>
		<lastmod>2009-01-22T18:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/generic-version-of-tetrabenazine-25-mg-tablets.html</loc>
		<lastmod>2009-01-22T18:11:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/knome-and-the-burden-of-knowing.html</loc>
		<lastmod>2009-01-21T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/high-dose-selenium-for-inflammatory-disease.html</loc>
		<lastmod>2009-01-19T17:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/early-diagnosis-of-preeclampsia.html</loc>
		<lastmod>2009-01-19T17:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/device-for-removal-of-amylase-from-body-fluids.html</loc>
		<lastmod>2009-01-19T17:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/controlled-release-pharmaceutical-preparations.html</loc>
		<lastmod>2009-01-19T17:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/controlled-release-oral-drug-delivery-system-containing-hydrogel-forming-polymer.html</loc>
		<lastmod>2009-01-19T17:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-new-aerosol-treatment-for-asthma-using-a-non-steroidal-complex-which-prevents-bronchial-remodelling.html</loc>
		<lastmod>2009-01-19T17:05:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bioteam39s-michael-cariaso-on-wikis-lims-and-snps.html</loc>
		<lastmod>2009-01-15T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bioteams-michael-cariaso-on-wikis-lims-and-snps.html</loc>
		<lastmod>2009-01-15T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oxford-nanopore-signs-next-generation-sequencing-deal-with-illumina.html</loc>
		<lastmod>2009-01-12T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/paul-bleicher-looking-back-at-phase-forward.html</loc>
		<lastmod>2009-01-09T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/afmanalyze-software-automation-and-analysis-of-atomic-force-microscopy-afm-data.html</loc>
		<lastmod>2008-12-25T11:37:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-and-efficient-technology-for-targeted-delivery-of-sirna.html</loc>
		<lastmod>2008-12-25T11:37:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/monoclonal-antibodies-to-the-tumor-specific-antigen-human-ror1.html</loc>
		<lastmod>2008-12-25T11:37:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/doxycycline-inducible-b16-melanoma-cell-lines-expressing-cxcr4-or-ccr10.html</loc>
		<lastmod>2008-12-25T11:37:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/145-dibenzobf-thiadiazepinez-56-dihydro-as-neuroprotective-agents-useful-for-the-treatment-of-alzheimer%c2%92s-and-other-neurodegenerative-diseases.html</loc>
		<lastmod>2008-12-23T10:59:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-azepane-derived-quaternary-amino-acids-and-their-applications.html</loc>
		<lastmod>2008-12-23T10:59:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-products-for-metabolic-diseases.html</loc>
		<lastmod>2008-12-23T10:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-topical-psoriasis-treatments.html</loc>
		<lastmod>2008-12-23T10:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-topical-acne-treatments.html</loc>
		<lastmod>2008-12-23T10:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mutant-nuclear-orphan-receptor-for-drug-metabolism-assays.html</loc>
		<lastmod>2008-12-18T10:29:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bioqatar-luring-biotech-dollars-to-the-desert.html</loc>
		<lastmod>2008-12-15T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dsec-recruits-pharmas-for-early-drug-safety-testing.html</loc>
		<lastmod>2008-12-15T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dsec-recruits-pharmas-for-early-drug-safety-testing-2.html</loc>
		<lastmod>2008-12-15T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hospital-iv-antibiotics.html</loc>
		<lastmod>2008-12-13T09:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmaceuticals-for-type-2-diabetes.html</loc>
		<lastmod>2008-12-13T09:13:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-014-cancerwound-healing-compositions-affecting-hyaluronic-acid-activity-for-the-treatment-of-cancer-and-wound-healing.html</loc>
		<lastmod>2008-12-12T07:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-013-rheumatoid-arthritis-novel-autoantigenic-peptides-for-use-in-the-diagnosis-and-treatment-of-rheumatoid-arthritis.html</loc>
		<lastmod>2008-12-12T07:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-012-cardiovascular-disease-novel-pharmacological-approach-for-the-control-of-homocysteine-levels-in-patients-with-end-stage-renal-disease.html</loc>
		<lastmod>2008-12-12T07:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-011-inflammation-preventing-il-2-mediated-inflammation-in-epithelial-cells.html</loc>
		<lastmod>2008-12-12T07:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-010-transplantation-sirna-containing-organ-storage-and-reperfusion-solution.html</loc>
		<lastmod>2008-12-12T07:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-005-ultrasound-transducer-mounting-assembly-for-3-d-ultrasound-imaging.html</loc>
		<lastmod>2008-12-12T07:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-004-ultrasound-3d-ultrasound-imaging-systems-and-methods-2.html</loc>
		<lastmod>2008-12-12T07:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-003-ultrasound-ultrasonic-blood-volume-flow-rate-meter.html</loc>
		<lastmod>2008-12-12T07:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-002-ultrasound-computer-controlled-positive-displacement-pump-for-physiological-blood-flow-simulation.html</loc>
		<lastmod>2008-12-12T07:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-001-magnetic-resonance-sliding-thin-slab-acquisition-of-mri-data-for-mra-slinky.html</loc>
		<lastmod>2008-12-12T07:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dagdigian-reid-and-schadt-to-headline-bio-it-world-expo-09.html</loc>
		<lastmod>2008-12-12T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/2009-clinical-trials-predictions-and-resolutions.html</loc>
		<lastmod>2008-12-12T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dagdigian-reid-and-schadt-to-headline-bio-it-world-expo-3909.html</loc>
		<lastmod>2008-12-12T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/climate-change-and-business.html</loc>
		<lastmod>2008-12-11T17:21:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bringing-personalized-medicine-to-cancer-patients.html</loc>
		<lastmod>2008-12-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eli-lilly-aims-for-800-million-pill-by-2010.html</loc>
		<lastmod>2008-12-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharma-restricts-drug-ads.html</loc>
		<lastmod>2008-12-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-to-make-generics.html</loc>
		<lastmod>2008-12-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genentech-roche%e2%80%99s-rituxan-drug-curbs-leukemia.html</loc>
		<lastmod>2008-12-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/improved-haematopoetic-stem-cell-expansion.html</loc>
		<lastmod>2008-12-11T06:50:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/invitrogen-foamaway-irradiated.html</loc>
		<lastmod>2008-12-10T17:20:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-day-he-had-his-genes-tested.html</loc>
		<lastmod>2008-12-10T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cam2032.html</loc>
		<lastmod>2008-12-10T06:10:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cam2029.html</loc>
		<lastmod>2008-12-10T06:10:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cam2028.html</loc>
		<lastmod>2008-12-10T06:10:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/member-services-fisher-scientific.html</loc>
		<lastmod>2008-12-09T17:36:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sc08-showcases-hpc-muscle-systems-top500-list.html</loc>
		<lastmod>2008-12-09T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neurology.html</loc>
		<lastmod>2008-12-05T03:48:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/products-for-cns-disorders.html</loc>
		<lastmod>2008-12-05T03:48:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cns-late-stage-or-marketed-product-opportunities.html</loc>
		<lastmod>2008-12-05T03:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rx-andor-otc-products-for-gastroenterology-market.html</loc>
		<lastmod>2008-12-05T03:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rx-and-or-otc-dermatology-products.html</loc>
		<lastmod>2008-12-05T03:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-gynecological-problems.html</loc>
		<lastmod>2008-12-05T03:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prescription-products-for-chronic-therapy-with-a-focus-on-womena%c2%80%c2%99s-health-and-urology-male-or-female.html</loc>
		<lastmod>2008-12-05T03:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/registered-or-late-stage-protein-therapeutics-required.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fazaclo-orally-dissolving-tablet-for-use-in-schizophrenia.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/control-of-acne-causing-organisms-in-a-topical-creamgel.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/micronano-devices-for-disease-diagnostics-and-drug-delivery.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ectopic-thymidylate-synthase-accelerates-the-development-of-hyperplastic-foci-and-adenomas-in-pancreatic-islets.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/technology-for-scim-sustained-release-injectables-of-peptides-proteins-and-small-molecules.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/p38-map-kinase-inhibitors-for-treatment-of-inflammation-related-disorders.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cancer-treatments.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/analgesics-anaesthetics-and-palliative-care-products.html</loc>
		<lastmod>2008-12-05T03:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/patented-skin-care-technology-available-for-licensing-in-north-america.html</loc>
		<lastmod>2008-12-05T03:48:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/timerx-technology-geminex-and-syncrodose.html</loc>
		<lastmod>2008-12-05T03:48:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/surgical-adhesion-barrier.html</loc>
		<lastmod>2008-12-05T03:48:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rx-atopic-dermatitis-treatment-avilable-for-pediatrics-and-pcp.html</loc>
		<lastmod>2008-12-05T03:48:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/httpnews-infowustleduimagesspacergif.html</loc>
		<lastmod>2008-12-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/researchers-solve-piece-of-large-scale-gene-silencing-mystery.html</loc>
		<lastmod>2008-12-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/drug-trials-for-autism.html</loc>
		<lastmod>2008-12-04T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-faces-another-tough-year.html</loc>
		<lastmod>2008-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/british-balance-gain-against-the-cost-of-the-latest-drugs.html</loc>
		<lastmod>2008-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rogue-stem-cell-clinics-spur-need-for-guidelines-doctors-say.html</loc>
		<lastmod>2008-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/europe-rejects-stem-cell-patent.html</loc>
		<lastmod>2008-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/stem-cell-heart-surgery-could-end-need-for-transplants.html</loc>
		<lastmod>2008-12-03T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck%e2%80%99s-former-seattle-chief-will-now-run-merck-boston.html</loc>
		<lastmod>2008-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eidetics%e2%80%99-analytic-tools-to-improve-trial-design-and-recruitment.html</loc>
		<lastmod>2008-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/us-style-tv-drug-ads-a-big-mistake-roche-exec.html</loc>
		<lastmod>2008-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/scrutiny-grows-of-drug-trials-abroad.html</loc>
		<lastmod>2008-12-02T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-detection-of-cancer-based-on-spatial-genome-organization-in-the-cell-nucleus.html</loc>
		<lastmod>2008-12-02T01:38:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-in-licensing-opportunities-in-hormone-replacement-therapy-hrt.html</loc>
		<lastmod>2008-12-01T01:01:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-in-licensing-opportunities-in-assisted-reproduction-technology-art.html</loc>
		<lastmod>2008-12-01T01:01:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-in-licensing-opportunities-in-psychiatry.html</loc>
		<lastmod>2008-12-01T01:01:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/helicon-group-has-identified-the-following-market-segments-as-high-potential-for-the-china-market-and-is-seeking-innovative-technologies-to-add-to-its-portfolio-emergency-medicineicu-general-and-p.html</loc>
		<lastmod>2008-12-01T01:01:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/compounds-that-induce-telomerase-activity.html</loc>
		<lastmod>2008-12-01T01:01:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmigene-inc-technology-associated-with-the-warfarin-dose-prediction-kit.html</loc>
		<lastmod>2008-12-01T01:01:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/miltefosine-based-fluorescent-compounds.html</loc>
		<lastmod>2008-12-01T01:01:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmigene-inctechnology-associated-with-the-pg-5801-dna-detection-kit-and-the-pg-5801-fastgel-kit.html</loc>
		<lastmod>2008-12-01T01:01:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmigene-inc-technology-associated-with-the-pg-1502-dna-detection-kit-and-the-pg1502-fastgel-kit.html</loc>
		<lastmod>2008-12-01T01:01:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hiv-gp41-membrane-proximal-external-region-arrayed-on-hepatitis-b-surface-antigen-particles-for-hiv-diagnostic-and-vaccine-applications.html</loc>
		<lastmod>2008-12-01T01:01:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/detection-of-hereditary-prostate-cancer.html</loc>
		<lastmod>2008-12-01T01:01:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nutra-pharma-featured-on-business-beyond.html</loc>
		<lastmod>2008-11-27T17:39:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/queensland-success-story-presented-by-hon-peter-beattie.html</loc>
		<lastmod>2008-11-26T17:21:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/medicon-valley-wwwmvaorg-medicon-valley-alliance.html</loc>
		<lastmod>2008-11-25T17:26:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/glutaminyl-cyclase-inhibitors.html</loc>
		<lastmod>2008-11-24T21:06:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/multiactivity-glutamic-acid-derivatives-and-their-potential-usefulness-in-the-treatment-of-alzheimer%c2%92s-disease.html</loc>
		<lastmod>2008-11-24T21:06:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-use-of-cathecholamines-for-the-differentiation-of-stem-cells-to-cardiomyocytes.html</loc>
		<lastmod>2008-11-24T21:06:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-detecting-minority-genomes-in-viral-quasispecies.html</loc>
		<lastmod>2008-11-24T21:06:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-2008-pennsylvania-bio.html</loc>
		<lastmod>2008-11-24T17:14:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/future-leaders-of-biotech-industry.html</loc>
		<lastmod>2008-11-23T17:19:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology-focus-interview-with-professor-uli-krull-1-of-4.html</loc>
		<lastmod>2008-11-22T18:30:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/high-school-biotech-movie-beatles-music-part-2.html</loc>
		<lastmod>2008-11-21T17:33:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ensymm-company.html</loc>
		<lastmod>2008-11-21T17:33:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/links/</loc>
		<lastmod>2008-11-20T17:30:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/contact/</loc>
		<lastmod>2008-11-20T17:28:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/about/</loc>
		<lastmod>2008-11-20T17:26:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ask-visual-science.html</loc>
		<lastmod>2008-11-20T17:15:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/high-school-biotech-movie-beatles-music-part-1.html</loc>
		<lastmod>2008-11-20T17:12:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology-focus-interview-uli-krull-quality-of-life-3-of-4.html</loc>
		<lastmod>2008-11-20T17:12:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/love-diabetes-is-it-really-diabetes.html</loc>
		<lastmod>2008-11-20T17:12:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/student-biotech-expo-nwabr.html</loc>
		<lastmod>2008-11-20T17:12:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/future-of-genetic-engineering-by-futurist-dr-patrick-dixon-genetic-mutations-and-genetic-disorders-gene-science-by-conference-keynote-speaker.html</loc>
		<lastmod>2008-11-20T17:12:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mri-coil.html</loc>
		<lastmod>2008-11-20T16:55:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/troponin-test-for-ami.html</loc>
		<lastmod>2008-11-20T16:55:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/indoline-compounds-for-the-treatment-of-spinal-muscular-atrophy-sma-and-other-diseases.html</loc>
		<lastmod>2008-11-19T16:45:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fluoxetine-orodispersible-tablet-20-mg.html</loc>
		<lastmod>2008-11-19T16:45:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/afm-14-anti-gpiibiiia-human-antibody-for-thrombosis-and-stroke.html</loc>
		<lastmod>2008-11-19T16:45:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/affimed-is-interested-in-working-with-companies-with-challenging-targets.html</loc>
		<lastmod>2008-11-19T16:45:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/venlafaxin-sr-caps-375-75-150-mg.html</loc>
		<lastmod>2008-11-19T16:45:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tramadol-sr-caps-50100-150-200-mg.html</loc>
		<lastmod>2008-11-19T16:45:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diethylstilboestrol.html</loc>
		<lastmod>2008-11-18T15:58:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-in-licensing-opportunities-in-haematology.html</loc>
		<lastmod>2008-11-18T15:58:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/small-molecule-modulators-of-the-thyroid-stimulating-hormone-tsh-receptor.html</loc>
		<lastmod>2008-11-18T15:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-disposable-contact-lens-based-glucose-biosensor.html</loc>
		<lastmod>2008-11-17T15:38:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-strategy-in-manipulation-of-stem-cell-fate-specification.html</loc>
		<lastmod>2008-11-14T15:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibody-apa11-as-a-marker-for-tcr-engaged-t-cells.html</loc>
		<lastmod>2008-11-14T15:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cinnamic-acid-derivatives-for-treating-metabolic-syndrome.html</loc>
		<lastmod>2008-11-13T15:13:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hpv-diagnostic-dna-chips.html</loc>
		<lastmod>2008-11-13T15:13:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/production-process-of-c4-synthons-by-biotransformation.html</loc>
		<lastmod>2008-11-13T15:13:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/male-contraceptive-pill.html</loc>
		<lastmod>2008-11-13T15:13:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/detector-of-fluorescence-applicable-to-life-sciences.html</loc>
		<lastmod>2008-11-13T15:13:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hiv-1-integrase-monoclonal-antibodies.html</loc>
		<lastmod>2008-11-12T14:31:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/detection-of-clinically-relevant-protein-variants.html</loc>
		<lastmod>2008-11-12T14:31:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-protease-inhibitors-in-cancer-therapy.html</loc>
		<lastmod>2008-11-11T14:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/stayzon-surgical-prep-product.html</loc>
		<lastmod>2008-11-11T14:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/spiral-flow-analysis.html</loc>
		<lastmod>2008-11-10T12:12:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-endothelial-antigen-for-behets-disease-bd.html</loc>
		<lastmod>2008-11-10T12:12:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/predictive-test-for-age-related-macular-degeneration-in-asymptomatic-individuals.html</loc>
		<lastmod>2008-11-07T09:51:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/high-yield-biosynthesis-of-6-hydroxynicotinic-acid-an-intermediate-for-pharmaceuticals-agrochemicals-and-feed-additives.html</loc>
		<lastmod>2008-11-07T09:51:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/compounds-to-prevent-or-delay-neural-sinapses-loss-during-aging-or-in-neurodegenerative-diseases.html</loc>
		<lastmod>2008-11-07T09:51:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/protein-inhibitor-as-therapeutic-agent-viral-immunologic-and-tumor-diseases.html</loc>
		<lastmod>2008-11-07T09:51:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-therapeutic-applications-of-retinoid-type-compounds.html</loc>
		<lastmod>2008-11-07T09:51:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amphoraacidform-microbicide.html</loc>
		<lastmod>2008-11-07T09:51:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-the-determination-of-the-rate-of-mitochondrial-respiration-and-its-application-to-the-search-for-regulators-of-the-uncoupling-proteins-ucp.html</loc>
		<lastmod>2008-11-07T09:51:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/endoscope-with-added-capability-to-measure-physiological-parameters.html</loc>
		<lastmod>2008-11-07T09:51:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/computer-aided-scoring-and-analysis-casa-for-rapid-and-robust-detection-of-biological-molecules-in-tissue-microarrays.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/therapeutic-targeting-of-csn5-a-negative-regulator-of-p53-and-p27-in-human-hepatocellular-carcinoma.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/molecular-motors-powered-by-proteins.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-infrared-ir-transparent-hydrophilic-membrane-that-can-be-used-for-filtration-printing-or-microarrays-and-cultivation-of-bacteria-and-other-microorganisms-for-reagent-free-ir-spectroscopic-id.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microarray-for-detection-and-subtyping-of-human-influenza-viruses.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-for-accurately-measuring-and-regulating-bound-adrenomedullin.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/interferon-beta-1a-ifn.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/filgrastim-g-csf.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/erythropoietin-epo.html</loc>
		<lastmod>2008-11-06T09:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dantrolene-apifinished-formulation.html</loc>
		<lastmod>2008-11-05T07:07:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/intra-articular-clodronate.html</loc>
		<lastmod>2008-11-05T07:07:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-product-designed-to-detect-the-presence-andor-the-severity-of-myocardial-ischemia-during-pharmacological-stress-testing.html</loc>
		<lastmod>2008-11-05T07:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/at9283-aurora-kinase-inhibitor-oncology.html</loc>
		<lastmod>2008-11-05T07:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/atopiclair-innovative-non-steroidal-cream-for-atopic-dermatitis.html</loc>
		<lastmod>2008-11-05T07:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sufentanil-transdermal-patch-sufentanil-tds.html</loc>
		<lastmod>2008-11-05T07:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fast-dissolving-oral-films-donepezil-rapidfilm-ondansetron-rapidfilm.html</loc>
		<lastmod>2008-11-05T07:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/labipatch-phyto.html</loc>
		<lastmod>2008-11-05T07:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/discovery-of-and-use-of-fragments-of-doc1-as-antiangiogenic-and-antitumor-therapy.html</loc>
		<lastmod>2008-11-05T07:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/system-for-correction-of-mri-head-motion.html</loc>
		<lastmod>2008-11-05T07:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-new-series-of-thalidomide-analogs-that-have-potent-anti-angiogenic-properties.html</loc>
		<lastmod>2008-11-04T06:18:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/4-and-8-mg-ondansetron-rapidfilm.html</loc>
		<lastmod>2008-11-04T06:18:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/5-and-10-mg-donepezil-rapidfilm.html</loc>
		<lastmod>2008-11-04T06:18:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/construction-of-a-recombinant-mammalian-expression-system-for-the-production-of-human-tgf-beta-1-and-members-of-tgf-beta-superfamily-cytokines.html</loc>
		<lastmod>2008-11-03T06:15:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-partners-for-potential-mergers-or-acquisition-mainly-middle-pharma-nutrition-or-trading-hospital-companies.html</loc>
		<lastmod>2008-11-03T06:15:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-for-the-identification-and-use-of-compounds-suitable-for-the-treatment-of-drug-resistant-cells.html</loc>
		<lastmod>2008-11-03T06:15:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/urgent-levobupivaccaine.html</loc>
		<lastmod>2008-10-31T04:10:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-licensing-for-the-uk.html</loc>
		<lastmod>2008-10-31T04:10:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/grafting-of-a-murine-antibody-onto-a-human-framework.html</loc>
		<lastmod>2008-10-31T04:10:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-anti-parafibromin-antibodies-to-diagnose-hyperparathyroidism-jaw-tumor-syndrome-hpt-jt-and-parathyroid-cancer.html</loc>
		<lastmod>2008-10-31T04:10:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/immunogenic-peptides-for-the-treatment-of-prostate-and-breast-cancer.html</loc>
		<lastmod>2008-10-31T04:10:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-anti-cd30-antibodies-and-recombinant-immunotoxins-containing-disulfide-stabilized-fv-fragments.html</loc>
		<lastmod>2008-10-31T04:10:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lentivirus-based-vector-system-for-gene-therapy-delivery.html</loc>
		<lastmod>2008-10-30T04:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cross-reactive-neutralizing-human-domain-antibody-against-hiv-1.html</loc>
		<lastmod>2008-10-30T04:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/low-dose-estradiolprogestin-tablets-cliovelle.html</loc>
		<lastmod>2008-10-30T04:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-stable-anti-cd22-antibodies.html</loc>
		<lastmod>2008-10-30T04:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/t-cell-receptor-alternate-reading-frame-protein-tarp-and-uses-thereof.html</loc>
		<lastmod>2008-10-30T04:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hybrid-adeno-retroviral-vector-for-the-transformation-of-cells.html</loc>
		<lastmod>2008-10-30T04:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-notch-1-monoclonal-antibodies-for-inducing-cellular-differentiation-and-apoptosis.html</loc>
		<lastmod>2008-10-30T04:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diclofenac-tds-matrix-patch.html</loc>
		<lastmod>2008-10-30T04:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/retinoid-acid-receptor-antagonists-in-bone-and-cartilage-repair.html</loc>
		<lastmod>2008-10-29T03:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rapid-optimization-of-dose-distribution-for-radiation-treatment.html</loc>
		<lastmod>2008-10-29T03:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diclofenac-sodium-25-mg-immediate-release-powder-in-sachet.html</loc>
		<lastmod>2008-10-29T03:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-drug-lead-for-oral-treatment-of-multiple-sclerosis.html</loc>
		<lastmod>2008-10-29T03:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/iodine-as-antiseptic-for-dental-use.html</loc>
		<lastmod>2008-10-29T03:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dispersible-concentrate-lipospheres-for-the-improved-bioavailability-of-pharmacologic-agents.html</loc>
		<lastmod>2008-10-29T03:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/brain-protection-in-traumatic-brain-injuries.html</loc>
		<lastmod>2008-10-29T03:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/apr-fastest-for-migraine.html</loc>
		<lastmod>2008-10-29T03:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-of-determining-the-prognosis-of-an-adenocarcinoma.html</loc>
		<lastmod>2008-10-29T03:27:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/peptides-for-prevention-of-pathological-calcification.html</loc>
		<lastmod>2008-10-27T00:46:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/non-pathogenic-burkholderia-strain.html</loc>
		<lastmod>2008-10-23T21:39:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mutagenesis-system-for-the-use-of-burkholderia-in-bioremediation.html</loc>
		<lastmod>2008-10-23T21:39:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-peptide-therapeutics-for-bone-regeneration.html</loc>
		<lastmod>2008-10-23T21:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/non-transgenic-rodent-model-for-alzheimers-disease-and-cerebral-ischemia.html</loc>
		<lastmod>2008-10-23T21:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-therapeutic-approach-to-the-prevention-and-treatment-of-staphylococcus-aureus-infections.html</loc>
		<lastmod>2008-10-23T21:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diagnostic-system-for-early-stage-osteoarthritis-and-therapeutic-discovery.html</loc>
		<lastmod>2008-10-23T21:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-protein-translation-inhibitor.html</loc>
		<lastmod>2008-10-23T21:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gene-expression-profiling-for-prognosis-of-a-non-hodgkin-lymphoma.html</loc>
		<lastmod>2008-10-22T21:20:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-pax-2-antibody.html</loc>
		<lastmod>2008-10-22T21:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-malarial-products.html</loc>
		<lastmod>2008-10-22T21:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nanoparticles-for-imaging-and-treatment-of-brain-tumors.html</loc>
		<lastmod>2008-10-22T21:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/induced-internalization-of-surface-receptors.html</loc>
		<lastmod>2008-10-22T21:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/metastasis-of-ovarian-cancer-using-antigen-immunisation.html</loc>
		<lastmod>2008-10-22T21:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/thymic-epithelial-progenitor-cells.html</loc>
		<lastmod>2008-10-22T21:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/soon-fda-approved-cetraxal-otic.html</loc>
		<lastmod>2008-10-22T21:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisitionin-licensing-of-anaesthetic-products-for-the-european-market.html</loc>
		<lastmod>2008-10-21T21:17:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/computational-model-predicts-cell-signaling-behavior.html</loc>
		<lastmod>2008-10-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/international-project-launched-to-sequence-human-microbiome-share-data.html</loc>
		<lastmod>2008-10-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oncology-products.html</loc>
		<lastmod>2008-10-15T17:07:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/collatamp-g-us.html</loc>
		<lastmod>2008-10-15T17:07:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/collarx-gentamicin-collatamp-g-topical.html</loc>
		<lastmod>2008-10-15T17:07:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/collarx-liquicoll-technologies.html</loc>
		<lastmod>2008-10-15T17:07:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/inn-413-an-orally-active-anti-estrogen-receptor-serd-targeting-breast-cancer.html</loc>
		<lastmod>2008-10-15T17:07:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-anti-angiogenesis-compound.html</loc>
		<lastmod>2008-10-15T17:07:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-allergy-target-for-induction-of-mast-cell-apoptosis.html</loc>
		<lastmod>2008-10-15T17:07:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/frk-kinase-inhibitor-a-drug-target-for-the-treatment-of-diabetes.html</loc>
		<lastmod>2008-10-15T17:07:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/necs-device.html</loc>
		<lastmod>2008-10-15T17:07:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/advanced-wound-care-products.html</loc>
		<lastmod>2008-10-14T15:58:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biochemist-robert-tjian-elected-as-new-hhmi-president.html</loc>
		<lastmod>2008-10-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/complete-genomics-service-targets-1000-genome-by-spring-2009.html</loc>
		<lastmod>2008-10-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech-search/</loc>
		<lastmod>2008-10-09T16:21:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-for-the-detection-and-treatment-of-lung-cancer.html</loc>
		<lastmod>2008-10-09T12:38:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fully-human-anti-human-nkg2d-monoclonal-antibody.html</loc>
		<lastmod>2008-10-09T12:38:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-pentosan-polysulfate-to-treat-certain-conditions-of-the-prostate.html</loc>
		<lastmod>2008-10-09T12:38:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-synthetic-nucleic-acid-for-the-development-of-a-vaccine-against-human-respiratory-syncytial-virus.html</loc>
		<lastmod>2008-10-09T12:38:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nalbuphine-er.html</loc>
		<lastmod>2008-10-09T12:38:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gastrodose-technology.html</loc>
		<lastmod>2008-10-09T12:38:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/recspec-speculum.html</loc>
		<lastmod>2008-10-09T12:38:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/elisa-based-serological-diagnosis-of-chlamydophila-abortus-in-sheep.html</loc>
		<lastmod>2008-10-09T12:38:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/scripps-navigenics-and-microsoft-sponsor-trial-on-personal-genetic-testing.html</loc>
		<lastmod>2008-10-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prostatic-adenocarcinoma-cells-expressing-or-lacking-the-tumor-suppressor-gene-pten.html</loc>
		<lastmod>2008-10-07T11:21:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/matriptase-hypomorphic-mouse-model-of-a-human-ichthyosis.html</loc>
		<lastmod>2008-10-07T11:21:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/non-toxic-cellular-stain.html</loc>
		<lastmod>2008-10-07T11:21:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microfabricated-particles-useful-as-mri-contrast-agents.html</loc>
		<lastmod>2008-10-06T11:07:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dna-nanoballs-petabytes-of-data-mark-complete-genomics-platform.html</loc>
		<lastmod>2008-10-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hospital-pharmaceutical-products.html</loc>
		<lastmod>2008-10-03T08:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisition-of-established-pharmaceuticals-in-the-uk-irish-market.html</loc>
		<lastmod>2008-10-03T08:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/topical-wound-care-treatments-for-burns-trauma-diabetic-wounds.html</loc>
		<lastmod>2008-10-03T08:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/topical-infection-control-%c2%96-including-surgery-preps-scrubs-and-sealants.html</loc>
		<lastmod>2008-10-03T08:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hospital-injectable-products.html</loc>
		<lastmod>2008-10-03T08:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/products-in-womens-health-cardiology-diabetes-in-phase-iiiii-or-currently-marketed-outside-of-the-usa.html</loc>
		<lastmod>2008-10-03T08:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-in-licensing-opportunities-in-pain-management-anaesthesia-and-oncology.html</loc>
		<lastmod>2008-10-03T08:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cyclized-ngr-peptide-for-tumor-targeting.html</loc>
		<lastmod>2008-10-03T08:56:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-chemoattractant-based-toxins-to-improve-vaccine-immune-responses-for-cancer-and-infectious-diseases.html</loc>
		<lastmod>2008-10-03T08:56:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bifunctional-compounds-that-bind-to-hormone-receptors.html</loc>
		<lastmod>2008-10-03T08:56:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-sexual-enhancement-consumer-products.html</loc>
		<lastmod>2008-10-02T08:49:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/quantitative-assessment-of-changes-in-tissue-status-in-disease-development-aging-or-degeneration-using-diffusion-tensor-magnetic-resonance-imaging.html</loc>
		<lastmod>2008-10-01T08:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/merck-kgaa-open-to-taking-part-in-imclone-bid.html</loc>
		<lastmod>2008-10-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-awards-25-billion-to-modernize-it-infrastructure.html</loc>
		<lastmod>2008-10-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/compositions-and-methods-for-increasing-recombinant-protein-yields-through-the-modification-of-cellular-properties.html</loc>
		<lastmod>2008-09-30T07:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/active-guidewire-visualization-device-and-system-for-mri-guided-interventions.html</loc>
		<lastmod>2008-09-30T07:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-vitro-model-for-hepatitis-c-virion-production.html</loc>
		<lastmod>2008-09-30T07:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-recombinant-immunotoxin-ss1p-anti-mesothelin-dsfv-pe38-a-therapeutic-treatment-for-lung-cancer-and-other-mesothelin-expressing-cancers.html</loc>
		<lastmod>2008-09-30T07:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/respiratory-syncytial-virus-rsv-vaccines-based-on-promoter-proximate-attenuation.html</loc>
		<lastmod>2008-09-30T07:59:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cambridge-biotech-raises-40m-to-test-alzheimers-drug.html</loc>
		<lastmod>2008-09-30T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bridg-moves-toward-double-layer-of-semantics.html</loc>
		<lastmod>2008-09-30T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/orchid-chem-us-merck-in-drug-discovery-pact.html</loc>
		<lastmod>2008-09-30T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pfizer-ends-heart-disease-research-focuses-on-cancer.html</loc>
		<lastmod>2008-09-30T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vitamin-d-receptor-antagonists-for-treating-breast-cancer.html</loc>
		<lastmod>2008-09-29T07:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/automated-method-for-rapid-detection-of-sickle-cell-disease-inhibitors.html</loc>
		<lastmod>2008-09-29T07:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aerosolized-vaccines.html</loc>
		<lastmod>2008-09-29T07:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/modified-sugar-substrates-and-methods-of-use.html</loc>
		<lastmod>2008-09-29T07:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/launching-strategic-medicine-inc.html</loc>
		<lastmod>2008-09-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/imclones-new-erbitux-problem.html</loc>
		<lastmod>2008-09-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cantor-genetically-engineered-humans-will-be-reality-by-2028.html</loc>
		<lastmod>2008-09-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cancer-studies-suggest-pathways-are-best-targets.html</loc>
		<lastmod>2008-09-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-way-to-make-stem-cells-is-safer-us-research.html</loc>
		<lastmod>2008-09-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-pig-model-could-improve-understanding-of-cystic-fibrosis.html</loc>
		<lastmod>2008-09-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-personal-and-sexual-lubricants.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/high-resolution-full-body-mr-angiography-series.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/surgical-instrument.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ditag-genome-scanning-technology.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/schizophrenia-susceptibility-gene.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/h2-caponin-marker.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oncolytic-adenovirus.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nlcq-1.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/monoclonal-antibodies-against-bordetella-pertussis-filamentous-hemagglutinin-fha-protein.html</loc>
		<lastmod>2008-09-26T05:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pfizer-moves-into-stem-cell-research.html</loc>
		<lastmod>2008-09-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechs-scavenge-for-funds-as-ipo-well-stays-dry.html</loc>
		<lastmod>2008-09-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lilly-ceo-forecasts-drug-makers-evolution.html</loc>
		<lastmod>2008-09-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/coformycin.html</loc>
		<lastmod>2008-09-25T05:02:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bristol-myers-presses-imclone-icahn-fires-back.html</loc>
		<lastmod>2008-09-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/patent-wars-hit-life-sciences-says-study.html</loc>
		<lastmod>2008-09-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/f12.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/markers-for-predicting-restenosis.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/heart-regeneration-cell-therapy-for-myocardial-infarction.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cell-therapy-for-urinary-incontinence-regeneration.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bec.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hyalomatrix-pa.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/altoprev-extended-release-lovastatin.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibody-multilineage-marker-for-surface-of-apoptotic-cells.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibody-marker-for-apoptotic-myeloid-cells.html</loc>
		<lastmod>2008-09-22T04:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hyalobarrier.html</loc>
		<lastmod>2008-09-17T01:57:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hyaloglide%c2%ae.html</loc>
		<lastmod>2008-09-17T01:57:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-consumer-diagnostic-kits-relevant-to-sexual-well-being.html</loc>
		<lastmod>2008-09-14T22:49:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eudramode-proprietary-oral-drug-delivery-technology-platform.html</loc>
		<lastmod>2008-09-14T22:49:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/post-procedure-products-to-improve-recovery-time-and-healing.html</loc>
		<lastmod>2008-09-11T17:17:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/intimate-hygiene-products-technologies-and-packaging.html</loc>
		<lastmod>2008-09-11T17:17:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oncology-products-2.html</loc>
		<lastmod>2008-09-11T17:17:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nces-small-molecules-indicated-for-inflammationautoimmune-disorders.html</loc>
		<lastmod>2008-09-11T17:17:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/inflammationautoimmune-commercialized-drugs.html</loc>
		<lastmod>2008-09-11T17:17:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-tumor-endothelial-markers-genes-that-distinguish-physiological-and-pathological-angiogenesis.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/braingenesis-biotechnology-bng-1-treatment-for-ischemia-stroke.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/small-molecule-inhibitors-of-c-met.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/over-expression-and-mutation-of-a-tyrosine-kinase-receptor-fgfr4-in-tumors.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/magnetic-resonance-imaging-methods-and-systems-for-estimating-cone-of-uncertainty.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-razoxane-for-the-treatment-of-alzheimer%c2%92s-disease.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-bovine-chimeric-respiratory-syncytial-virus-rsv-vaccines.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/2-amino-o4-substituted-pteridines-improved-chemotherapy-adjuvants.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-of-treating-and-preventing-renal-cancer-using-a-dimethane-sulfonate-compound.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/quantitative-immunoassays-for-measurement-of-topoisomerase-i-as-a-pharmacodynamic-marker-for-the-effect-of-anti-cancer-drugs.html</loc>
		<lastmod>2008-09-11T17:17:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/botulinum-toxoid.html</loc>
		<lastmod>2008-09-10T16:51:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/monodispersed-and-modified-yersinia-pestis-capsular-f1-v-antigen-fusion-proteins-for-vaccination-against-bubonic-and-pneumonic-plague.html</loc>
		<lastmod>2008-09-09T15:50:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hiv-immunogen-and-method-of-making-and-using-same.html</loc>
		<lastmod>2008-09-09T15:50:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/radiotracers-for-imaging-cannabinoid-sub-type1-cb1-receptor.html</loc>
		<lastmod>2008-09-09T15:50:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/total-synthesis-of-northebaine-normorphine-noroxymorphone-enantiomers-and-derivatives-via-n-nor-intermediates.html</loc>
		<lastmod>2008-09-09T15:50:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-of-preventing-tissue-ischemia.html</loc>
		<lastmod>2008-09-09T15:50:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/matrix-tablets-hydro-and-lipo-inert.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-rapid-point-of-care-device-for-diagnosis-of-acetaminophen-toxicity-08-27.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tears-as-a-non-invasive-screening-medium-05-11.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/natal-screening-and-glyconutritional-replacement-of-infant-nutritional-formulations-that-enhance-mortality-rates-and-development-08-37.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fast-dispersible-tablets.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/coated-bead-system.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-dual-chamber-dispenser-for-rx-and-otc-dermatology-products.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sulidin-nimesulide-lps-non-steroidal-topical-anti-inflammatory-gel-for-the-local-treatment-of-painful-inflammatory-conditions.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neo-penotran-topical-broad-spectrum-anti-infective-vaginal-pessary-and-cream-for-the-treatment-of-three-main-types-of-vaginal-infections-and-mixed-forms-of-vaginitis.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/kortos-cream-and-kortos-hc-cream-for-the-treatment-of-acute-hemorrhoids-anal-fissure-and-anal-pruritus.html</loc>
		<lastmod>2008-09-08T13:52:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/womens-health-urology-late-stage-or-marketed-product-opportunities.html</loc>
		<lastmod>2008-09-05T08:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hospital-pharmaceutical-products-2.html</loc>
		<lastmod>2008-09-05T08:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/blood-productsplasma-expanders.html</loc>
		<lastmod>2008-09-05T08:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anaesthetics.html</loc>
		<lastmod>2008-09-05T08:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisition-of-established-pharmaceuticals-in-the-uk-market-2.html</loc>
		<lastmod>2008-09-05T08:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-battery-of-genetic-biomarkers-of-severe-outcome-in-patients-with-elevated-triglyceride-levels.html</loc>
		<lastmod>2008-09-05T08:10:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cytochrome-p450-license-programme.html</loc>
		<lastmod>2008-09-05T08:10:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/casac-a-th1-adjuvant.html</loc>
		<lastmod>2008-09-05T08:10:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/blood-diagnostic-marker-for-alzheimers-disease.html</loc>
		<lastmod>2008-09-05T08:10:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cell-culture-supplements-for-generating-mature-functional-stabilized-blood-vessels-in-vitro.html</loc>
		<lastmod>2008-09-05T08:10:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/therapeutic-factors-for-stabilizing-blood-vessels-and-preventing-hemorrhage-and-promoting-angiogenesis-following-ischemia.html</loc>
		<lastmod>2008-09-05T08:10:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/high-precision-radiostereometric-analysis-rsa-system-for-monitoring-micro-movement-in-orthopedic-implants.html</loc>
		<lastmod>2008-09-05T08:10:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-to-in-license-and-distribute-opportunities-in-wound-care-products.html</loc>
		<lastmod>2008-09-04T07:41:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-to-in-license-and-distribute-opportunities-in-blood-derivatives.html</loc>
		<lastmod>2008-09-04T07:41:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/topical-compound-inhibits-nociceptive-pain-and-tnf-alpha-secretion.html</loc>
		<lastmod>2008-09-01T23:47:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fibromyalgia-pharmaceutical.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ropinirole-requip-for-a-fibromylagia-indication.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prostagenics-offers-license-for-all-capridines-including-capridine-beta.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ur-1505-immunomodulator-phase-ii.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/desalazine-anti-inflammatory-agent-phase-i.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/l-histidine-as-an-anti-oxidant-neuroprotective-agent-and-medical-food.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/enhanced-t-cell-activation-by-costimulation-a-potentially-novel-approach-for-the-prevention-andor-therapy-of-cancer-excluding-prostate-diseases-and-melanoma-and-for-infectious-diseases.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/enhanced-t-cell-activation-by-costimulation-an-effective-immunotherapy-for-cancer-and-infectious-diseases.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neoskina%c2%ae-for-skin-and-mucous-wound-healing-1x5ml-tube.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/apharinea%c2%ae-for-the-treatment-of-oral-ulcers-2x2-ml-re-plugable-ampoules.html</loc>
		<lastmod>2008-08-28T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/macrolide-conjugates.html</loc>
		<lastmod>2008-08-26T21:19:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-spring-biotech-igen%c2%97a-biodegradable-collagen-implant-for-glaucoma-pterygium-and-selected-ophthalmic-laser-and-ophthalmic-surgery-treatment.html</loc>
		<lastmod>2008-08-26T21:19:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pitdc-novel-compound-for-treatment-of-treatment-of-bacterial-infections-andor-renal-cancer-disease.html</loc>
		<lastmod>2008-08-25T18:09:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pitdc-anti-depression-pharmaceutical-composition-containing-polygala-extract.html</loc>
		<lastmod>2008-08-25T18:09:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/products-in-dermatology-diabetology-respiratory-and-muscle-skeletal.html</loc>
		<lastmod>2008-08-21T13:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-licensing-opportunities-in-dermatology.html</loc>
		<lastmod>2008-08-21T13:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-and-ethical-products-dexo-us-dexo-france.html</loc>
		<lastmod>2008-08-21T13:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fgfr-inhibitors.html</loc>
		<lastmod>2008-08-21T13:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/late-stage-products-in-cns-immunology-infectious-disease-and-dermatology-areas.html</loc>
		<lastmod>2008-08-21T13:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pdg-technology-a-novel-technology-for-drug-delivery.html</loc>
		<lastmod>2008-08-21T13:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/at7519-cell-cycle-inhibitor-oncology.html</loc>
		<lastmod>2008-08-21T13:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/at13387-hsp90-inhibitor-oncology.html</loc>
		<lastmod>2008-08-21T13:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-microbicidal-products.html</loc>
		<lastmod>2008-08-20T12:56:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-licensing-of-a-dermal-fillers.html</loc>
		<lastmod>2008-08-20T12:56:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seking-to-purchase-or-in-license-late-stage-or-currently-marketed-assets.html</loc>
		<lastmod>2008-08-20T12:56:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-licensing.html</loc>
		<lastmod>2008-08-20T12:56:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-to-purchase-late-stage-or-approved-specialty-pharmaceutical-products-in-the-areas-of-dermatology-cardiovascular-womens-health-and-pediatrics.html</loc>
		<lastmod>2008-08-20T12:56:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/decapinol-toothpaste-intelligent-treatment-for-gingivitis-prevention-of-periodontitis.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tclair-effective-ophthalmic-solution-indicated-for-the-relief-of-dry-eye.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/t-go-spho220-gel-that-alleviates-the-symptoms-of-teething.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/xclair-cream-for-radiation-induced-dermatitis.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aloclaira%c2%84%c2%a2gel.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aloclaira%c2%84%c2%a2-spray.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aloclaira%c2%84%c2%a2-rinse.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/optimags-tds-modular-coating-machines.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/opitmags-special-knife-coater-technology.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-tetrahydroisoquinoline-derivatives.html</loc>
		<lastmod>2008-08-19T11:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/woody-waste-aplenty-in-trial-%e2%80%98coordinating%e2%80%99-activities.html</loc>
		<lastmod>2008-08-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/now-sponsors-can-build-their-own-recruitment-knowledge-base.html</loc>
		<lastmod>2008-08-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/herpclair-indicated-for-the-treatment-of-herpes-simplex-virus-hsv-type-1-infections.html</loc>
		<lastmod>2008-08-18T10:05:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sst-saliva-supporting-tablets-for-patients-with-xerostomia.html</loc>
		<lastmod>2008-08-18T10:05:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sphr913-anti-wrinkle-serum-developed-to-lessen-the-effects-of-skin-ageing.html</loc>
		<lastmod>2008-08-18T10:05:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/posidorm.html</loc>
		<lastmod>2008-08-15T10:00:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/non-steroidal-anti-inflammatory-compounds-antioxidants-and-5-lo-inhibitors.html</loc>
		<lastmod>2008-08-15T10:00:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/carbonic-anhydrase-inhibiting-agents.html</loc>
		<lastmod>2008-08-15T10:00:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-microbial-agents.html</loc>
		<lastmod>2008-08-15T10:00:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aldose-reductase-inhibiting-agents.html</loc>
		<lastmod>2008-08-15T10:00:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/looking-for-partners-to-promote-new-patented-registered-oral-hygiene-skin-injury-and-gynaecological-products.html</loc>
		<lastmod>2008-08-15T10:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/125-mg-diclofenac-k-film-coated-immediate-release-tablets-otc.html</loc>
		<lastmod>2008-08-15T10:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diclofenac-potassium-immediate-release-tablets-25-and-50-mg.html</loc>
		<lastmod>2008-08-15T10:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/transdermal-diclofenac.html</loc>
		<lastmod>2008-08-15T10:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-sexual-enhancement.html</loc>
		<lastmod>2008-08-14T06:00:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/conjugates-of-ligand-linker-and-cytotoxic-agent-and-related-compositions-and-methods-of-use.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/monoclonal-antibodies-to-hiv-1-vpr.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/polyamine-compounds-that-bind-tar-rna-of-hiv-and-methods-of-treating-viral-disorders.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/broadly-neutralizing-anti-hiv-monoclonal-antibody-that-targets-a-new-epitope-on-gp41.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fluorescent-cell-lines-for-detection-of-dna-damage.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/species-independent-a3-adenosine-receptor-agonists.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sh2-domain-binding-inhibitors.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/extracellular-matrix-gene-chips-to-detect-metastatic-tumors.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nup98-hoxd13-transgenic-mice.html</loc>
		<lastmod>2008-08-14T06:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/granulocyte-colony-stimulating-factor.html</loc>
		<lastmod>2008-08-13T03:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-vaginal-applicator.html</loc>
		<lastmod>2008-08-13T03:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tilrr.html</loc>
		<lastmod>2008-08-13T03:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fpga-system-for-protein-identification.html</loc>
		<lastmod>2008-08-13T03:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cder-stresses-active-post-approval-surveillance-3.html</loc>
		<lastmod>2008-08-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/therapeutics-for-prion-diseases.html</loc>
		<lastmod>2008-08-08T01:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/control-of-multi-resistant-bacteria-mrsa-vre-and-esbl-in-a-topical-application.html</loc>
		<lastmod>2008-08-08T01:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/control-of-impetigo-caused-by-streptococcus-and-staphylococcus.html</loc>
		<lastmod>2008-08-08T01:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/remote-blood-glucose-monitor.html</loc>
		<lastmod>2008-08-08T01:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pancreatin.html</loc>
		<lastmod>2008-08-08T01:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eurand-minitabs-nifedipine-sr-capsules-30-and-60mg-once-daily.html</loc>
		<lastmod>2008-08-08T01:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diffucaps-ketoprofen-sr-capsules-100-and-200mg.html</loc>
		<lastmod>2008-08-08T01:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acetylation-of-cytokeratin-8.html</loc>
		<lastmod>2008-08-08T01:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/briti-formalizing-instruction-in-trial-related-imaging.html</loc>
		<lastmod>2008-08-06T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/auditory-neuronal-differentiation.html</loc>
		<lastmod>2008-08-04T17:28:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lubricants-massage-and-intimate-care.html</loc>
		<lastmod>2008-07-30T14:38:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/colorimetric-sensors-for-dna.html</loc>
		<lastmod>2008-07-30T14:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fluorcanasite-glass-ceramic-for-dentistry.html</loc>
		<lastmod>2008-07-30T14:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/steroid-derivatives-as-inhibitors-of-human-tyrosyl-dna-phosphodiesterase-tdp1.html</loc>
		<lastmod>2008-07-30T14:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/protein-tyrosine-phosphotase-inhibitors-as-inhibitors-of-human-tyrosyl-dna-phosphodiesterase-tdp1-and-methods-of-treating-disorders.html</loc>
		<lastmod>2008-07-30T14:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/treatment-of-alcoholism-by-inhibition-of-the-neuropeptide-y-receptor.html</loc>
		<lastmod>2008-07-30T14:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-for-promoting-stem-cell-proliferation-and-survival.html</loc>
		<lastmod>2008-07-30T14:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibodies-and-antisera-recognizing-members-of-the-arfgap-family-of-proteins.html</loc>
		<lastmod>2008-07-30T14:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/synthetic-analogs-of-juxtamembrane-domain-of-igf-1-receptor-as-anti-cancer-agents.html</loc>
		<lastmod>2008-07-29T14:24:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/metabolic-biomarkers-indicate-exposure-to-gamma-radiation.html</loc>
		<lastmod>2008-07-24T10:03:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/consortium-strategizing-to-bring-more-studies-to-lombardia.html</loc>
		<lastmod>2008-07-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/is-us-patient-recruitment-a-%e2%80%98losing-proposition%e2%80%99.html</loc>
		<lastmod>2008-07-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-analgesic-product-for-inflammatory-pain.html</loc>
		<lastmod>2008-07-21T05:15:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/stem-cell-factor-for-preventing-chemotherapy-induced-depletion-of-blood-cells.html</loc>
		<lastmod>2008-07-21T05:15:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eye-drops-for-the-delivery-of-an-anti-glycation-agent-that-prevents-and-treats-diabetes-and-age-related-pathologies-l-11323.html</loc>
		<lastmod>2008-07-21T05:15:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/therapeutic-applications-of-tetracyclines-as-calpain-inhibitors-l-11570.html</loc>
		<lastmod>2008-07-21T05:15:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-carrier-proteins-derived-from-staphylococcus-nuclease-for-high-yield-peptide-production-l-11391.html</loc>
		<lastmod>2008-07-21T05:15:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/proton-pump-inhibitors-in-cancer-therapy.html</loc>
		<lastmod>2008-07-21T05:15:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/versatile-and-sterilizable-probe-for-the-extraction-and-quantification-of-volatile-compounds-in-liquids-l-11320.html</loc>
		<lastmod>2008-07-21T05:15:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/optimized-large-scale-transient-gene-expression-with-a-serum-free-suspension-growing-hek293-cell-line-l-11565.html</loc>
		<lastmod>2008-07-21T05:15:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-cell-assay-for-triplet-repeat-instability.html</loc>
		<lastmod>2008-07-17T23:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/early-detection-of-dysfunctional-vascular-endothelium.html</loc>
		<lastmod>2008-07-17T23:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/improved-cluster-analysis-of-genetic-microarray-images.html</loc>
		<lastmod>2008-07-17T23:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-barrier-protection.html</loc>
		<lastmod>2008-07-17T23:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rapid-and-sensitive-detection-of-nucleic-acid-sequence-variations.html</loc>
		<lastmod>2008-07-17T23:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/flow-through-thermal-expansion-compensated-microcells-for-analytical-transmission-infrared-spectroscopy.html</loc>
		<lastmod>2008-07-17T23:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-method-to-quantify-polymorphisms-in-electropherograms-08-33.html</loc>
		<lastmod>2008-07-17T23:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/preparation-methods-for-biodegradable-micro-particles-containing-polypeptide-drugs-%c2%96-non-organic-suspension-%c2%96-encapsulation-techniques-08-34.html</loc>
		<lastmod>2008-07-17T23:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/piperidine-amide-compounds-with-5-ht2a-receptor-antagonist-activity-for-the-treatment-of-schizophrenia.html</loc>
		<lastmod>2008-07-17T23:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-serotoninergic-ligands-for-the-treatment-of-cns-indications.html</loc>
		<lastmod>2008-07-17T23:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aryl-amide-compounds-for-the-treatment-of-epilepsy.html</loc>
		<lastmod>2008-07-17T23:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/treatment-of-skin-conditions-using-dkk1.html</loc>
		<lastmod>2008-07-16T23:26:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neutralization-of-hepatitis-c-virus-hcv.html</loc>
		<lastmod>2008-07-16T23:26:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/comprehensive-integrated-testing-protocol-citp-for-quantitative-measurement-of-lung-function-08-01.html</loc>
		<lastmod>2008-07-16T23:26:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/therapeutic-application-of-fatty-acid-amide-hydrolase-inhibitors.html</loc>
		<lastmod>2008-07-16T23:26:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antimicrobial-peptides.html</loc>
		<lastmod>2008-07-15T22:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-novel-therapeutic-strategy-for-the-treatment-of-hyperpigmentation-and-melanoma.html</loc>
		<lastmod>2008-07-15T22:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cripto-1-as-a-biomarker-for-cardiac-ischemia.html</loc>
		<lastmod>2008-07-15T22:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cripto-1-represents-a-biomarker-for-chronic-inflammatory-diseases.html</loc>
		<lastmod>2008-07-15T22:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-detection-and-quantification-of-plk1-expression-and-activity.html</loc>
		<lastmod>2008-07-15T22:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vitamin-mediated-drug-delivery-technologies.html</loc>
		<lastmod>2008-07-15T22:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mugard-oral-rinse.html</loc>
		<lastmod>2008-07-15T22:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-non-invasive-test-of-oocyte-quality-in-assisted-conception.html</loc>
		<lastmod>2008-07-14T21:51:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cder-stresses-active-post-approval-surveillance-2.html</loc>
		<lastmod>2008-07-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rnai-patent-revoked.html</loc>
		<lastmod>2008-07-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oral-topical-or-transdermal-products-in-any-therapeutical-area.html</loc>
		<lastmod>2008-07-10T15:55:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pre-filled-syringes-for-critical-care-apomorphine.html</loc>
		<lastmod>2008-07-08T13:51:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biopharmaceuticals.html</loc>
		<lastmod>2008-07-08T13:51:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/crf-patient-compliance-triples-with-e-diaries.html</loc>
		<lastmod>2008-07-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisitionin-licensing-of-ophthalmology-products-for-the-european-market.html</loc>
		<lastmod>2008-07-07T12:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sinlice-is-a-new-anti-lice-composition-specifically-formulated-as-a-dry-on-suffocation-based-product.html</loc>
		<lastmod>2008-07-07T12:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/salinum-is-a-saliva-substitute-indicated-for-the-relief-of-symptoms-of-dry-mouth-or-xerostomia.html</loc>
		<lastmod>2008-07-07T12:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sebclair-new-approved-cream-for-the-treatment-of-seborrheic-dermatitis.html</loc>
		<lastmod>2008-07-07T12:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmaceuticals.html</loc>
		<lastmod>2008-07-07T12:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/decapinol-rinse-is-a-new-product-indicated-for-the-treatment-of-gingivitis-and-prevention-of-periodontitis.html</loc>
		<lastmod>2008-07-04T10:12:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmaceuticals-for-gastrointestinal-diseases.html</loc>
		<lastmod>2008-07-03T09:19:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/paracetamol-injection.html</loc>
		<lastmod>2008-07-03T09:19:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/technology-driven-product-targets-for-in-licensing-in-india.html</loc>
		<lastmod>2008-07-03T09:19:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/animal-restraint-jacket.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/computer-aided-orthodedic-surgery-suite.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bone-binding-conjugate-for-the-treatment-of-osteoporosis.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/butylcholinesterase-binding-compounds-for-monitoring-and-inhibiting-the-progression-of-alzheimers-disease.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/automated-microbiology-laboratory-system.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/binding-ligands-for-neurodegenerative-imaging-and-therapy.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cell-nanofiber-composite-and-cell-nanofiber-composite-amalgam-based-engineered-intervertebral-disc.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cell-nanofiber-composite-based-engineered-cartilage.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bioreactor-device-and-method-and-system-for-fabricating-tissue.html</loc>
		<lastmod>2008-07-03T09:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisitionin-licensing-of-dermatological-products-for-the-european-market.html</loc>
		<lastmod>2008-06-27T00:30:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/esmolol-cyclosporine-ketoprofen-tramadol-injections.html</loc>
		<lastmod>2008-06-27T00:30:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-pyridinic-sulfonamide-derivates.html</loc>
		<lastmod>2008-06-27T00:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/colorimetric-detection-of-enantiomeric-excess.html</loc>
		<lastmod>2008-06-27T00:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cd33-specific-bite-antibodies-in-aml.html</loc>
		<lastmod>2008-06-27T00:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mcsp-specific-bite-antibodies-in-malignant-melanoma.html</loc>
		<lastmod>2008-06-27T00:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ige-specific-bite-antibodies-in-allergy-and-asthma.html</loc>
		<lastmod>2008-06-27T00:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/her2-specific-bite-antibodies-in-breast-cancer.html</loc>
		<lastmod>2008-06-27T00:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/egfr-specific-bite-antibodies-in-squamous-cell-and-adenocarcinoma.html</loc>
		<lastmod>2008-06-27T00:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ibm-ceo-survey-shows-hunger-for-change-in-life-sciences.html</loc>
		<lastmod>2008-06-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pfizer-eyes-new-use-for-stem-cells.html</loc>
		<lastmod>2008-06-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gsk-releases-genomic-data-via-cabig.html</loc>
		<lastmod>2008-06-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/geospiza-joins-illumina-connect.html</loc>
		<lastmod>2008-06-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-microrna-profile-for-androgen-responsive-prostate-cancer.html</loc>
		<lastmod>2008-06-23T19:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/immunogenic-peptides-and-methods-of-use-for-treating-prostrate-and-uterine-cancers.html</loc>
		<lastmod>2008-06-23T19:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-new-mouse-monoclonal-antibody-against-human-microphthalmia-transcription-factor-mitf.html</loc>
		<lastmod>2008-06-23T19:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diagnostic-indicator-for-a-later-age-onset-neurodegenerative-disease-amyotrophic-lateral-sclerosis-als.html</loc>
		<lastmod>2008-06-23T19:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cortifil-fluticasone-005-cream.html</loc>
		<lastmod>2008-06-16T12:49:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nnrti-as-antagonists-of-cell-proliferation-and-inducers-of-cell-differentiation.html</loc>
		<lastmod>2008-06-16T12:49:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cetraxal-and-cetraxal-plus.html</loc>
		<lastmod>2008-06-16T12:49:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cder-stresses-active-post-approval-surveillance.html</loc>
		<lastmod>2008-06-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aids-nanoparticles-for-delivery-of-a-pharmacologically-active-agent.html</loc>
		<lastmod>2008-06-15T11:57:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/quality-nutraceuticals-on-sustained-release-platform-for-out-licecing.html</loc>
		<lastmod>2008-06-13T10:22:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aids-use-of-hiv-1-tat-to-target-andor-activate-antigen-presenting-cells-andor-to-deliver-cargo-molecules.html</loc>
		<lastmod>2008-06-13T10:22:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/academia-sinica-a-new-organometallic-complex-as-an-efficient-dna-molecule-binder.html</loc>
		<lastmod>2008-06-12T10:19:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/academia-sinica-characterization-and-identification-of-pulmonary-stem-cells-as-a-target-for-viral-infection.html</loc>
		<lastmod>2008-06-12T10:19:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-library-of-synthetic-ngf-agonists-that-bind-in-a-highly-specific-manner-the-tropomyosin-kinases-trk-receptor.html</loc>
		<lastmod>2008-06-11T03:30:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/looking-for-licensee-of-ajw-anti-von-willebrand-factor-humanized-monoclonal-antibody.html</loc>
		<lastmod>2008-06-11T03:30:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmaceutical-composition-based-on-mutants-created-by-insertions-and-deletions-of-ezrin.html</loc>
		<lastmod>2008-06-10T03:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-of-inactivating-prions.html</loc>
		<lastmod>2008-06-09T00:31:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amplification-of-t-cells-from-human-cord-blood-in-serum-deprived-culture.html</loc>
		<lastmod>2008-06-09T00:31:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/compositions-and-methods-for-use-in-affecting-hematopoietic-stem-cell-populations-in-mammals.html</loc>
		<lastmod>2008-06-09T00:31:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/licensing-opportunities-in-ophthalmology-drugs-or-therapeutic-devices.html</loc>
		<lastmod>2008-06-05T22:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/early-stage-academic-research.html</loc>
		<lastmod>2008-06-05T22:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diagnostic-biomarkers-for-ectopic-pregnancy.html</loc>
		<lastmod>2008-06-05T22:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/wound-closure-systems-%c2%96-including-sealants-devices-and-dressings.html</loc>
		<lastmod>2008-06-05T22:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-combination-of-anti-cd22-immunotoxins-with-standard-chemotherapeutic-agents-on-a-human-burkitt-lymphoma-cell-line.html</loc>
		<lastmod>2008-06-05T22:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aids-hiv-1-tatenv-complex-for-vaccination-against-hivaids.html</loc>
		<lastmod>2008-06-05T22:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-inhibitor-for-the-treatment-of-notch2-associated-tumors.html</loc>
		<lastmod>2008-06-05T22:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pegylated-filgrastim.html</loc>
		<lastmod>2008-06-04T21:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/salvat-svt-40776.html</loc>
		<lastmod>2008-06-04T21:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/immunotoxins-with-deletions-in-domain-ii-that-remove-immunogenic-epitopes-with-minimal-loss-of-cytotoxic-activity.html</loc>
		<lastmod>2008-06-04T21:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/treatment-and-diagnosis-of-cancer-diabetes-and-other-disorders-using-adrenomedullin-peptides-and-antibodies.html</loc>
		<lastmod>2008-06-04T21:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/muramyl-dipeptide-as-a-therapeutic-agent-for-inflammation.html</loc>
		<lastmod>2008-06-04T21:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/telomerase-suppressor-compositions-and-methods-for-diagnosis-and-treatment-of-cancer.html</loc>
		<lastmod>2008-06-04T21:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-use-of-an-inducible-plasmid-vector-encoding-for-active-tgf-beta-for-the-treatment-of-autoimmune-diseases.html</loc>
		<lastmod>2008-06-04T21:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-glutathione-derivatives-and-their-use-in-antiviral-therapy.html</loc>
		<lastmod>2008-06-03T15:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-treatment-of-cognitive-and-learning-impairment.html</loc>
		<lastmod>2008-06-03T15:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/colorectal-cancer-antigen.html</loc>
		<lastmod>2008-06-03T15:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/recombinant-fsh.html</loc>
		<lastmod>2008-06-03T15:41:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eberconazole.html</loc>
		<lastmod>2008-06-03T15:41:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/aids-recombinant-herpes-simplex-virus-and-uses-thereof.html</loc>
		<lastmod>2008-06-01T11:11:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/avuganetm.html</loc>
		<lastmod>2008-05-30T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-015-diabetes-new-biomarker-panel-for-the-detection-and-diagnosis-of-type-1-diabetes.html</loc>
		<lastmod>2008-05-30T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/topical-vitamin-a-products.html</loc>
		<lastmod>2008-05-30T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/topical-anesthetic-for-long-term-care-market.html</loc>
		<lastmod>2008-05-30T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/medical-adhesive-available-for-home-care-veterinary-market.html</loc>
		<lastmod>2008-05-30T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/adhesive-remover-available-for-long-term-care-market-veterinary-market.html</loc>
		<lastmod>2008-05-30T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/zemab.html</loc>
		<lastmod>2008-05-30T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/savene-for-anthracycline-extravasation.html</loc>
		<lastmod>2008-05-30T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/top-geneticist-plans-to-leave-job-at-nih.html</loc>
		<lastmod>2008-05-30T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ai-improves-automated-high-throughput-screening.html</loc>
		<lastmod>2008-05-30T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gta4-enabler-of-life-sciences-research.html</loc>
		<lastmod>2008-05-29T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alnylam-partners-with-takeda.html</loc>
		<lastmod>2008-05-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/partnerscompanies-looking-for-a-strategic-partnership-to-give-them-privileged-access-to-hospital-markets-in-europe.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dermatology-productstechnologies-for-atopic-dermatitis.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-partners-who-want-to-divest-well-established-products-in-any-therapeutic-area.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-in-licensing-opportunities-for-europe-with-a-priority-for-france-germany-and-uk-for-products-ready-to-market-in-hospitals-or-under-clinical-development.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/commercialisation-of-novel-drugs-biopharmaceuticals-and-drug-delivery-technologies-in-latin-america.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tnf-alpha-converting-enzyme-inhibitory-agents-and-stimulatory-agents.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tmc1-a-deafness-related-gene.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/targeted-therapeutic-protein-glycoslyation-technology.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/preparation-and-use-of-androgenic-compounds-nandrolone-17beta-carbonates.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/potent-pharmacophoric-delta-and-mu-opioid-receptor-antagonists-and-conversion-of-endomorphin-mu-opioid-agonists-to-antagonists.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-006-ultrasound-3d-ultrasound-imaging-system-and-process-for-percutaneous-breast-tissue-biopsy.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-004-ultrasound-3d-ultrasound-imaging-systems-and-methods.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bio-009-schizophrenia-novel-neurodevelopmental-animal-model-of-schizophrenia.html</loc>
		<lastmod>2008-05-28T05:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cdisc-standards-take-hold-edc-often-a-veneer.html</loc>
		<lastmod>2008-05-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dutch-scientists-claim-to-sequence-female-dna.html</loc>
		<lastmod>2008-05-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/matching-tumors-to-drugs.html</loc>
		<lastmod>2008-05-27T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmaceutical-compositions-and-methods-for-preventing-skin-tumor-formation-and-causing-regression-of-existing-tumors.html</loc>
		<lastmod>2008-05-26T01:37:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-inhibitors-of-3-hydroxy-3-methylglutaryl-coenzyme-a-reductase-as-a-modality-in-cancer-therapy.html</loc>
		<lastmod>2008-05-26T01:37:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/oligodeoxyribonucleotides-comprising-o6-benzylguanine-and-their-use.html</loc>
		<lastmod>2008-05-26T01:37:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-of-inhibiting-abcg2-and-related-treatments.html</loc>
		<lastmod>2008-05-26T01:37:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-and-materials-for-identifying-polymorphic-variants-diagnosing-susceptibilities-and-treating-disease.html</loc>
		<lastmod>2008-05-26T01:37:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-to-expand-scrutiny-of-risks-from-drugs-after-they%e2%80%99re-approved-for-sale.html</loc>
		<lastmod>2008-05-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tessella-introduces-drug-supply-forecasting-tool.html</loc>
		<lastmod>2008-05-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bush-signs-genetic-anti-discrimination-law.html</loc>
		<lastmod>2008-05-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/genes-for-niemann-pick-type-c-disease.html</loc>
		<lastmod>2008-05-21T21:44:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-and-cosmetic-products.html</loc>
		<lastmod>2008-05-21T21:44:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-nuclease-protection-from-tissue-injury-by-znii-aminothiol-chelates-and-derivatives-07-14.html</loc>
		<lastmod>2008-05-21T21:44:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anyara.html</loc>
		<lastmod>2008-05-21T21:44:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-of-inducing-memory-b-cell-development-and-terminal-differentiation.html</loc>
		<lastmod>2008-05-21T21:44:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/researchers-pinpoint-new-protein-tool-in-fight-against-cancer.html</loc>
		<lastmod>2008-05-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/companies-racing-to-use-stem-cells-to-find-and-test-new-drugs.html</loc>
		<lastmod>2008-05-21T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/benztropinamine-analogs-as-dopamine-transport-inhibitors.html</loc>
		<lastmod>2008-05-20T21:15:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibodies-that-specifically-recognize-s100a15-a-protein-involved-in-epidermal-differentiation-and-inflammation.html</loc>
		<lastmod>2008-05-20T21:15:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-compounds-for-melanoma-therapy.html</loc>
		<lastmod>2008-05-20T21:15:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dna-sequencing-in-a-snap.html</loc>
		<lastmod>2008-05-20T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/single-dose-treatment-for-mixed-cervical-vaginal-infections.html</loc>
		<lastmod>2008-05-19T18:43:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/processes-for-preparing-nanowire-scaffolds-on-metallic-substrates-and-uses-of-the-scaffolds-07-42.html</loc>
		<lastmod>2008-05-19T18:43:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bird-flu-not-forgotten-by-glaxosmithkline.html</loc>
		<lastmod>2008-05-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/skin-color-gene-variations-raise-cancer-risks-decode-finds.html</loc>
		<lastmod>2008-05-19T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dermatology-productstechnologies-for-acne.html</loc>
		<lastmod>2008-05-18T17:22:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/asymmetrically-coated-tablets-for-controlled-drug-release-05-25.html</loc>
		<lastmod>2008-05-18T17:22:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lilly%e2%80%99s-science-grid-goes-open-source.html</loc>
		<lastmod>2008-05-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/susie-stephens.html</loc>
		<lastmod>2008-05-16T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-smoking-cessation.html</loc>
		<lastmod>2008-05-15T15:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/archexin-targeted-cancer-drug.html</loc>
		<lastmod>2008-05-15T15:22:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tadg-12-variant-d-expression-in-tumors-cancer-03-07.html</loc>
		<lastmod>2008-05-15T15:22:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-compounds-and-methods-to-block-hepatitis-c-virus-replication-04-09.html</loc>
		<lastmod>2008-05-15T15:22:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/maternal-multi-nutrient-against-diabetes-related-birth-defects-03-29.html</loc>
		<lastmod>2008-05-15T15:22:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/interleukin-8-and-cxcr-receptors-as-therapeutic-targets-for-tumor-osteolysis-04-01.html</loc>
		<lastmod>2008-05-15T15:22:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/treatment-to-destroy-virus-particles.html</loc>
		<lastmod>2008-05-14T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-genetic-diagnostic-test-for-early-onset-alzheimers-disease.html</loc>
		<lastmod>2008-05-14T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-to-treat-foot-infections.html</loc>
		<lastmod>2008-05-14T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lpcn-1035-longer-acting-version-of-a-leading-respiratory-product.html</loc>
		<lastmod>2008-05-14T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lpcn-1019-immunosuppressant-anda-opportunity.html</loc>
		<lastmod>2008-05-14T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/golden-biotechnology-antroquinonol-a-new-chemical-entity-with-application-in-cancer-therapy-and-auto-immune-disease-therapy.html</loc>
		<lastmod>2008-05-14T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/developer-of-phototherapy-devices-that-harness-the-healing-power-of-low-level-narrow-band.html</loc>
		<lastmod>2008-05-14T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/drypod-dpi-device.html</loc>
		<lastmod>2008-05-14T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/multicolored-fluorescent-cell-lines-for-high-throughput-angiogenesis-and-cytotoxicity-screening.html</loc>
		<lastmod>2008-05-14T14:44:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cartisorb-glucosamine-sulfate-sachets-ctd-dossier-ready-for-registration.html</loc>
		<lastmod>2008-05-13T13:44:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bis010-semi-synthetic-polysaccharide-for-the-treatment-of-musculoskeletal-and-chronic-inflammatory-disorders-including-osteoarthritis-and-cartilage-degeneration.html</loc>
		<lastmod>2008-05-13T13:44:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/segmenting-colon-wall-via-level-set-techniques.html</loc>
		<lastmod>2008-05-12T13:15:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/microarray-binding-sensors-using-carbon-nanotube-transistors.html</loc>
		<lastmod>2008-05-12T13:15:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-papillomavirus-microrna-diagnostics-and-therapeutics.html</loc>
		<lastmod>2008-05-12T13:15:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-monoclonal-antibody-against-mesothelin.html</loc>
		<lastmod>2008-05-12T13:15:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-treating-problems-with-the-foot-and-leg.html</loc>
		<lastmod>2008-05-08T04:23:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-surgical-clip-for-vascular-bypass-and-tissue-grafts-08-31.html</loc>
		<lastmod>2008-05-08T04:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/therapy-for-nephrogenic-systemic-fibrosis-and-scleroderma-rapamycin-inhibition-of-the-phospho-70-ribosomal-s6-kinase-08-23.html</loc>
		<lastmod>2008-05-08T04:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gl1001.html</loc>
		<lastmod>2008-05-08T04:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-and-improved-murine-monoclonal-antibodies-against-cd22.html</loc>
		<lastmod>2008-05-08T04:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/regulation-of-the-p21-gene-and-uses-thereof-00-05cip05-20.html</loc>
		<lastmod>2008-05-06T04:06:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/polypeptides-for-eliciting-neutralizing-antibodies-against-hiv.html</loc>
		<lastmod>2008-05-06T04:06:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/muc1-mediated-cancer-vaccine.html</loc>
		<lastmod>2008-05-06T04:06:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/improved-management-of-multiple-myeloma-treatment-outcomes-08-12.html</loc>
		<lastmod>2008-05-06T04:06:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dermotology-wart-immunotherapy-99-19-cip.html</loc>
		<lastmod>2008-05-06T04:06:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/influenza-vaccines-therapeutics-and-monoclonal-antibodies.html</loc>
		<lastmod>2008-05-05T02:39:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/modifications-of-plant-growth-and-development-by-cell-cycle-technology.html</loc>
		<lastmod>2008-04-30T22:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/assay-for-identification-of-influenza-neutralizing-antibodies.html</loc>
		<lastmod>2008-04-30T22:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/motorized-bicycle-exercise-trainer-mbet-02-22.html</loc>
		<lastmod>2008-04-29T22:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-cytoplasmic-polyadenylation-element-binding-hcpeb-protein-02-13_05-03.html</loc>
		<lastmod>2008-04-29T22:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gene-expression-profiling-high-risk-entity-of-multiple-myeloma-02-08.html</loc>
		<lastmod>2008-04-29T22:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prion-specific-antibody.html</loc>
		<lastmod>2008-04-29T22:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/proprietary-cpg-reagents-to-analyse-the-methylation-status-of-all-human-genes.html</loc>
		<lastmod>2008-04-28T21:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mbd3-deficient-embryonic-stem-cell-line.html</loc>
		<lastmod>2008-04-28T21:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibiotic-steroid-combination-topical-ointment.html</loc>
		<lastmod>2008-04-28T21:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sunten-phytotech-std05207-std05207-fractionated-herbal-extract-demonstrating-cholesteroltriglyceride-lowering-and-a-drug-candidate-for-the-treatment-of-gi-disorders-developed-from-a-single-acti.html</loc>
		<lastmod>2008-04-28T21:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sunten-phytotech-std06-combination-of-active-ingredients-for-treatment-of-various-skin-diseases.html</loc>
		<lastmod>2008-04-28T21:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/synthesis-of-nucleoside-triphosphates.html</loc>
		<lastmod>2008-04-28T21:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/breast-cancer-risk-tied-to-gene-variants-by-decode-scientists.html</loc>
		<lastmod>2008-04-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/altered-viruses-reversed-progressive-blindness-studies-say.html</loc>
		<lastmod>2008-04-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tgf-beta-gene-expression-signature-in-cancer-prognosis.html</loc>
		<lastmod>2008-04-27T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/modulators-of-nuclear-hormone-receptor-activity-novel-compounds-diverse-applications-for-infectious-diseases-including-anthrax-b-anthracis.html</loc>
		<lastmod>2008-04-27T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/immunoglobulins-with-potent-and-broad-antiviral-hiv-activity-based-on-scfv-joined-by-flexible-linker-to-fc.html</loc>
		<lastmod>2008-04-27T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/active-mri-compatible-and-visible-imri-catheter.html</loc>
		<lastmod>2008-04-27T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/psm-peptides-as-vaccine-targets-against-methicillin-resistant-staphylococcus-aureus.html</loc>
		<lastmod>2008-04-27T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-new-technology-for-identification-of-genes-expressed-in-hypoxia-conditions.html</loc>
		<lastmod>2008-04-27T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ribosomal-protein-s3-rps3-an-essential-component-of-nf-kappab-is-a-novel-and-selective-drug-target.html</loc>
		<lastmod>2008-04-27T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-fold-back-diabody-format-for-diphtheria-toxin-based-immunotoxins-that-can-increase-binding-and-potency.html</loc>
		<lastmod>2008-04-27T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-chemical-substructure-matching-algorithm-and-implementation.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-inhibitors-of-multidrug-resistant-proteins-such-as-abcg2.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-p53-mutations-and-a-genetic-system-in-yeast-for-functional-identification-of-human-p53-mutations.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biologically-active-macrolides-compositions-and-uses-thereof.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/synergistic-effect-of-tgf-beta-blockade-and-immunogenic-agents-on-tumors.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/eeyarestatins-novel-deubiquitination-inhibitors-for-the-treatment-of-drug-resistant-cancers.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/an-improved-non-viral-system-for-tumor-specific-suicide-gene-therapy.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-and-composition-for-optimizing-left-ventricular-videointensity-in-echocardiography.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-pharmacophore-for-isatin-beta-thiosemicarbazone-compounds-with-mdr1-inverse-activity.html</loc>
		<lastmod>2008-04-25T20:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/why-glaxo-bought-sirtris.html</loc>
		<lastmod>2008-04-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/senate-passes-gina.html</loc>
		<lastmod>2008-04-24T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mdp-002-cancer-single-stage-freezing-and-embedding-system-for-use-in-mohs-surgery-andor-other-tissue-histopathological-procedures.html</loc>
		<lastmod>2008-04-23T19:08:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mdp-006-fetal-health-detection-of-early-changes-in-fetal-eeg-due-to-asphyxia-with-acidemia-during-labour.html</loc>
		<lastmod>2008-04-23T19:08:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/chinese-hamster-cell-lines-for-the-discovery-of-cancer-chemotherapeutic-drugs.html</loc>
		<lastmod>2008-04-23T19:08:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-high-throughput-screening-system-for-compounds-affecting-scar-formation-and-tissue-regeneration.html</loc>
		<lastmod>2008-04-23T19:08:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/target-for-limiting-scarring-and-promoting-regeneration-following-spinal-cord-injury.html</loc>
		<lastmod>2008-04-23T19:08:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mapping-internal-and-bulk-motion-of-an-object-with-phase-labeling-in-magnetic-resonance-imaging.html</loc>
		<lastmod>2008-04-23T19:08:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gsk-buys-sirtris.html</loc>
		<lastmod>2008-04-23T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/erythropoietin.html</loc>
		<lastmod>2008-04-22T15:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prolidase-expression-construct-useful-as-anti-angiogenesis-screen.html</loc>
		<lastmod>2008-04-22T15:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rapid-clostridium-botulinum-diagnostic-for-food-safety-and-biodefense-applications.html</loc>
		<lastmod>2008-04-22T15:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vegf-b-as-a-therapeutic-agent-for-neurodegenerative-disease.html</loc>
		<lastmod>2008-04-22T15:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/epoxy-guaiane-cancer-inhibitors-new-class-of-natural-products-isolated-from-the-african-plant-phyllanthus-englerii.html</loc>
		<lastmod>2008-04-22T15:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hiv-monoclonal-antibodies.html</loc>
		<lastmod>2008-04-22T15:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/states-crack-down-on-online-gene-tests.html</loc>
		<lastmod>2008-04-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-identifies-tainted-heparin-in-11-countries.html</loc>
		<lastmod>2008-04-22T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pharmaceuticals-for-cardiovascular-disease.html</loc>
		<lastmod>2008-04-21T12:59:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/device-and-methods-for-in-vivo-flow-cytometry-non-invasive-and-sensitive-detection-of-circulating-cancer-cells-using-photoacoustic-waves.html</loc>
		<lastmod>2008-04-21T12:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nitrite-and-nitrite-methemoglobin-therapy-to-detoxify-stroma-free-hemoglobin-based-blood-substitutes.html</loc>
		<lastmod>2008-04-21T12:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/substituted-36-diphenyl-7h-124-triazolo34-b-134-thiadiazines-as-potent-inhibitors-of-pde4a-pde4b-and-pde4d.html</loc>
		<lastmod>2008-04-21T12:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-and-compositions-for-the-diagnosis-of-neuroendocrine-lung-cancer.html</loc>
		<lastmod>2008-04-21T12:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/n-acetyl-mannosamine-as-a-therapeutic-agent.html</loc>
		<lastmod>2008-04-21T12:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/mucin-binding-lectin-imaging-agents-for-colonic-polyp-imaging.html</loc>
		<lastmod>2008-04-21T12:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cell-line-pe-developed-from-mouse-skin-tumors-demonstrates-unique-qualities.html</loc>
		<lastmod>2008-04-21T12:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/glaxo-signs-drug-development-deal-with-regulus.html</loc>
		<lastmod>2008-04-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pfizer-ceo-stands-by-his-plan-frustrating-investors.html</loc>
		<lastmod>2008-04-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-100-genome.html</loc>
		<lastmod>2008-04-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gns-building-a-snps-to-outcomes-engine.html</loc>
		<lastmod>2008-04-18T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-polysaccharide-based-bioadhesive-hydrogel.html</loc>
		<lastmod>2008-04-18T00:01:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ia-a-novel-anti-inflammatory-agent.html</loc>
		<lastmod>2008-04-18T00:01:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rnase-bacterial-inhibitor.html</loc>
		<lastmod>2008-04-18T00:01:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/postoperative-autologous-hemoconcentrator.html</loc>
		<lastmod>2008-04-18T00:01:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/expression-of-retinoic-acid-receptor-alpha2-isoform-rar-alpha-2-as-a-predictor-of-cancer-survival-and-best-treatment-modality.html</loc>
		<lastmod>2008-04-18T00:01:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/emd-serono-expands-cancer-research-in-massachusetts.html</loc>
		<lastmod>2008-04-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/jim-collins-joins-gene-network-sciences-as-cso.html</loc>
		<lastmod>2008-04-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/james-watson%e2%80%99s-personal-genome-published-in-nature.html</loc>
		<lastmod>2008-04-17T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-issues-pharmacogenomic-guidance.html</loc>
		<lastmod>2008-04-15T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biomarker-may-predict-response-to-cancer-therapy.html</loc>
		<lastmod>2008-04-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/drugmakers-vie-for-18-million-alzheimers-patients.html</loc>
		<lastmod>2008-04-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/computation-to-unravel-how-genes-are-regulated.html</loc>
		<lastmod>2008-04-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/simple-new-technique-raises-fears-of-human-cloning.html</loc>
		<lastmod>2008-04-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/amgen-develops-six-cancer-drugs-as-anemia-decline-hurts-revenue.html</loc>
		<lastmod>2008-04-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diffucaps-vitamin-c-300mg-zinc-5mg.html</loc>
		<lastmod>2008-04-12T18:53:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diagnostic-method-to-detect-endometriosis.html</loc>
		<lastmod>2008-04-12T18:53:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/interleukin-12-il-12-paracrine-gene-delivery-enhances-cancer-and-viral-immunotherapy-using-cytotoxic-t-lymphocytes-ctl.html</loc>
		<lastmod>2008-04-12T18:53:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/us-biotechs-for-sale.html</loc>
		<lastmod>2008-04-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/al-gore-helps-navigenics-launch-personal-genomics-service.html</loc>
		<lastmod>2008-04-11T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/diffucaps-isosorbide-dinitrate-sr-capsules-20-40-60-and-80mg.html</loc>
		<lastmod>2008-04-10T14:49:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alendronate-hcl-70mg-once-weekly-tablets.html</loc>
		<lastmod>2008-04-10T14:49:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/drug-delivery-systems.html</loc>
		<lastmod>2008-04-10T14:49:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/contents-april-20082.html</loc>
		<lastmod>2008-04-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/takeda-to-buy-millennium-pharmaceuticals.html</loc>
		<lastmod>2008-04-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/medincell-is-looking-for-licensing-in-new-oral-or-parenteral-drug-delivery-systems.html</loc>
		<lastmod>2008-04-09T08:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/womens-health-and-urology-male-and-female-prescription-products.html</loc>
		<lastmod>2008-04-09T08:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-licensing-to-scandinavia.html</loc>
		<lastmod>2008-04-09T08:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-skin-disorders.html</loc>
		<lastmod>2008-04-09T08:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/otc-products-for-gastrointestinal-problems.html</loc>
		<lastmod>2008-04-09T08:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-for-co-culture-of-stem-cells-and-feeder-cells-using-a-polymer-membrane.html</loc>
		<lastmod>2008-04-09T08:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/computer-aided-gait-analysis-for-neuromuscular-diseases.html</loc>
		<lastmod>2008-04-09T08:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/detection-of-pathogenic-fungal-species.html</loc>
		<lastmod>2008-04-09T08:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/automated-guided-vehicle-enunciator-system.html</loc>
		<lastmod>2008-04-09T08:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/codon-optimized-genes-for-subunit-vaccines.html</loc>
		<lastmod>2008-04-09T08:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-target-anti-lung-cancer-sirna-therapies-treatment-drugs.html</loc>
		<lastmod>2008-04-09T08:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-omega-conotoxins.html</loc>
		<lastmod>2008-04-09T08:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/drug-makers-near-old-goal-a-legal-shield.html</loc>
		<lastmod>2008-04-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-drug-targets-three-kinds-of-leukemia.html</loc>
		<lastmod>2008-04-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/study-cancer-drug-trials-being-stopped-too-soon.html</loc>
		<lastmod>2008-04-09T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/contents-april-2008.html</loc>
		<lastmod>2008-04-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/z-dummy-file.html</loc>
		<lastmod>2008-04-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/inspire-will-introduce-trials-to-online-community-members.html</loc>
		<lastmod>2008-04-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/exco-intouch-text-messaging-keeps-sites-connected-to-patients.html</loc>
		<lastmod>2008-04-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pht-sitepad-collects-epro-at-the-site.html</loc>
		<lastmod>2008-04-08T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/let-us-guide-you-to-the-best-global-pharma-opportunities-2.html</loc>
		<lastmod>2008-04-08T00:47:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/avian-influenza-vaccine.html</loc>
		<lastmod>2008-04-08T00:46:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dendritic-cell-dc-generation-and-manipulation-technology-for-the-development-of-cancer-vaccines-and-rheumatoid-arthritis-ra-therapeutics-cytoplasmic-transduction-peptide-ctp-technology.html</loc>
		<lastmod>2008-04-08T00:46:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-releases-five-year-drug-safety-plan.html</loc>
		<lastmod>2008-04-07T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-23andme-respond-to-gene-drug-test-article.html</loc>
		<lastmod>2008-04-07T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/two-piece-wrist-hand-finger-splint-for-treatment-of-non-rigid-contractures.html</loc>
		<lastmod>2008-04-07T00:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/therapeutic-target-for-treatment-of-alzheimers-disease-and-other-neurodegenerative-disorders.html</loc>
		<lastmod>2008-04-07T00:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/therapeutic-target-and-antibody-for-prostate-cancer.html</loc>
		<lastmod>2008-04-07T00:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/protective-and-therapeutic-agent-for-alcoholic-hepatotoxicity.html</loc>
		<lastmod>2008-04-07T00:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/polymer-protein-compositions-for-cns-delivery.html</loc>
		<lastmod>2008-04-07T00:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/use-of-attenuated-viruses-for-delivery-of-cytokines.html</loc>
		<lastmod>2008-04-07T00:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prostate-cancer-cell-line.html</loc>
		<lastmod>2008-04-07T00:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/transferrin-conjugated-nanoparticles.html</loc>
		<lastmod>2008-04-07T00:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/male-infertility-oligozoospermia.html</loc>
		<lastmod>2008-04-04T23:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-new-method-for-improving-the-therapeutic-efficacy-of-l-asparaginase-in-multiple-types-of-cancer.html</loc>
		<lastmod>2008-04-04T23:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/macrocyclic-grb2-sh2-domain-binding-inhibitors-new-anti-cancer-and-anti-angiogenic-therapeutic-agents.html</loc>
		<lastmod>2008-04-04T23:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-vivo-assessment-of-tissue-microstructure-and-microdynamics-estimation-of-the-average-propagator-from-magnetic-resonance-data.html</loc>
		<lastmod>2008-04-04T23:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fast-electron-paramagnetic-resonance-imaging-epri-using-cw-epr-spectrometer-with-sinusoidal-rapid-scan-and-digital-signal-processing.html</loc>
		<lastmod>2008-04-04T23:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/testetrol-an-orally-active-androgen-to-supplement-testosterone.html</loc>
		<lastmod>2008-04-04T23:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/morphine-sulfate-oad-caps.html</loc>
		<lastmod>2008-04-04T23:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-benztropine-analogs-for-treatment-of-cocaine-abuse-and-other-mental-disorders.html</loc>
		<lastmod>2008-04-04T23:50:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nics-unleashes-kraken-supercomputer.html</loc>
		<lastmod>2008-04-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/jhu-researchers-urge-registry-for-genetic-tests.html</loc>
		<lastmod>2008-04-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seeking-targets-antibodies-or-recombinant-proteins-to-be-developed-in-europe-possibly-with-lfbs-high-adcc-mabs-platform-or-in-transgenic-animals-through-lfbgtc-strategic-alliance-addressing-se.html</loc>
		<lastmod>2008-04-03T23:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/adamantane-analogues.html</loc>
		<lastmod>2008-04-03T23:48:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/method-to-inhibit-reperfusion-injury-in-cerebral-stroke.html</loc>
		<lastmod>2008-04-03T23:48:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sonographic-trocar.html</loc>
		<lastmod>2008-04-03T23:48:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/self-closing-trocar-for-minimally-invasive-surgery.html</loc>
		<lastmod>2008-04-03T23:48:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/right-angle-harmonic-scalpel-for-minimally-invasive-surgery.html</loc>
		<lastmod>2008-04-03T23:48:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pfizer-cancels-melanoma-drug.html</loc>
		<lastmod>2008-04-03T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/the-gelinspector-program-for-data-generation-of-western-blots.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/combination-cancer-therapy.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-method-for-intracellular-delivery.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-jakstat-screening-technology-and-targets.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tribbles-2.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tribbles.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/liposomal-formulations-comprising-non-liposome-forming-amphiphiles-ceramides.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-method-for-loading-liposomes-with-biological-materials.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/polyesters-derived-from-amino-acids.html</loc>
		<lastmod>2008-04-02T19:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/artemisinin-based-antimalarial-for-african-market.html</loc>
		<lastmod>2008-04-01T19:58:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/human-monoclonal-antibody-technology-platform.html</loc>
		<lastmod>2008-04-01T19:58:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/let-us-guide-you-to-the-best-global-pharma-opportunities.html</loc>
		<lastmod>2008-04-01T19:58:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/database-for-microbial-identification.html</loc>
		<lastmod>2008-04-01T19:58:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/laparoscopic-devices-for-minimally-invasive-surgery.html</loc>
		<lastmod>2008-04-01T19:58:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-products.html</loc>
		<lastmod>2008-04-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/handheld-clinical-data-capture.html</loc>
		<lastmod>2008-04-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pcr-amplification-improved-5-fold.html</loc>
		<lastmod>2008-04-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/informatics-software-with-semantic-technologies.html</loc>
		<lastmod>2008-04-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bluearc-doubles-titan-storage-to-four-petabytes.html</loc>
		<lastmod>2008-04-01T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/first-trimester-pre-eclampsia-diagnostic-test.html</loc>
		<lastmod>2008-03-31T17:49:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alzheimers-disease-mri-imaging-agent.html</loc>
		<lastmod>2008-03-31T17:49:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/antibiotics-with-enhanced-safety-profile-for-intestinal-microflora.html</loc>
		<lastmod>2008-03-31T17:49:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/delivery-technologies.html</loc>
		<lastmod>2008-03-31T17:49:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/soluleavestm-melt-in-the-mouth-film-strips.html</loc>
		<lastmod>2008-03-31T17:49:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/study-ties-genetic-variations-to-schizophrenia.html</loc>
		<lastmod>2008-03-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-deadlines-may-impact-drug-safety.html</loc>
		<lastmod>2008-03-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/doubt-cast-on-two-drugs-used-to-lower-cholesterol.html</loc>
		<lastmod>2008-03-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/provisio-moves-into-the-business-of-protocol-feasibility-assessment.html</loc>
		<lastmod>2008-03-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/many-unknowns-surround-novel-trial-designs.html</loc>
		<lastmod>2008-03-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/clinphone-combines-three-tools-in-one.html</loc>
		<lastmod>2008-03-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/molecular-modelers-take-up-challenge-with-eyes-wide-open.html</loc>
		<lastmod>2008-03-31T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/murine-mammary-carcinoma-cell-line-c3l5.html</loc>
		<lastmod>2008-03-27T13:24:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/micro-fine-dry-powder-pulmonary-drug-delivery-technology-suite.html</loc>
		<lastmod>2008-03-27T13:24:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/swallowing-air-pulse-therapy-system.html</loc>
		<lastmod>2008-03-27T13:24:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/handheld-platform-for-audiology-and-speech-language-pathology.html</loc>
		<lastmod>2008-03-27T13:24:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-once-per-day-product-opportunities-for-known-compounds-with-additional-upside-for-decreased-aes.html</loc>
		<lastmod>2008-03-26T12:06:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nih-laptop-theft-how-safe-is-your-data.html</loc>
		<lastmod>2008-03-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dealing-with-the-data-deluge-three-things-it-should-do.html</loc>
		<lastmod>2008-03-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/uk-to-force-drugmakers-to-share-clinical-trial-data.html</loc>
		<lastmod>2008-03-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda%e2%80%99s-woodcock-denies-agency-is-risk-averse-on-drugs.html</loc>
		<lastmod>2008-03-26T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/patent-law-changes-could-alter-rules-for-life-sciences.html</loc>
		<lastmod>2008-03-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/health-canada-publishes-draft-biosimilar-guidance.html</loc>
		<lastmod>2008-03-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/identifying-the-genes-that-put-the-stem-in-cell.html</loc>
		<lastmod>2008-03-25T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/license-out.html</loc>
		<lastmod>2008-03-24T03:18:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/platelet-stability-kit.html</loc>
		<lastmod>2008-03-24T03:18:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-models-of-chronic-neurodegenerative-disease.html</loc>
		<lastmod>2008-03-24T03:18:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cetraben-emollient-cream.html</loc>
		<lastmod>2008-03-24T03:18:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/medingel-a-new-drug-delivery-system-to-be-used-for-long-acting-injectable-formulations.html</loc>
		<lastmod>2008-03-24T03:18:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/highly-dispersible-xanthan-gum.html</loc>
		<lastmod>2008-03-21T02:43:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fluconasole.html</loc>
		<lastmod>2008-03-19T18:57:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/flumazenil-100mcgsml-x-5ml-100mcgsml-x-10ml-ampoules.html</loc>
		<lastmod>2008-03-19T18:57:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cv-oab-products.html</loc>
		<lastmod>2008-03-19T18:57:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/decapinol-spray-a-new-and-intelligent-treatment-for-gingivitis-prevention-of-periodontitis.html</loc>
		<lastmod>2008-03-17T18:39:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pol7080-a-unique-pseudomonas-antibiotic.html</loc>
		<lastmod>2008-03-16T13:16:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/derivatives-of-ellipticine-exhibit-specific-potent-cell-cycle-arrest-and-accelerated-apoptotic-responses-for-anti-tumor-function-05-24.html</loc>
		<lastmod>2008-03-16T13:16:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-powerful-tool-for-monitoring-of-kinase-activity.html</loc>
		<lastmod>2008-03-16T13:16:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-for-altering-acetic-acid-production-and-enhancing-cell-death-in-bacteria.html</loc>
		<lastmod>2008-03-16T13:16:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cross-linked-ionic-core-micelles-for-efficient-delivery-of-therapeutics.html</loc>
		<lastmod>2008-03-16T13:16:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dentofix-out-license-complete-denture-product-range.html</loc>
		<lastmod>2008-03-16T13:16:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/peptide-that-prevents-gastrointestinal-infections.html</loc>
		<lastmod>2008-03-14T12:04:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/pancreatic-cancer-specific-target-muc17.html</loc>
		<lastmod>2008-03-12T10:04:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novel-therapeutic-target-for-pancreatic-cancer-pd2.html</loc>
		<lastmod>2008-03-12T10:04:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/modified-release-or-drug-delivery-cardiovascular-cns-respiratory-dermatology-gi-obgyn-oncology-biotech.html</loc>
		<lastmod>2008-03-11T09:50:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/compounds-for-treating-cataracts-and-neurodegenerative-disorders.html</loc>
		<lastmod>2008-03-06T02:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/implants-for-reconstructing-mucosal-lumen.html</loc>
		<lastmod>2008-03-06T02:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/histamine-containing-composition-for-the-treatment-of-allergic-diseases.html</loc>
		<lastmod>2008-03-06T02:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-obesity-polypeptides.html</loc>
		<lastmod>2008-03-06T02:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/direct-str-amplification-from-whole-blood-and-blood-or-saliva-spotted-fta-without-dna-purification.html</loc>
		<lastmod>2008-03-06T02:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/supply-spf-micro-pigs-cro-services-for-glp-studies-using-micro-pigs.html</loc>
		<lastmod>2008-03-06T02:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/dental-bone-grafts.html</loc>
		<lastmod>2008-03-06T02:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lotuzol-anti-depressant-serenitytab.html</loc>
		<lastmod>2008-03-06T02:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/methods-and-composition-for-the-detection-and-treatment-of-hiv-1.html</loc>
		<lastmod>2008-03-05T02:10:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/congenic-rat-models-for-estrogen-induced-mammary-cancer-and-other-conditions.html</loc>
		<lastmod>2008-03-05T02:10:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-009-radiotracer-99tc-cysteine-rhenium-colloid.html</loc>
		<lastmod>2008-03-05T02:10:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/img-010-x-ray-pulse-injector-for-quantitative-angiographic-blood-flow-measurements.html</loc>
		<lastmod>2008-03-05T02:10:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/rib-fracture-score-and-protocol-to-manage-trauma-patients-with-multiple-rib-fractures-02-26.html</loc>
		<lastmod>2008-03-04T01:59:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cpg-retrieval-of-dna-from-formalin-fixed-pathology-specimens-for-increased-sensitivity-for-methylation-specific-pcr-02-12.html</loc>
		<lastmod>2008-03-04T01:59:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/encased-stent-e-stent-02-27.html</loc>
		<lastmod>2008-03-04T01:59:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/animal-intravascular-catheter.html</loc>
		<lastmod>2008-03-04T01:59:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cyclic-histatin-peptide-antifungal-agent.html</loc>
		<lastmod>2008-03-03T01:35:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/uses-of-type-iv-collagen-in-regeneration-and-restoration-of-renal-cell-injury-02-28.html</loc>
		<lastmod>2008-03-03T01:35:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/preconception-classification-algorithm-for-adverse-reproductive-events-precare-07-33.html</loc>
		<lastmod>2008-03-03T01:35:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bone-marrow-derived-cells-that-stimulate-pancreatic-regeneration-in-type-ii-diabetes.html</loc>
		<lastmod>2008-03-03T01:35:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biomarkers-for-the-early-detection-of-pre-eclampsia.html</loc>
		<lastmod>2008-03-03T01:35:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/a-secreted-therapeutic-and-drug-discovery-target-for-early-stage-osteoarthritis.html</loc>
		<lastmod>2008-03-03T01:35:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ear-nose-and-throat-medication-novel-formulationsdelivery.html</loc>
		<lastmod>2008-02-28T22:11:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/prescription-products-with-dermatological-indications.html</loc>
		<lastmod>2008-02-28T22:11:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/glucomedtm-glucosamine-625-mg-tablets-for-treatment-of-osteoarthritis-in-humans.html</loc>
		<lastmod>2008-02-28T22:11:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/satcon.html</loc>
		<lastmod>2008-02-27T22:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/decapinol-gum-applicator-decapinol-is-indicated-for-the-treatment-of-gingivitis-and-prevention-of-periodontitis-in-the-periodontal-pocket.html</loc>
		<lastmod>2008-02-27T22:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/decapinol-gel-an-intelligent-treatment-preventing-gingivitis-and-periodontitis.html</loc>
		<lastmod>2008-02-27T22:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/neurotonin-improvement-of-ssri-characteristics.html</loc>
		<lastmod>2008-02-27T22:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ico-008-phase-2-human-monoclonal-antibody-targeting-eotaxin-1.html</loc>
		<lastmod>2008-02-27T22:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/fda-says-it-approved-the-wrong-drug-plant.html</loc>
		<lastmod>2008-02-19T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-2.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-4.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-3.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-5.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-6.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-8.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-7.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-13.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-12.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-11.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-10.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-9.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-18.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-17.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-16.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-15.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-14.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-20.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/life-science-it-market-expected-to-grow-in-europe-report-19.html</loc>
		<lastmod>2008-02-06T22:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/inforsense-launches-visualsense-targets-spotfire.html</loc>
		<lastmod>2008-02-06T01:11:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/world-class-researchers-in-gene-tie-up.html</loc>
		<lastmod>2008-01-31T23:36:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/democrats-seek-more-fda-funds.html</loc>
		<lastmod>2008-01-31T23:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/democrats-seek-more-fda-funds-2.html</loc>
		<lastmod>2008-01-31T23:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/democrats-seek-more-fda-funds-5.html</loc>
		<lastmod>2008-01-31T23:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/democrats-seek-more-fda-funds-4.html</loc>
		<lastmod>2008-01-31T23:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/democrats-seek-more-fda-funds-3.html</loc>
		<lastmod>2008-01-31T23:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/democrats-seek-more-fda-funds-6.html</loc>
		<lastmod>2008-01-31T23:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tainted-drugs-tied-to-maker-of-abortion-pill.html</loc>
		<lastmod>2008-01-31T23:29:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alzheimers-research-target-may-be-a-dead-end.html</loc>
		<lastmod>2008-01-28T00:17:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/collexis-creates-a-%e2%80%98myspace%e2%80%99-for-scientists.html</loc>
		<lastmod>2008-01-27T23:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nih-helps-scientists-sleuthing-for-clues-in-the-human-genome.html</loc>
		<lastmod>2008-01-25T04:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/nih-helps-scientists-sleuthing-for-clues-in-the-human-genome-2.html</loc>
		<lastmod>2008-01-25T04:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/evado-tackles-edc-shortcomings.html</loc>
		<lastmod>2008-01-25T04:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/investigator-shortage-the-chief-challenge-in-india.html</loc>
		<lastmod>2008-01-25T03:53:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/investigator-shortage-the-chief-challenge-in-india-3.html</loc>
		<lastmod>2008-01-25T03:53:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/investigator-shortage-the-chief-challenge-in-india-2.html</loc>
		<lastmod>2008-01-25T03:53:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/investigator-shortage-the-chief-challenge-in-india-4.html</loc>
		<lastmod>2008-01-25T03:53:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/scientists-advance-in-effort-to-create-synthetic-organism-2.html</loc>
		<lastmod>2008-01-24T22:46:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/scientists-advance-in-effort-to-create-synthetic-organism.html</loc>
		<lastmod>2008-01-24T22:46:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/seqwright-launches-gps-personal-genomics-service.html</loc>
		<lastmod>2008-01-24T06:53:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/balancing-storage-performance-and-energy-consumption.html</loc>
		<lastmod>2008-01-22T05:09:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/project-to-map-1000-peoples-dna.html</loc>
		<lastmod>2008-01-22T03:22:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novartis-hit-by-weak-us-economy.html</loc>
		<lastmod>2008-01-17T23:24:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/symyx-president-on-mdl-acquisition.html</loc>
		<lastmod>2008-01-11T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/are-you-an-innovator-11.html</loc>
		<lastmod>2008-01-09T13:32:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/something-for-nothing-free-drugs-courtesy-of-big-pharma-7.html</loc>
		<lastmod>2008-01-02T11:02:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/bioethics-of-animal-testing-7.html</loc>
		<lastmod>2007-12-26T00:20:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/alarmist-news-alters-public-perception-of-risk-3.html</loc>
		<lastmod>2007-12-23T11:40:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/product-of-natureor-not-3.html</loc>
		<lastmod>2007-12-19T10:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/whole-cells-versus-enzymes-for-bioproduct-processes-2.html</loc>
		<lastmod>2007-12-17T12:13:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/career-options-in-biotechnology-3.html</loc>
		<lastmod>2007-12-13T23:32:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech-highlights-2007.html</loc>
		<lastmod>2007-12-12T00:20:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/technology-transfer-is-a-project-in-itself-7.html</loc>
		<lastmod>2007-12-04T23:14:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/cgmp-facilities-in-demand-for-drugs-entering-clinical-trials-2.html</loc>
		<lastmod>2007-12-02T15:45:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/response-to-primate-clones-alarming-2.html</loc>
		<lastmod>2007-11-30T16:06:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gently-used-lab-equipment.html</loc>
		<lastmod>2007-11-28T14:26:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech-research-not-just-a-money-grab-3.html</loc>
		<lastmod>2007-11-24T16:57:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotech-research-not-just-a-money-grab-4.html</loc>
		<lastmod>2007-11-24T16:57:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/swot-analysis-and-your-business-plan.html</loc>
		<lastmod>2007-11-21T10:52:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/swot-analysis-and-your-business-plan-3.html</loc>
		<lastmod>2007-11-21T10:52:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/intellectual-property-and-cpos-2.html</loc>
		<lastmod>2007-11-19T13:38:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/big-pharma-not-into-discovery-4.html</loc>
		<lastmod>2007-11-14T13:53:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/plan-expression-systems-early-on-2.html</loc>
		<lastmod>2007-11-12T12:53:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/71.html</loc>
		<lastmod>2007-11-05T16:50:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/establishing-milestones-3.html</loc>
		<lastmod>2007-11-05T16:50:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/establishing-milestones-4.html</loc>
		<lastmod>2007-11-05T16:50:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/will-marker-assisted-selection-reduce-poverty.html</loc>
		<lastmod>2007-11-02T12:30:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/will-marker-assisted-selection-reduce-poverty-2.html</loc>
		<lastmod>2007-11-02T12:30:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sitemap/</loc>
		<lastmod>2007-11-01T15:20:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/legal/</loc>
		<lastmod>2007-11-01T15:19:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/archives/</loc>
		<lastmod>2007-11-01T15:09:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tramadol-fast-melt.html</loc>
		<lastmod>2007-11-01T14:46:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisition-of-hospital-pharmaceutical-products-for-the-uk-market.html</loc>
		<lastmod>2007-11-01T14:46:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/acquisition-of-established-pharmaceuticals-in-the-uk-market.html</loc>
		<lastmod>2007-11-01T14:46:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/apomorphine-levopromazine-injections.html</loc>
		<lastmod>2007-11-01T14:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/anti-il-2-mt204-mab-for-the-treatment-of-inflammatory-and-autoimmune-diseases.html</loc>
		<lastmod>2007-11-01T14:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/in-license-or-acquire-pain-control-gi-and-cns-brands-and-companies.html</loc>
		<lastmod>2007-11-01T14:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/xgel-polymer-technology.html</loc>
		<lastmod>2007-11-01T14:45:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/licensing-in-biotechnology.html</loc>
		<lastmod>2007-11-01T14:36:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/glaxosmithkline-wins-court-order-halting-new-us-patent-rules.html</loc>
		<lastmod>2007-10-31T22:50:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/grids-work-like-a-charmm-for-molecular-dynamics.html</loc>
		<lastmod>2007-10-31T22:40:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/memo-finds-fda-limited-in-foreign-firm-oversight.html</loc>
		<lastmod>2007-10-31T00:08:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/gov-patrick-massachusetts-is-losing-edge-in-biotech.html</loc>
		<lastmod>2007-10-31T00:01:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/chinese-chemicals-flow-unchecked-to-world-drug-market.html</loc>
		<lastmod>2007-10-30T23:52:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/hire-a-consultant-for-your-outsourcing-needs.html</loc>
		<lastmod>2007-10-30T14:39:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/new-lasers-peer-into-cells.html</loc>
		<lastmod>2007-10-30T03:21:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biogen-gets-a-dose-of-skepticism.html</loc>
		<lastmod>2007-10-29T23:37:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/participants-left-uninformed-in-some-halted-medical-trials.html</loc>
		<lastmod>2007-10-29T23:33:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/who%e2%80%99s-in-charge-of-finding-cures.html</loc>
		<lastmod>2007-10-28T23:28:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/novartis-plans-700-million-singapore-biotech-plant.html</loc>
		<lastmod>2007-10-28T23:25:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/increasing-titer-worth-the-expense.html</loc>
		<lastmod>2007-10-26T12:59:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/outsourcing-options.html</loc>
		<lastmod>2007-10-25T18:10:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/outsourcing-for-biomedical-manufacturing.html</loc>
		<lastmod>2007-10-22T17:40:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/video-resources-for-teaching-middle-school-science.html</loc>
		<lastmod>2007-10-19T15:33:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/choosing-biotech-stocks.html</loc>
		<lastmod>2007-10-16T23:03:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/business-courses-compliment-a-science-degree.html</loc>
		<lastmod>2007-10-12T14:34:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/2007-nobel-prize-in-medicine-awarded.html</loc>
		<lastmod>2007-10-08T23:19:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/case-studies-to-teach-biotech.html</loc>
		<lastmod>2007-10-05T14:16:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/jj-to-cut-up-to-4-of-jobs-shut-facilities.html</loc>
		<lastmod>2007-10-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lilly-bucks-trend-in-biotech-pursuit.html</loc>
		<lastmod>2007-10-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/unsafe-at-the-fda.html</loc>
		<lastmod>2007-10-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/protein-distinguishes-fetal-and-adult-stem-cells.html</loc>
		<lastmod>2007-10-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/race-based-medicine-a-recipe-for-controversy.html</loc>
		<lastmod>2007-10-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/tgen-finds-genetic-links-to-lou-gehrigs-disease.html</loc>
		<lastmod>2007-10-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ibm-drops-price-on-supercomputer.html</loc>
		<lastmod>2007-10-04T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/biotechnology-and-space-research.html</loc>
		<lastmod>2007-10-01T11:11:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lupin-announces-approval-of-ceftriaxone-10g-vials.html</loc>
		<lastmod>2006-09-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/healthsonix-achieves-milestone-of-over-107000-sound-pressure-wavetreatments.html</loc>
		<lastmod>2006-09-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/inviragen-announces-exclusive-patent-license-agreement-with-the-centers-for-disease-control.html</loc>
		<lastmod>2006-09-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/sixth-us-patent-awarded-to-sru-biosystems.html</loc>
		<lastmod>2006-09-14T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/targeted-genetics-enhances-patent-portfolio-related-to-aav-serotype-1.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/unimed-pharmaceuticals-inc-settles-androgelr-litigation-with-watson-pharmaceuticals-inc-and-paddock-laboratoriespar-pharmaceutical-companies-inc.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/watson-and-unimed-pharmaceuticals-inc-settle-lawsuit-over-androgelr-testosterone-gel.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/par-pharmaceutical-announces-agreement-with-unimed-pharmaceuticals-to-settle-androgelr-patent-litigation.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/power3-makes-extensive-medical-research-available-to-industry-partners-database-of-patient-samples-is-basis-for-identification-of-protein-biomarkers.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/research-and-markets-germany-has-a-strong-generic-manufacturing-sector-headed-by-three-main-companies-hexal-ratiopharm-and-stada-arzneimittel.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/respiratory-market-to-avoid-collapse-global-asthmacopd-sales-forecast-to-grow-to-over-30-billion-by-2012.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/idera-pharmaceuticals-announces-the-issuance-of-us-patent-claiming-compounds-that-target-toll-like-receptor-9.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/upstream-biosciences-inc-announces-provisional-patent-filing-ofovarian-cancer-biomarkers.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/ranbaxy-invalidates-pfizers-281-patent-in-the-netherlands.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/lux-biosciences-gains-exclusive-worldwide-license-for-polyarylate-patent-estate-from-rutgers-university-for-ophthalmic-use.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/vical-extends-patent-coverage-for-vaxfectintm-adjuvant-to-conventional-vaccines.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/court-in-the-netherlands-upholds-basic-lipitor-patent-prevents-launch-of-ranbaxy-product-before-november-2011.html</loc>
		<lastmod>2006-09-13T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/implantation-dun-dispositif-unique-de-monitorage-cardiaque-sans-fil-2.html</loc>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://biotechlicense.com/implantation-dun-dispositif-unique-de-monitorage-cardiaque-sans-fil.html</loc>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
</urlset>